#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Random Forest Based Classification of Alcohol Dependence Patients and Healthy Controls Using Resting State MRI
#Text=Currently, classification of alcohol use disorder (AUD) is made on clinical grounds; however, robust evidence shows that chronic alcohol use leads to neurochemical and neurocircuitry adaptations.
1-1	0-6	Random	_	
1-2	7-13	Forest	_	
1-3	14-19	Based	_	
1-4	20-34	Classification	_	
1-5	35-37	of	_	
1-6	38-45	Alcohol	_	
1-7	46-56	Dependence	_	
1-8	57-65	Patients	_	
1-9	66-69	and	_	
1-10	70-77	Healthy	_	
1-11	78-86	Controls	_	
1-12	87-92	Using	_	
1-13	93-100	Resting	_	
1-14	101-106	State	_	
1-15	107-110	MRI	_	
1-16	111-120	Currently	_	
1-17	120-121	,	_	
1-18	122-136	classification	_	
1-19	137-139	of	_	
1-20	140-147	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]	
1-21	148-151	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]	
1-22	152-160	disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]	
1-23	161-162	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]	
1-24	162-165	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]	
1-25	165-166	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]	
1-26	167-169	is	_	
1-27	170-174	made	_	
1-28	175-177	on	_	
1-29	178-186	clinical	_	
1-30	187-194	grounds	_	
1-31	194-195	;	_	
1-32	196-203	however	_	
1-33	203-204	,	_	
1-34	205-211	robust	_	
1-35	212-220	evidence	_	
1-36	221-226	shows	_	
1-37	227-231	that	_	
1-38	232-239	chronic	_	
1-39	240-247	alcohol	_	
1-40	248-251	use	_	
1-41	252-257	leads	_	
1-42	258-260	to	_	
1-43	261-274	neurochemical	_	
1-44	275-278	and	_	
1-45	279-293	neurocircuitry	_	
1-46	294-305	adaptations	_	
1-47	305-306	.	_	

#Text=Identifications of the neuronal networks that are affected by alcohol would provide a more systematic way of diagnosis and provide novel insights into the pathophysiology of AUD.
2-1	307-322	Identifications	_	
2-2	323-325	of	_	
2-3	326-329	the	_	
2-4	330-338	neuronal	_	
2-5	339-347	networks	_	
2-6	348-352	that	_	
2-7	353-356	are	_	
2-8	357-365	affected	_	
2-9	366-368	by	_	
2-10	369-376	alcohol	_	
2-11	377-382	would	_	
2-12	383-390	provide	_	
2-13	391-392	a	_	
2-14	393-397	more	_	
2-15	398-408	systematic	_	
2-16	409-412	way	_	
2-17	413-415	of	_	
2-18	416-425	diagnosis	_	
2-19	426-429	and	_	
2-20	430-437	provide	_	
2-21	438-443	novel	_	
2-22	444-452	insights	_	
2-23	453-457	into	_	
2-24	458-461	the	_	
2-25	462-477	pathophysiology	_	
2-26	478-480	of	_	
2-27	481-484	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
2-28	484-485	.	_	

#Text=In this study, we identified network-level brain features of AUD, and further quantified resting-state within-network, and between-network connectivity features in a multivariate fashion that are classifying AUD, thus providing additional information about how each network contributes to alcoholism.
3-1	486-488	In	_	
3-2	489-493	this	_	
3-3	494-499	study	_	
3-4	499-500	,	_	
3-5	501-503	we	_	
3-6	504-514	identified	_	
3-7	515-528	network-level	_	
3-8	529-534	brain	_	
3-9	535-543	features	_	
3-10	544-546	of	_	
3-11	547-550	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
3-12	550-551	,	_	
3-13	552-555	and	_	
3-14	556-563	further	_	
3-15	564-574	quantified	_	
3-16	575-588	resting-state	_	
3-17	589-603	within-network	_	
3-18	603-604	,	_	
3-19	605-608	and	_	
3-20	609-624	between-network	_	
3-21	625-637	connectivity	_	
3-22	638-646	features	_	
3-23	647-649	in	_	
3-24	650-651	a	_	
3-25	652-664	multivariate	_	
3-26	665-672	fashion	_	
3-27	673-677	that	_	
3-28	678-681	are	_	
3-29	682-693	classifying	_	
3-30	694-697	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
3-31	697-698	,	_	
3-32	699-703	thus	_	
3-33	704-713	providing	_	
3-34	714-724	additional	_	
3-35	725-736	information	_	
3-36	737-742	about	_	
3-37	743-746	how	_	
3-38	747-751	each	_	
3-39	752-759	network	_	
3-40	760-771	contributes	_	
3-41	772-774	to	_	
3-42	775-785	alcoholism	_	
3-43	785-786	.	_	

#Text=Resting-state fMRI were collected from 92 individuals (46 controls and 46 AUDs).
4-1	787-800	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]	
4-2	801-805	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]	
4-3	806-810	were	_	
4-4	811-820	collected	_	
4-5	821-825	from	_	
4-6	826-828	92	_	
4-7	829-840	individuals	_	
4-8	841-842	(	_	
4-9	842-844	46	_	
4-10	845-853	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
4-11	854-857	and	_	
4-12	858-860	46	_	
4-13	861-865	AUDs	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
4-14	865-866	)	_	
4-15	866-867	.	_	

#Text=Probabilistic Independent Component Analysis (PICA) was used to extract brain functional networks and their corresponding time-course for AUD and controls.
5-1	868-881	Probabilistic	_	
5-2	882-893	Independent	_	
5-3	894-903	Component	_	
5-4	904-912	Analysis	_	
5-5	913-914	(	_	
5-6	914-918	PICA	_	
5-7	918-919	)	_	
5-8	920-923	was	_	
5-9	924-928	used	_	
5-10	929-931	to	_	
5-11	932-939	extract	_	
5-12	940-945	brain	_	
5-13	946-956	functional	_	
5-14	957-965	networks	_	
5-15	966-969	and	_	
5-16	970-975	their	_	
5-17	976-989	corresponding	_	
5-18	990-1001	time-course	_	
5-19	1002-1005	for	_	
5-20	1006-1009	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
5-21	1010-1013	and	_	
5-22	1014-1022	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
5-23	1022-1023	.	_	

#Text=Both within-network connectivity for each network and between-network connectivity for each pair of networks were used as features.
6-1	1024-1028	Both	_	
6-2	1029-1043	within-network	_	
6-3	1044-1056	connectivity	_	
6-4	1057-1060	for	_	
6-5	1061-1065	each	_	
6-6	1066-1073	network	_	
6-7	1074-1077	and	_	
6-8	1078-1093	between-network	_	
6-9	1094-1106	connectivity	_	
6-10	1107-1110	for	_	
6-11	1111-1115	each	_	
6-12	1116-1120	pair	_	
6-13	1121-1123	of	_	
6-14	1124-1132	networks	_	
6-15	1133-1137	were	_	
6-16	1138-1142	used	_	
6-17	1143-1145	as	_	
6-18	1146-1154	features	_	
6-19	1154-1155	.	_	

#Text=Random forest was applied for pattern classification.
7-1	1156-1162	Random	_	
7-2	1163-1169	forest	_	
7-3	1170-1173	was	_	
7-4	1174-1181	applied	_	
7-5	1182-1185	for	_	
7-6	1186-1193	pattern	_	
7-7	1194-1208	classification	_	
7-8	1208-1209	.	_	

#Text=The results showed that within-networks features were able to identify AUD and control with 87.0% accuracy and 90.5% precision, respectively.
8-1	1210-1213	The	_	
8-2	1214-1221	results	_	
8-3	1222-1228	showed	_	
8-4	1229-1233	that	_	
8-5	1234-1249	within-networks	_	
8-6	1250-1258	features	_	
8-7	1259-1263	were	_	
8-8	1264-1268	able	_	
8-9	1269-1271	to	_	
8-10	1272-1280	identify	_	
8-11	1281-1284	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
8-12	1285-1288	and	_	
8-13	1289-1296	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
8-14	1297-1301	with	_	
8-15	1302-1307	87.0%	_	
8-16	1308-1316	accuracy	_	
8-17	1317-1320	and	_	
8-18	1321-1326	90.5%	_	
8-19	1327-1336	precision	_	
8-20	1336-1337	,	_	
8-21	1338-1350	respectively	_	
8-22	1350-1351	.	_	

#Text=Networks that were most informative included two; Executive Control Networks (ECN), and Reward Network (RN).
9-1	1352-1360	Networks	_	
9-2	1361-1365	that	_	
9-3	1366-1370	were	_	
9-4	1371-1375	most	_	
9-5	1376-1387	informative	_	
9-6	1388-1396	included	_	
9-7	1397-1400	two	_	
9-8	1400-1401	;	_	
9-9	1402-1411	Executive	_	
9-10	1412-1419	Control	_	
9-11	1420-1428	Networks	_	
9-12	1429-1430	(	_	
9-13	1430-1433	ECN	_	
9-14	1433-1434	)	_	
9-15	1434-1435	,	_	
9-16	1436-1439	and	_	
9-17	1440-1446	Reward	_	
9-18	1447-1454	Network	_	
9-19	1455-1456	(	_	
9-20	1456-1458	RN	_	
9-21	1458-1459	)	_	
9-22	1459-1460	.	_	

#Text=The between-network features achieved 67.4% accuracy and 70.0% precision.
10-1	1461-1464	The	_	
10-2	1465-1480	between-network	_	
10-3	1481-1489	features	_	
10-4	1490-1498	achieved	_	
10-5	1499-1504	67.4%	_	
10-6	1505-1513	accuracy	_	
10-7	1514-1517	and	_	
10-8	1518-1523	70.0%	_	
10-9	1524-1533	precision	_	
10-10	1533-1534	.	_	

#Text=The between-network connectivity between RN-Default Mode Network (DMN) and RN-ECN contribute the most to the prediction.
11-1	1535-1538	The	_	
11-2	1539-1554	between-network	_	
11-3	1555-1567	connectivity	_	
11-4	1568-1575	between	_	
11-5	1576-1586	RN-Default	_	
11-6	1587-1591	Mode	_	
11-7	1592-1599	Network	_	
11-8	1600-1601	(	_	
11-9	1601-1604	DMN	_	
11-10	1604-1605	)	_	
11-11	1606-1609	and	_	
11-12	1610-1616	RN-ECN	_	
11-13	1617-1627	contribute	_	
11-14	1628-1631	the	_	
11-15	1632-1636	most	_	
11-16	1637-1639	to	_	
11-17	1640-1643	the	_	
11-18	1644-1654	prediction	_	
11-19	1654-1655	.	_	

#Text=In conclusion, within-network functional connectivity offered maximal information for AUD classification, when compared with between-network connectivity.
12-1	1656-1658	In	_	
12-2	1659-1669	conclusion	_	
12-3	1669-1670	,	_	
12-4	1671-1685	within-network	_	
12-5	1686-1696	functional	_	
12-6	1697-1709	connectivity	_	
12-7	1710-1717	offered	_	
12-8	1718-1725	maximal	_	
12-9	1726-1737	information	_	
12-10	1738-1741	for	_	
12-11	1742-1745	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
12-12	1746-1760	classification	_	
12-13	1760-1761	,	_	
12-14	1762-1766	when	_	
12-15	1767-1775	compared	_	
12-16	1776-1780	with	_	
12-17	1781-1796	between-network	_	
12-18	1797-1809	connectivity	_	
12-19	1809-1810	.	_	

#Text=Further, our results suggest that connectivity within the ECN and RN are informative in classifying AUD.
13-1	1811-1818	Further	_	
13-2	1818-1819	,	_	
13-3	1820-1823	our	_	
13-4	1824-1831	results	_	
13-5	1832-1839	suggest	_	
13-6	1840-1844	that	_	
13-7	1845-1857	connectivity	_	
13-8	1858-1864	within	_	
13-9	1865-1868	the	_	
13-10	1869-1872	ECN	_	
13-11	1873-1876	and	_	
13-12	1877-1879	RN	_	
13-13	1880-1883	are	_	
13-14	1884-1895	informative	_	
13-15	1896-1898	in	_	
13-16	1899-1910	classifying	_	
13-17	1911-1914	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
13-18	1914-1915	.	_	

#Text=Our findings suggest that machine-learning algorithms provide an alternative technique to quantify large-scale network differences and offer new insights into the identification of potential biomarkers for the clinical diagnosis of AUD.
14-1	1916-1919	Our	_	
14-2	1920-1928	findings	_	
14-3	1929-1936	suggest	_	
14-4	1937-1941	that	_	
14-5	1942-1958	machine-learning	_	
14-6	1959-1969	algorithms	_	
14-7	1970-1977	provide	_	
14-8	1978-1980	an	_	
14-9	1981-1992	alternative	_	
14-10	1993-2002	technique	_	
14-11	2003-2005	to	_	
14-12	2006-2014	quantify	_	
14-13	2015-2026	large-scale	_	
14-14	2027-2034	network	_	
14-15	2035-2046	differences	_	
14-16	2047-2050	and	_	
14-17	2051-2056	offer	_	
14-18	2057-2060	new	_	
14-19	2061-2069	insights	_	
14-20	2070-2074	into	_	
14-21	2075-2078	the	_	
14-22	2079-2093	identification	_	
14-23	2094-2096	of	_	
14-24	2097-2106	potential	_	
14-25	2107-2117	biomarkers	_	
14-26	2118-2121	for	_	
14-27	2122-2125	the	_	
14-28	2126-2134	clinical	_	
14-29	2135-2144	diagnosis	_	
14-30	2145-2147	of	_	
14-31	2148-2151	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
14-32	2151-2152	.	_	

#Text=Introduction
#Text=Alcohol dependence is a chronic relapsing disorder with an impulsive drive toward alcohol consumption and an inability to inhibit its consumption despite negative consequences.
15-1	2153-2165	Introduction	_	
15-2	2166-2173	Alcohol	_	
15-3	2174-2184	dependence	_	
15-4	2185-2187	is	_	
15-5	2188-2189	a	_	
15-6	2190-2197	chronic	_	
15-7	2198-2207	relapsing	_	
15-8	2208-2216	disorder	_	
15-9	2217-2221	with	_	
15-10	2222-2224	an	_	
15-11	2225-2234	impulsive	_	
15-12	2235-2240	drive	_	
15-13	2241-2247	toward	_	
15-14	2248-2255	alcohol	_	
15-15	2256-2267	consumption	_	
15-16	2268-2271	and	_	
15-17	2272-2274	an	_	
15-18	2275-2284	inability	_	
15-19	2285-2287	to	_	
15-20	2288-2295	inhibit	_	
15-21	2296-2299	its	_	
15-22	2300-2311	consumption	_	
15-23	2312-2319	despite	_	
15-24	2320-2328	negative	_	
15-25	2329-2341	consequences	_	
15-26	2341-2342	.	_	

#Text=Currently, AUD is a diagnosis that is based on clinical history, not based on underlying neurobiology or neuronal network abnormalities.
16-1	2343-2352	Currently	_	
16-2	2352-2353	,	_	
16-3	2354-2357	AUD	_	
16-4	2358-2360	is	_	
16-5	2361-2362	a	_	
16-6	2363-2372	diagnosis	_	
16-7	2373-2377	that	_	
16-8	2378-2380	is	_	
16-9	2381-2386	based	_	
16-10	2387-2389	on	_	
16-11	2390-2398	clinical	_	
16-12	2399-2406	history	_	
16-13	2406-2407	,	_	
16-14	2408-2411	not	_	
16-15	2412-2417	based	_	
16-16	2418-2420	on	_	
16-17	2421-2431	underlying	_	
16-18	2432-2444	neurobiology	_	
16-19	2445-2447	or	_	
16-20	2448-2456	neuronal	_	
16-21	2457-2464	network	_	
16-22	2465-2478	abnormalities	_	
16-23	2478-2479	.	_	

#Text=It is important to identify the brain biomarkers that can be used to improve diagnostic identification of alcoholism at various stages and predicting treatment outcomes.
17-1	2480-2482	It	_	
17-2	2483-2485	is	_	
17-3	2486-2495	important	_	
17-4	2496-2498	to	_	
17-5	2499-2507	identify	_	
17-6	2508-2511	the	_	
17-7	2512-2517	brain	_	
17-8	2518-2528	biomarkers	_	
17-9	2529-2533	that	_	
17-10	2534-2537	can	_	
17-11	2538-2540	be	_	
17-12	2541-2545	used	_	
17-13	2546-2548	to	_	
17-14	2549-2556	improve	_	
17-15	2557-2567	diagnostic	_	
17-16	2568-2582	identification	_	
17-17	2583-2585	of	_	
17-18	2586-2596	alcoholism	_	
17-19	2597-2599	at	_	
17-20	2600-2607	various	_	
17-21	2608-2614	stages	_	
17-22	2615-2618	and	_	
17-23	2619-2629	predicting	_	
17-24	2630-2639	treatment	_	
17-25	2640-2648	outcomes	_	
17-26	2648-2649	.	_	

#Text=There is growing interest in studying functional connectivity among brain networks in alcoholism and drug addiction.
18-1	2650-2655	There	_	
18-2	2656-2658	is	_	
18-3	2659-2666	growing	_	
18-4	2667-2675	interest	_	
18-5	2676-2678	in	_	
18-6	2679-2687	studying	_	
18-7	2688-2698	functional	_	
18-8	2699-2711	connectivity	_	
18-9	2712-2717	among	_	
18-10	2718-2723	brain	_	
18-11	2724-2732	networks	_	
18-12	2733-2735	in	_	
18-13	2736-2746	alcoholism	_	
18-14	2747-2750	and	_	
18-15	2751-2755	drug	_	
18-16	2756-2765	addiction	_	
18-17	2765-2766	.	_	

#Text=Resting state functional connectivity (rs-FC), which is measured by temporal coherence in low-frequency fluctuations of distinct brain regions, has been shown to be an effective method in studying functional organization of the brain.
19-1	2767-2774	Resting	_	
19-2	2775-2780	state	_	
19-3	2781-2791	functional	_	
19-4	2792-2804	connectivity	_	
19-5	2805-2806	(	_	
19-6	2806-2811	rs-FC	_	
19-7	2811-2812	)	_	
19-8	2812-2813	,	_	
19-9	2814-2819	which	_	
19-10	2820-2822	is	_	
19-11	2823-2831	measured	_	
19-12	2832-2834	by	_	
19-13	2835-2843	temporal	_	
19-14	2844-2853	coherence	_	
19-15	2854-2856	in	_	
19-16	2857-2870	low-frequency	_	
19-17	2871-2883	fluctuations	_	
19-18	2884-2886	of	_	
19-19	2887-2895	distinct	_	
19-20	2896-2901	brain	_	
19-21	2902-2909	regions	_	
19-22	2909-2910	,	_	
19-23	2911-2914	has	_	
19-24	2915-2919	been	_	
19-25	2920-2925	shown	_	
19-26	2926-2928	to	_	
19-27	2929-2931	be	_	
19-28	2932-2934	an	_	
19-29	2935-2944	effective	_	
19-30	2945-2951	method	_	
19-31	2952-2954	in	_	
19-32	2955-2963	studying	_	
19-33	2964-2974	functional	_	
19-34	2975-2987	organization	_	
19-35	2988-2990	of	_	
19-36	2991-2994	the	_	
19-37	2995-3000	brain	_	
19-38	3000-3001	.	_	

#Text=Researchers have shown disrupted functional integration is associated with chronic alcohol use by using traditional group-level analysis.
20-1	3002-3013	Researchers	_	
20-2	3014-3018	have	_	
20-3	3019-3024	shown	_	
20-4	3025-3034	disrupted	_	
20-5	3035-3045	functional	_	
20-6	3046-3057	integration	_	
20-7	3058-3060	is	_	
20-8	3061-3071	associated	_	
20-9	3072-3076	with	_	
20-10	3077-3084	chronic	_	
20-11	3085-3092	alcohol	_	
20-12	3093-3096	use	_	
20-13	3097-3099	by	_	
20-14	3100-3105	using	_	
20-15	3106-3117	traditional	_	
20-16	3118-3129	group-level	_	
20-17	3130-3138	analysis	_	
20-18	3138-3139	.	_	

#Text=However, the group-level analysis cannot quantify the complex interactions of both within- and between-network connectivity and identify the subtle difference of each individual.
21-1	3140-3147	However	_	
21-2	3147-3148	,	_	
21-3	3149-3152	the	_	
21-4	3153-3164	group-level	_	
21-5	3165-3173	analysis	_	
21-6	3174-3180	cannot	_	
21-7	3181-3189	quantify	_	
21-8	3190-3193	the	_	
21-9	3194-3201	complex	_	
21-10	3202-3214	interactions	_	
21-11	3215-3217	of	_	
21-12	3218-3222	both	_	
21-13	3223-3229	within	_	
21-14	3229-3230	-	_	
21-15	3231-3234	and	_	
21-16	3235-3250	between-network	_	
21-17	3251-3263	connectivity	_	
21-18	3264-3267	and	_	
21-19	3268-3276	identify	_	
21-20	3277-3280	the	_	
21-21	3281-3287	subtle	_	
21-22	3288-3298	difference	_	
21-23	3299-3301	of	_	
21-24	3302-3306	each	_	
21-25	3307-3317	individual	_	
21-26	3317-3318	.	_	

#Text=Machine-learning algorithms provide alternative tools to look into multivariate patterns in the data, and help us move from group-level analysis to case-by-case individual-level analysis.
22-1	3319-3335	Machine-learning	_	
22-2	3336-3346	algorithms	_	
22-3	3347-3354	provide	_	
22-4	3355-3366	alternative	_	
22-5	3367-3372	tools	_	
22-6	3373-3375	to	_	
22-7	3376-3380	look	_	
22-8	3381-3385	into	_	
22-9	3386-3398	multivariate	_	
22-10	3399-3407	patterns	_	
22-11	3408-3410	in	_	
22-12	3411-3414	the	_	
22-13	3415-3419	data	_	
22-14	3419-3420	,	_	
22-15	3421-3424	and	_	
22-16	3425-3429	help	_	
22-17	3430-3432	us	_	
22-18	3433-3437	move	_	
22-19	3438-3442	from	_	
22-20	3443-3454	group-level	_	
22-21	3455-3463	analysis	_	
22-22	3464-3466	to	_	
22-23	3467-3479	case-by-case	_	
22-24	3480-3496	individual-level	_	
22-25	3497-3505	analysis	_	
22-26	3505-3506	.	_	

#Text=Machine-learning approach has been used on resting state fMRI data in classifying schizophrenia, autism, Alzheimer’s disease, attention-deficit/hyperactivity disorder (ADHD), Parkinson disease, major depressive disorder, and epilepsy etc.
23-1	3507-3523	Machine-learning	_	
23-2	3524-3532	approach	_	
23-3	3533-3536	has	_	
23-4	3537-3541	been	_	
23-5	3542-3546	used	_	
23-6	3547-3549	on	_	
23-7	3550-3557	resting	_	
23-8	3558-3563	state	_	
23-9	3564-3568	fMRI	_	
23-10	3569-3573	data	_	
23-11	3574-3576	in	_	
23-12	3577-3588	classifying	_	
23-13	3589-3602	schizophrenia	_	
23-14	3602-3603	,	_	
23-15	3604-3610	autism	_	
23-16	3610-3611	,	_	
23-17	3612-3621	Alzheimer	_	
23-18	3621-3622	’	_	
23-19	3622-3623	s	_	
23-20	3624-3631	disease	_	
23-21	3631-3632	,	_	
23-22	3633-3650	attention-deficit	_	
23-23	3650-3651	/	_	
23-24	3651-3664	hyperactivity	_	
23-25	3665-3673	disorder	_	
23-26	3674-3675	(	_	
23-27	3675-3679	ADHD	_	
23-28	3679-3680	)	_	
23-29	3680-3681	,	_	
23-30	3682-3691	Parkinson	_	
23-31	3692-3699	disease	_	
23-32	3699-3700	,	_	
23-33	3701-3706	major	_	
23-34	3707-3717	depressive	_	
23-35	3718-3726	disorder	_	
23-36	3726-3727	,	_	
23-37	3728-3731	and	_	
23-38	3732-3740	epilepsy	_	
23-39	3741-3744	etc	_	
23-40	3744-3745	.	_	

#Text=To date, only a few studies have explored the addiction field using machine learning approaches, for example, in heavy cannabis users, Smokers, and heroin-dependent individuals.
24-1	3746-3748	To	_	
24-2	3749-3753	date	_	
24-3	3753-3754	,	_	
24-4	3755-3759	only	_	
24-5	3760-3761	a	_	
24-6	3762-3765	few	_	
24-7	3766-3773	studies	_	
24-8	3774-3778	have	_	
24-9	3779-3787	explored	_	
24-10	3788-3791	the	_	
24-11	3792-3801	addiction	_	
24-12	3802-3807	field	_	
24-13	3808-3813	using	_	
24-14	3814-3821	machine	_	
24-15	3822-3830	learning	_	
24-16	3831-3841	approaches	_	
24-17	3841-3842	,	_	
24-18	3843-3846	for	_	
24-19	3847-3854	example	_	
24-20	3854-3855	,	_	
24-21	3856-3858	in	_	
24-22	3859-3864	heavy	_	
24-23	3865-3873	cannabis	_	
24-24	3874-3879	users	_	
24-25	3879-3880	,	_	
24-26	3881-3888	Smokers	_	
24-27	3888-3889	,	_	
24-28	3890-3893	and	_	
24-29	3894-3910	heroin-dependent	_	
24-30	3911-3922	individuals	_	
24-31	3922-3923	.	_	

#Text=However, no study to date has explored rs-FC using machine learning in classifying AUD.
25-1	3924-3931	However	_	
25-2	3931-3932	,	_	
25-3	3933-3935	no	_	
25-4	3936-3941	study	_	
25-5	3942-3944	to	_	
25-6	3945-3949	date	_	
25-7	3950-3953	has	_	
25-8	3954-3962	explored	_	
25-9	3963-3968	rs-FC	_	
25-10	3969-3974	using	_	
25-11	3975-3982	machine	_	
25-12	3983-3991	learning	_	
25-13	3992-3994	in	_	
25-14	3995-4006	classifying	_	
25-15	4007-4010	AUD	_	
25-16	4010-4011	.	_	

#Text=In this study, we sought to identify both within-network and between-network connectivity features in a multivariate fashion that are predictive of alcohol dependence.
26-1	4012-4014	In	_	
26-2	4015-4019	this	_	
26-3	4020-4025	study	_	
26-4	4025-4026	,	_	
26-5	4027-4029	we	_	
26-6	4030-4036	sought	_	
26-7	4037-4039	to	_	
26-8	4040-4048	identify	_	
26-9	4049-4053	both	_	
26-10	4054-4068	within-network	_	
26-11	4069-4072	and	_	
26-12	4073-4088	between-network	_	
26-13	4089-4101	connectivity	_	
26-14	4102-4110	features	_	
26-15	4111-4113	in	_	
26-16	4114-4115	a	_	
26-17	4116-4128	multivariate	_	
26-18	4129-4136	fashion	_	
26-19	4137-4141	that	_	
26-20	4142-4145	are	_	
26-21	4146-4156	predictive	_	
26-22	4157-4159	of	_	
26-23	4160-4167	alcohol	_	
26-24	4168-4178	dependence	_	
26-25	4178-4179	.	_	

#Text=We hypothesized that the machine-learning algorithms can identify the biomarkers which are involved in AUD.
27-1	4180-4182	We	_	
27-2	4183-4195	hypothesized	_	
27-3	4196-4200	that	_	
27-4	4201-4204	the	_	
27-5	4205-4221	machine-learning	_	
27-6	4222-4232	algorithms	_	
27-7	4233-4236	can	_	
27-8	4237-4245	identify	_	
27-9	4246-4249	the	_	
27-10	4250-4260	biomarkers	_	
27-11	4261-4266	which	_	
27-12	4267-4270	are	_	
27-13	4271-4279	involved	_	
27-14	4280-4282	in	_	
27-15	4283-4286	AUD	_	
27-16	4286-4287	.	_	

#Text=Furthermore, we also hypothesized that subtle differences in the within-network connectivity and between-network connectivity between AUD and controls during the resting state could be revealed and provide quantitative information about how each network contributes to AUD.
28-1	4288-4299	Furthermore	_	
28-2	4299-4300	,	_	
28-3	4301-4303	we	_	
28-4	4304-4308	also	_	
28-5	4309-4321	hypothesized	_	
28-6	4322-4326	that	_	
28-7	4327-4333	subtle	_	
28-8	4334-4345	differences	_	
28-9	4346-4348	in	_	
28-10	4349-4352	the	_	
28-11	4353-4367	within-network	_	
28-12	4368-4380	connectivity	_	
28-13	4381-4384	and	_	
28-14	4385-4400	between-network	_	
28-15	4401-4413	connectivity	_	
28-16	4414-4421	between	_	
28-17	4422-4425	AUD	_	
28-18	4426-4429	and	_	
28-19	4430-4438	controls	_	
28-20	4439-4445	during	_	
28-21	4446-4449	the	_	
28-22	4450-4457	resting	_	
28-23	4458-4463	state	_	
28-24	4464-4469	could	_	
28-25	4470-4472	be	_	
28-26	4473-4481	revealed	_	
28-27	4482-4485	and	_	
28-28	4486-4493	provide	_	
28-29	4494-4506	quantitative	_	
28-30	4507-4518	information	_	
28-31	4519-4524	about	_	
28-32	4525-4528	how	_	
28-33	4529-4533	each	_	
28-34	4534-4541	network	_	
28-35	4542-4553	contributes	_	
28-36	4554-4556	to	_	
28-37	4557-4560	AUD	_	
28-38	4560-4561	.	_	

#Text=More specifically, we are interested in answering the following questions: 1) whether rs-FC features are able to distinguish between AUD and controls; 2) Which brain-based features are able to diagnose and are potentially predictive of alcohol dependence?
29-1	4562-4566	More	_	
29-2	4567-4579	specifically	_	
29-3	4579-4580	,	_	
29-4	4581-4583	we	_	
29-5	4584-4587	are	_	
29-6	4588-4598	interested	_	
29-7	4599-4601	in	_	
29-8	4602-4611	answering	_	
29-9	4612-4615	the	_	
29-10	4616-4625	following	_	
29-11	4626-4635	questions	_	
29-12	4635-4636	:	_	
29-13	4637-4638	1	_	
29-14	4638-4639	)	_	
29-15	4640-4647	whether	_	
29-16	4648-4653	rs-FC	_	
29-17	4654-4662	features	_	
29-18	4663-4666	are	_	
29-19	4667-4671	able	_	
29-20	4672-4674	to	_	
29-21	4675-4686	distinguish	_	
29-22	4687-4694	between	_	
29-23	4695-4698	AUD	_	
29-24	4699-4702	and	_	
29-25	4703-4711	controls	_	
29-26	4711-4712	;	_	
29-27	4713-4714	2	_	
29-28	4714-4715	)	_	
29-29	4716-4721	Which	_	
29-30	4722-4733	brain-based	_	
29-31	4734-4742	features	_	
29-32	4743-4746	are	_	
29-33	4747-4751	able	_	
29-34	4752-4754	to	_	
29-35	4755-4763	diagnose	_	
29-36	4764-4767	and	_	
29-37	4768-4771	are	_	
29-38	4772-4783	potentially	_	
29-39	4784-4794	predictive	_	
29-40	4795-4797	of	_	
29-41	4798-4805	alcohol	_	
29-42	4806-4816	dependence	_	
29-43	4816-4817	?	_	

#Text=and 3) Can we quantify how well they identify AUD and what are the best neuronal predictors of AUD?
30-1	4818-4821	and	_	
30-2	4822-4823	3	_	
30-3	4823-4824	)	_	
30-4	4825-4828	Can	_	
30-5	4829-4831	we	_	
30-6	4832-4840	quantify	_	
30-7	4841-4844	how	_	
30-8	4845-4849	well	_	
30-9	4850-4854	they	_	
30-10	4855-4863	identify	_	
30-11	4864-4867	AUD	_	
30-12	4868-4871	and	_	
30-13	4872-4876	what	_	
30-14	4877-4880	are	_	
30-15	4881-4884	the	_	
30-16	4885-4889	best	_	
30-17	4890-4898	neuronal	_	
30-18	4899-4909	predictors	_	
30-19	4910-4912	of	_	
30-20	4913-4916	AUD	_	
30-21	4916-4917	?	_	

#Text=Methods and Materials
#Text=2.1 Participants
#Text=Forty-six controls and 46 short-term abstinent patients were recruited by the National Institute on Alcohol Abuse and Alcoholism part of the National Institutes of Health, USA (Table 1).
31-1	4918-4925	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
31-2	4926-4929	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
31-3	4930-4939	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
31-4	4940-4943	2.1	_	
31-5	4944-4956	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-6	4957-4966	Forty-six	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-7	4967-4975	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
31-8	4976-4979	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-9	4980-4982	46	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-10	4983-4993	short-term	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-11	4994-5003	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-12	5004-5012	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-13	5013-5017	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-14	5018-5027	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-15	5028-5030	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-16	5031-5034	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-17	5035-5043	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-18	5044-5053	Institute	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-19	5054-5056	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-20	5057-5064	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-21	5065-5070	Abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-22	5071-5074	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-23	5075-5085	Alcoholism	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-24	5086-5090	part	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-25	5091-5093	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-26	5094-5097	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-27	5098-5106	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-28	5107-5117	Institutes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-29	5118-5120	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-30	5121-5127	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-31	5127-5128	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-32	5129-5132	USA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
31-33	5133-5134	(	_	
31-34	5134-5139	Table	_	
31-35	5140-5141	1	_	
31-36	5141-5142	)	_	
31-37	5142-5143	.	_	

#Text=Healthy controls were recruited through newspaper advertisements and information notices distributed in the Washington, D.C. metropolitan area.
32-1	5144-5151	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-2	5152-5160	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
32-3	5161-5165	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-4	5166-5175	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-5	5176-5183	through	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-6	5184-5193	newspaper	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-7	5194-5208	advertisements	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-8	5209-5212	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-9	5213-5224	information	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-10	5225-5232	notices	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-11	5233-5244	distributed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-12	5245-5247	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-13	5248-5251	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-14	5252-5262	Washington	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-15	5262-5263	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-16	5264-5267	D.C	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-17	5267-5268	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-18	5269-5281	metropolitan	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-19	5282-5286	area	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
32-20	5286-5287	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=Patients were recruited from the 1-SE inpatient alcohol withdrawal treatment unit at the National Institutes of Health Clinical Research Center in Bethesda, Maryland.
33-1	5288-5296	Patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-2	5297-5301	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-3	5302-5311	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-4	5312-5316	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-5	5317-5320	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-6	5321-5322	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-7	5322-5323	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-8	5323-5325	SE	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-9	5326-5335	inpatient	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-10	5336-5343	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-11	5344-5354	withdrawal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-12	5355-5364	treatment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-13	5365-5369	unit	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-14	5370-5372	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-15	5373-5376	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-16	5377-5385	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-17	5386-5396	Institutes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-18	5397-5399	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-19	5400-5406	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-20	5407-5415	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-21	5416-5424	Research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-22	5425-5431	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-23	5432-5434	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-24	5435-5443	Bethesda	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-25	5443-5444	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-26	5445-5453	Maryland	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
33-27	5453-5454	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=Alcohol detoxification procedure generally took 3 to 10 days after admission in the inpatient unit.
34-1	5455-5462	Alcohol	_	
34-2	5463-5477	detoxification	_	
34-3	5478-5487	procedure	_	
34-4	5488-5497	generally	_	
34-5	5498-5502	took	_	
34-6	5503-5504	3	_	
34-7	5505-5507	to	_	
34-8	5508-5510	10	_	
34-9	5511-5515	days	_	
34-10	5516-5521	after	_	
34-11	5522-5531	admission	_	
34-12	5532-5534	in	_	
34-13	5535-5538	the	_	
34-14	5539-5548	inpatient	_	
34-15	5549-5553	unit	_	
34-16	5553-5554	.	_	

#Text=The fMRI session was conducted following hospitalization for at least 1 week (7 to 43 days, Table 1).
35-1	5555-5558	The	_	
35-2	5559-5563	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
35-3	5564-5571	session	_	
35-4	5572-5575	was	_	
35-5	5576-5585	conducted	_	
35-6	5586-5595	following	_	
35-7	5596-5611	hospitalization	_	
35-8	5612-5615	for	_	
35-9	5616-5618	at	_	
35-10	5619-5624	least	_	
35-11	5625-5626	1	_	
35-12	5627-5631	week	_	
35-13	5632-5633	(	_	
35-14	5633-5634	7	_	
35-15	5635-5637	to	_	
35-16	5638-5640	43	_	
35-17	5641-5645	days	_	
35-18	5645-5646	,	_	
35-19	5647-5652	Table	_	
35-20	5653-5654	1	_	
35-21	5654-5655	)	_	
35-22	5655-5656	.	_	

#Text=Written informed consent to the study was obtained from all of subjects, which was approved by the Institutional Review Board of the National Institute on Alcohol Abuse and Alcoholism.
#Text=2.2 Assessments
#Text=The Structured Clinical Interview for DSM-IV-TR (SCID) was administered to all participants to determine diagnoses of alcohol dependence as well as other substance use and psychiatric disorders.
36-1	5657-5664	Written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-2	5665-5673	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-3	5674-5681	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-4	5682-5684	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-5	5685-5688	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-6	5689-5694	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-7	5695-5698	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-8	5699-5707	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-9	5708-5712	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-10	5713-5716	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-11	5717-5719	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-12	5720-5728	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-13	5728-5729	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-14	5730-5735	which	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-15	5736-5739	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-16	5740-5748	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-17	5749-5751	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-18	5752-5755	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-19	5756-5769	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-20	5770-5776	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-21	5777-5782	Board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-22	5783-5785	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-23	5786-5789	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-24	5790-5798	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-25	5799-5808	Institute	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-26	5809-5811	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-27	5812-5819	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-28	5820-5825	Abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-29	5826-5829	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-30	5830-5840	Alcoholism	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
36-31	5840-5841	.	_	
36-32	5842-5845	2.2	_	
36-33	5846-5857	Assessments	_	
36-34	5858-5861	The	_	
36-35	5862-5872	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
36-36	5873-5881	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
36-37	5882-5891	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
36-38	5892-5895	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
36-39	5896-5905	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
36-40	5906-5907	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
36-41	5907-5911	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
36-42	5911-5912	)	_	
36-43	5913-5916	was	_	
36-44	5917-5929	administered	_	
36-45	5930-5932	to	_	
36-46	5933-5936	all	_	
36-47	5937-5949	participants	_	
36-48	5950-5952	to	_	
36-49	5953-5962	determine	_	
36-50	5963-5972	diagnoses	_	
36-51	5973-5975	of	_	
36-52	5976-5983	alcohol	_	
36-53	5984-5994	dependence	_	
36-54	5995-5997	as	_	
36-55	5998-6002	well	_	
36-56	6003-6005	as	_	
36-57	6006-6011	other	_	
36-58	6012-6021	substance	_	
36-59	6022-6025	use	_	
36-60	6026-6029	and	_	
36-61	6030-6041	psychiatric	_	
36-62	6042-6051	disorders	_	
36-63	6051-6052	.	_	

#Text=A 90 day Timeline Followback (TLFB) calendar was used to measure the frequency and amount of drinking for all subjects.
37-1	6053-6054	A	_	
37-2	6055-6057	90	_	
37-3	6058-6061	day	_	
37-4	6062-6070	Timeline	_	
37-5	6071-6081	Followback	_	
37-6	6082-6083	(	_	
37-7	6083-6087	TLFB	_	
37-8	6087-6088	)	_	
37-9	6089-6097	calendar	_	
37-10	6098-6101	was	_	
37-11	6102-6106	used	_	
37-12	6107-6109	to	_	
37-13	6110-6117	measure	_	
37-14	6118-6121	the	_	
37-15	6122-6131	frequency	_	
37-16	6132-6135	and	_	
37-17	6136-6142	amount	_	
37-18	6143-6145	of	_	
37-19	6146-6154	drinking	_	
37-20	6155-6158	for	_	
37-21	6159-6162	all	_	
37-22	6163-6171	subjects	_	
37-23	6171-6172	.	_	

#Text=The amount of lifetime alcohol intake for controls was measured by using the lifetime drinking history.
38-1	6173-6176	The	_	
38-2	6177-6183	amount	_	
38-3	6184-6186	of	_	
38-4	6187-6195	lifetime	_	
38-5	6196-6203	alcohol	_	
38-6	6204-6210	intake	_	
38-7	6211-6214	for	_	
38-8	6215-6223	controls	_	
38-9	6224-6227	was	_	
38-10	6228-6236	measured	_	
38-11	6237-6239	by	_	
38-12	6240-6245	using	_	
38-13	6246-6249	the	_	
38-14	6250-6258	lifetime	_	
38-15	6259-6267	drinking	_	
38-16	6268-6275	history	_	
38-17	6275-6276	.	_	

#Text=A smoking questionnaire was used to determine the amount and frequency of a participant’s cigarette use.
#Text=2.3 Exclusionary criteria
#Text=Exclusionary criteria included pregnancy, claustrophobia, significant neurological, or medical diagnoses.
39-1	6277-6278	A	_	
39-2	6279-6286	smoking	_	
39-3	6287-6300	questionnaire	_	
39-4	6301-6304	was	_	
39-5	6305-6309	used	_	
39-6	6310-6312	to	_	
39-7	6313-6322	determine	_	
39-8	6323-6326	the	_	
39-9	6327-6333	amount	_	
39-10	6334-6337	and	_	
39-11	6338-6347	frequency	_	
39-12	6348-6350	of	_	
39-13	6351-6352	a	_	
39-14	6353-6364	participant	_	
39-15	6364-6365	’	_	
39-16	6365-6366	s	_	
39-17	6367-6376	cigarette	_	
39-18	6377-6380	use	_	
39-19	6380-6381	.	_	
39-20	6382-6385	2.3	_	
39-21	6386-6398	Exclusionary	_	
39-22	6399-6407	criteria	_	
39-23	6408-6420	Exclusionary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-24	6421-6429	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-25	6430-6438	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-26	6439-6448	pregnancy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-27	6448-6449	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-28	6450-6464	claustrophobia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-29	6464-6465	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-30	6466-6477	significant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-31	6478-6490	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-32	6490-6491	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-33	6492-6494	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-34	6495-6502	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-35	6503-6512	diagnoses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-36	6512-6513	.	_	

#Text=Subjects were also excluded if they had ferromagnetic objects in the body, a positive HIV test, active suicidal or homicidal ideations, or were currently taking psychotropic medication.
40-1	6514-6522	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-2	6523-6527	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-3	6528-6532	also	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-4	6533-6541	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-5	6542-6544	if	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-6	6545-6549	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-7	6550-6553	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-8	6554-6567	ferromagnetic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-9	6568-6575	objects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-10	6576-6578	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-11	6579-6582	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-12	6583-6587	body	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-13	6587-6588	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-14	6589-6590	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-15	6591-6599	positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-16	6600-6603	HIV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-17	6604-6608	test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-18	6608-6609	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-19	6610-6616	active	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-20	6617-6625	suicidal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-21	6626-6628	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-22	6629-6638	homicidal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-23	6639-6648	ideations	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-24	6648-6649	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-25	6650-6652	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-26	6653-6657	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-27	6658-6667	currently	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-28	6668-6674	taking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-29	6675-6687	psychotropic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-30	6688-6698	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
40-31	6698-6699	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	

#Text=A failed neuromotor examination was exclusionary as well.
41-1	6700-6701	A	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
41-2	6702-6708	failed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
41-3	6709-6719	neuromotor	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
41-4	6720-6731	examination	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
41-5	6732-6735	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
41-6	6736-6748	exclusionary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
41-7	6749-6751	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
41-8	6752-6756	well	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
41-9	6756-6757	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	

#Text=Participants were instructed not to consume any alcohol for 24 hours and no more than half a cup of caffeinated beverages 12 hours prior to each scanning visit.
42-1	6758-6770	Participants	_	
42-2	6771-6775	were	_	
42-3	6776-6786	instructed	_	
42-4	6787-6790	not	_	
42-5	6791-6793	to	_	
42-6	6794-6801	consume	_	
42-7	6802-6805	any	_	
42-8	6806-6813	alcohol	_	
42-9	6814-6817	for	_	
42-10	6818-6820	24	_	
42-11	6821-6826	hours	_	
42-12	6827-6830	and	_	
42-13	6831-6833	no	_	
42-14	6834-6838	more	_	
42-15	6839-6843	than	_	
42-16	6844-6848	half	_	
42-17	6849-6850	a	_	
42-18	6851-6854	cup	_	
42-19	6855-6857	of	_	
42-20	6858-6869	caffeinated	_	
42-21	6870-6879	beverages	_	
42-22	6880-6882	12	_	
42-23	6883-6888	hours	_	
42-24	6889-6894	prior	_	
42-25	6895-6897	to	_	
42-26	6898-6902	each	_	
42-27	6903-6911	scanning	_	
42-28	6912-6917	visit	_	
42-29	6917-6918	.	_	

#Text=Participants could not participate if they had a positive alcohol breathalyzer or urine drug screen on the day of the scan.
43-1	6919-6931	Participants	_	
43-2	6932-6937	could	_	
43-3	6938-6941	not	_	
43-4	6942-6953	participate	_	
43-5	6954-6956	if	_	
43-6	6957-6961	they	_	
43-7	6962-6965	had	_	
43-8	6966-6967	a	_	
43-9	6968-6976	positive	_	
43-10	6977-6984	alcohol	_	
43-11	6985-6997	breathalyzer	_	
43-12	6998-7000	or	_	
43-13	7001-7006	urine	_	
43-14	7007-7011	drug	_	
43-15	7012-7018	screen	_	
43-16	7019-7021	on	_	
43-17	7022-7025	the	_	
43-18	7026-7029	day	_	
43-19	7030-7032	of	_	
43-20	7033-7036	the	_	
43-21	7037-7041	scan	_	
43-22	7041-7042	.	_	

#Text=Controls were excluded if they met criteria for any current or past AUD.
44-1	7043-7051	Controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-2	7052-7056	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-3	7057-7065	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-4	7066-7068	if	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-5	7069-7073	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-6	7074-7077	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-7	7078-7086	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-8	7087-7090	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-9	7091-7094	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-10	7095-7102	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-11	7103-7105	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-12	7106-7110	past	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-13	7111-7114	AUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[15]	
44-14	7114-7115	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=All subjects were required to be right handed and deemed physically healthy by a clinician.
45-1	7116-7119	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-2	7120-7128	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-3	7129-7133	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-4	7134-7142	required	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-5	7143-7145	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-6	7146-7148	be	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-7	7149-7154	right	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-8	7155-7161	handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-9	7162-7165	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-10	7166-7172	deemed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-11	7173-7183	physically	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-12	7184-7191	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-13	7192-7194	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-14	7195-7196	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-15	7197-7206	clinician	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
45-16	7206-7207	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	

#Text=Participants with AUD could not have severe symptoms of alcohol withdrawal defined by a Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA) score of greater than 8.
#Text=2.4 MRI Data acquisition
#Text=Five minutes of closed-eyes rs-fMRI (150 volumes) were collected using a 3T SIEMENS Skyra MRI scanner.
46-1	7208-7220	Participants	_	
46-2	7221-7225	with	_	
46-3	7226-7229	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
46-4	7230-7235	could	_	
46-5	7236-7239	not	_	
46-6	7240-7244	have	_	
46-7	7245-7251	severe	_	
46-8	7252-7260	symptoms	_	
46-9	7261-7263	of	_	
46-10	7264-7271	alcohol	_	
46-11	7272-7282	withdrawal	_	
46-12	7283-7290	defined	_	
46-13	7291-7293	by	_	
46-14	7294-7295	a	_	
46-15	7296-7304	Clinical	_	
46-16	7305-7314	Institute	_	
46-17	7315-7325	Withdrawal	_	
46-18	7326-7336	Assessment	_	
46-19	7337-7339	of	_	
46-20	7340-7347	Alcohol	_	
46-21	7348-7353	Scale	_	
46-22	7354-7355	(	_	
46-23	7355-7359	CIWA	_	
46-24	7359-7360	)	_	
46-25	7361-7366	score	_	
46-26	7367-7369	of	_	
46-27	7370-7377	greater	_	
46-28	7378-7382	than	_	
46-29	7383-7384	8	_	
46-30	7384-7385	.	_	
46-31	7386-7389	2.4	_	
46-32	7390-7393	MRI	_	
46-33	7394-7398	Data	_	
46-34	7399-7410	acquisition	_	
46-35	7411-7415	Five	_	
46-36	7416-7423	minutes	_	
46-37	7424-7426	of	_	
46-38	7427-7438	closed-eyes	_	
46-39	7439-7446	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
46-40	7447-7448	(	_	
46-41	7448-7451	150	_	
46-42	7452-7459	volumes	_	
46-43	7459-7460	)	_	
46-44	7461-7465	were	_	
46-45	7466-7475	collected	_	
46-46	7476-7481	using	_	
46-47	7482-7483	a	_	
46-48	7484-7486	3T	_	
46-49	7487-7494	SIEMENS	_	
46-50	7495-7500	Skyra	_	
46-51	7501-7504	MRI	_	
46-52	7505-7512	scanner	_	
46-53	7512-7513	.	_	

#Text=Resting state fMRI datasets were collected using a single-shot gradient echo planar imaging pulse sequence with thirty-six axial slices acquired parallel to the anterior/posterior commissural line (TR = 2000ms, TE = 30ms, flip angle=90°, 3.75 mm × 3.75 mm × 3.8 mm voxels).
47-1	7514-7521	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[17]	
47-2	7522-7527	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[17]	
47-3	7528-7532	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[17]	
47-4	7533-7541	datasets	_	
47-5	7542-7546	were	_	
47-6	7547-7556	collected	_	
47-7	7557-7562	using	_	
47-8	7563-7564	a	_	
47-9	7565-7576	single-shot	_	
47-10	7577-7585	gradient	_	
47-11	7586-7590	echo	_	
47-12	7591-7597	planar	_	
47-13	7598-7605	imaging	_	
47-14	7606-7611	pulse	_	
47-15	7612-7620	sequence	_	
47-16	7621-7625	with	_	
47-17	7626-7636	thirty-six	_	
47-18	7637-7642	axial	_	
47-19	7643-7649	slices	_	
47-20	7650-7658	acquired	_	
47-21	7659-7667	parallel	_	
47-22	7668-7670	to	_	
47-23	7671-7674	the	_	
47-24	7675-7683	anterior	_	
47-25	7683-7684	/	_	
47-26	7684-7693	posterior	_	
47-27	7694-7705	commissural	_	
47-28	7706-7710	line	_	
47-29	7711-7712	(	_	
47-30	7712-7714	TR	_	
47-31	7715-7716	=	_	
47-32	7717-7723	2000ms	_	
47-33	7723-7724	,	_	
47-34	7725-7727	TE	_	
47-35	7728-7729	=	_	
47-36	7730-7734	30ms	_	
47-37	7734-7735	,	_	
47-38	7736-7740	flip	_	
47-39	7741-7746	angle	_	
47-40	7746-7747	=	_	
47-41	7747-7749	90	_	
47-42	7749-7750	°	_	
47-43	7750-7751	,	_	
47-44	7752-7756	3.75	_	
47-45	7757-7759	mm	_	
47-46	7760-7761	×	_	
47-47	7762-7766	3.75	_	
47-48	7767-7769	mm	_	
47-49	7770-7771	×	_	
47-50	7772-7775	3.8	_	
47-51	7776-7778	mm	_	
47-52	7779-7785	voxels	_	
47-53	7785-7786	)	_	
47-54	7786-7787	.	_	

#Text=High-resolution T1-weighted 3-D structural scans were acquired for each subject using an MPRAGE sequence (TR = 1200ms TE =30ms, 256 × 256 matrix, 128 axial slices).
#Text=2.5 rs-fMRI data pre-processing
#Text=Using Functional MRI of the Brain (FMRIB)’s Software Library (FSL) package (www.fmrib.ox.ac.uk/fsl) we applied; 1) slice timing correction for interleaved acquisitions using interpolation with a Hanning windowing kernel; 2) motion correction using Motion Correction using FMRIB’s Linear Image Registration Tool (MCFLIRT); 3) non-brain removal using Brain Extraction Tool (BET); 4) spatial smoothing using a Gaussian kernel of full width at half maximum 5mm; 5) grand-mean intensity normalization of the entire 4D dataset by a single multiplicative factor, the size of the voxels is 4×4×4 mm3; 6) high-pass temporal filtering (Gaussian-weighted least-squares straight line fitting, with sigma=50s); 7) removing trends and regressing out a set of nuisance variables such as motion parameters and it’s derivatives, signals from cerebrospinal fluid (CSF) and white matter using fsl_glm; and 8) registration to high resolution structural MNI standard space images using the FMRIB’s Linear Image Registration Tool (FLIRT).
48-1	7788-7803	High-resolution	_	
48-2	7804-7806	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[18]	
48-3	7806-7807	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[18]	
48-4	7807-7815	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[18]	
48-5	7816-7817	3	_	
48-6	7817-7818	-	_	
48-7	7818-7819	D	_	
48-8	7820-7830	structural	_	
48-9	7831-7836	scans	_	
48-10	7837-7841	were	_	
48-11	7842-7850	acquired	_	
48-12	7851-7854	for	_	
48-13	7855-7859	each	_	
48-14	7860-7867	subject	_	
48-15	7868-7873	using	_	
48-16	7874-7876	an	_	
48-17	7877-7883	MPRAGE	_	
48-18	7884-7892	sequence	_	
48-19	7893-7894	(	_	
48-20	7894-7896	TR	_	
48-21	7897-7898	=	_	
48-22	7899-7905	1200ms	_	
48-23	7906-7908	TE	_	
48-24	7909-7910	=	_	
48-25	7910-7914	30ms	_	
48-26	7914-7915	,	_	
48-27	7916-7919	256	_	
48-28	7920-7921	×	_	
48-29	7922-7925	256	_	
48-30	7926-7932	matrix	_	
48-31	7932-7933	,	_	
48-32	7934-7937	128	_	
48-33	7938-7943	axial	_	
48-34	7944-7950	slices	_	
48-35	7950-7951	)	_	
48-36	7951-7952	.	_	
48-37	7953-7956	2.5	_	
48-38	7957-7964	rs-fMRI	_	
48-39	7965-7969	data	_	
48-40	7970-7984	pre-processing	_	
48-41	7985-7990	Using	_	
48-42	7991-8001	Functional	_	
48-43	8002-8005	MRI	_	
48-44	8006-8008	of	_	
48-45	8009-8012	the	_	
48-46	8013-8018	Brain	_	
48-47	8019-8020	(	_	
48-48	8020-8025	FMRIB	_	
48-49	8025-8026	)	_	
48-50	8026-8027	’	_	
48-51	8027-8028	s	_	
48-52	8029-8037	Software	_	
48-53	8038-8045	Library	_	
48-54	8046-8047	(	_	
48-55	8047-8050	FSL	_	
48-56	8050-8051	)	_	
48-57	8052-8059	package	_	
48-58	8060-8061	(	_	
48-59	8061-8079	www.fmrib.ox.ac.uk	_	
48-60	8079-8080	/	_	
48-61	8080-8083	fsl	_	
48-62	8083-8084	)	_	
48-63	8085-8087	we	_	
48-64	8088-8095	applied	_	
48-65	8095-8096	;	_	
48-66	8097-8098	1	_	
48-67	8098-8099	)	_	
48-68	8100-8105	slice	_	
48-69	8106-8112	timing	_	
48-70	8113-8123	correction	_	
48-71	8124-8127	for	_	
48-72	8128-8139	interleaved	_	
48-73	8140-8152	acquisitions	_	
48-74	8153-8158	using	_	
48-75	8159-8172	interpolation	_	
48-76	8173-8177	with	_	
48-77	8178-8179	a	_	
48-78	8180-8187	Hanning	_	
48-79	8188-8197	windowing	_	
48-80	8198-8204	kernel	_	
48-81	8204-8205	;	_	
48-82	8206-8207	2	_	
48-83	8207-8208	)	_	
48-84	8209-8215	motion	_	
48-85	8216-8226	correction	_	
48-86	8227-8232	using	_	
48-87	8233-8239	Motion	_	
48-88	8240-8250	Correction	_	
48-89	8251-8256	using	_	
48-90	8257-8262	FMRIB	_	
48-91	8262-8263	’	_	
48-92	8263-8264	s	_	
48-93	8265-8271	Linear	_	
48-94	8272-8277	Image	_	
48-95	8278-8290	Registration	_	
48-96	8291-8295	Tool	_	
48-97	8296-8297	(	_	
48-98	8297-8304	MCFLIRT	_	
48-99	8304-8305	)	_	
48-100	8305-8306	;	_	
48-101	8307-8308	3	_	
48-102	8308-8309	)	_	
48-103	8310-8319	non-brain	_	
48-104	8320-8327	removal	_	
48-105	8328-8333	using	_	
48-106	8334-8339	Brain	_	
48-107	8340-8350	Extraction	_	
48-108	8351-8355	Tool	_	
48-109	8356-8357	(	_	
48-110	8357-8360	BET	_	
48-111	8360-8361	)	_	
48-112	8361-8362	;	_	
48-113	8363-8364	4	_	
48-114	8364-8365	)	_	
48-115	8366-8373	spatial	_	
48-116	8374-8383	smoothing	_	
48-117	8384-8389	using	_	
48-118	8390-8391	a	_	
48-119	8392-8400	Gaussian	_	
48-120	8401-8407	kernel	_	
48-121	8408-8410	of	_	
48-122	8411-8415	full	_	
48-123	8416-8421	width	_	
48-124	8422-8424	at	_	
48-125	8425-8429	half	_	
48-126	8430-8437	maximum	_	
48-127	8438-8441	5mm	_	
48-128	8441-8442	;	_	
48-129	8443-8444	5	_	
48-130	8444-8445	)	_	
48-131	8446-8456	grand-mean	_	
48-132	8457-8466	intensity	_	
48-133	8467-8480	normalization	_	
48-134	8481-8483	of	_	
48-135	8484-8487	the	_	
48-136	8488-8494	entire	_	
48-137	8495-8497	4D	_	
48-138	8498-8505	dataset	_	
48-139	8506-8508	by	_	
48-140	8509-8510	a	_	
48-141	8511-8517	single	_	
48-142	8518-8532	multiplicative	_	
48-143	8533-8539	factor	_	
48-144	8539-8540	,	_	
48-145	8541-8544	the	_	
48-146	8545-8549	size	_	
48-147	8550-8552	of	_	
48-148	8553-8556	the	_	
48-149	8557-8563	voxels	_	
48-150	8564-8566	is	_	
48-151	8567-8568	4	_	
48-152	8568-8569	×	_	
48-153	8569-8570	4	_	
48-154	8570-8571	×	_	
48-155	8571-8572	4	_	
48-156	8573-8576	mm3	_	
48-157	8576-8577	;	_	
48-158	8578-8579	6	_	
48-159	8579-8580	)	_	
48-160	8581-8590	high-pass	_	
48-161	8591-8599	temporal	_	
48-162	8600-8609	filtering	_	
48-163	8610-8611	(	_	
48-164	8611-8628	Gaussian-weighted	_	
48-165	8629-8642	least-squares	_	
48-166	8643-8651	straight	_	
48-167	8652-8656	line	_	
48-168	8657-8664	fitting	_	
48-169	8664-8665	,	_	
48-170	8666-8670	with	_	
48-171	8671-8676	sigma	_	
48-172	8676-8677	=	_	
48-173	8677-8680	50s	_	
48-174	8680-8681	)	_	
48-175	8681-8682	;	_	
48-176	8683-8684	7	_	
48-177	8684-8685	)	_	
48-178	8686-8694	removing	_	
48-179	8695-8701	trends	_	
48-180	8702-8705	and	_	
48-181	8706-8716	regressing	_	
48-182	8717-8720	out	_	
48-183	8721-8722	a	_	
48-184	8723-8726	set	_	
48-185	8727-8729	of	_	
48-186	8730-8738	nuisance	_	
48-187	8739-8748	variables	_	
48-188	8749-8753	such	_	
48-189	8754-8756	as	_	
48-190	8757-8763	motion	_	
48-191	8764-8774	parameters	_	
48-192	8775-8778	and	_	
48-193	8779-8781	it	_	
48-194	8781-8782	’	_	
48-195	8782-8783	s	_	
48-196	8784-8795	derivatives	_	
48-197	8795-8796	,	_	
48-198	8797-8804	signals	_	
48-199	8805-8809	from	_	
48-200	8810-8823	cerebrospinal	_	
48-201	8824-8829	fluid	_	
48-202	8830-8831	(	_	
48-203	8831-8834	CSF	_	
48-204	8834-8835	)	_	
48-205	8836-8839	and	_	
48-206	8840-8845	white	_	
48-207	8846-8852	matter	_	
48-208	8853-8858	using	_	
48-209	8859-8866	fsl_glm	_	
48-210	8866-8867	;	_	
48-211	8868-8871	and	_	
48-212	8872-8873	8	_	
48-213	8873-8874	)	_	
48-214	8875-8887	registration	_	
48-215	8888-8890	to	_	
48-216	8891-8895	high	_	
48-217	8896-8906	resolution	_	
48-218	8907-8917	structural	_	
48-219	8918-8921	MNI	_	
48-220	8922-8930	standard	_	
48-221	8931-8936	space	_	
48-222	8937-8943	images	_	
48-223	8944-8949	using	_	
48-224	8950-8953	the	_	
48-225	8954-8959	FMRIB	_	
48-226	8959-8960	’	_	
48-227	8960-8961	s	_	
48-228	8962-8968	Linear	_	
48-229	8969-8974	Image	_	
48-230	8975-8987	Registration	_	
48-231	8988-8992	Tool	_	
48-232	8993-8994	(	_	
48-233	8994-8999	FLIRT	_	
48-234	8999-9000	)	_	
48-235	9000-9001	.	_	

#Text=We used a stringent threshold for head motion in the pre-processing step.
49-1	9002-9004	We	_	
49-2	9005-9009	used	_	
49-3	9010-9011	a	_	
49-4	9012-9021	stringent	_	
49-5	9022-9031	threshold	_	
49-6	9032-9035	for	_	
49-7	9036-9040	head	_	
49-8	9041-9047	motion	_	
49-9	9048-9050	in	_	
49-10	9051-9054	the	_	
49-11	9055-9069	pre-processing	_	
49-12	9070-9074	step	_	
49-13	9074-9075	.	_	

#Text=Subjects with head motion greater than 0.3 mm for translation and 0.3° for rotation between consecutive TRs were removed from the study.
50-1	9076-9084	Subjects	_	
50-2	9085-9089	with	_	
50-3	9090-9094	head	_	
50-4	9095-9101	motion	_	
50-5	9102-9109	greater	_	
50-6	9110-9114	than	_	
50-7	9115-9118	0.3	_	
50-8	9119-9121	mm	_	
50-9	9122-9125	for	_	
50-10	9126-9137	translation	_	
50-11	9138-9141	and	_	
50-12	9142-9145	0.3	_	
50-13	9145-9146	°	_	
50-14	9147-9150	for	_	
50-15	9151-9159	rotation	_	
50-16	9160-9167	between	_	
50-17	9168-9179	consecutive	_	
50-18	9180-9183	TRs	_	
50-19	9184-9188	were	_	
50-20	9189-9196	removed	_	
50-21	9197-9201	from	_	
50-22	9202-9205	the	_	
50-23	9206-9211	study	_	
50-24	9211-9212	.	_	

#Text=The head motion was not different between the two groups.
#Text=2.6 rs-fMRI connectivity analysis
#Text=1.
51-1	9213-9216	The	_	
51-2	9217-9221	head	_	
51-3	9222-9228	motion	_	
51-4	9229-9232	was	_	
51-5	9233-9236	not	_	
51-6	9237-9246	different	_	
51-7	9247-9254	between	_	
51-8	9255-9258	the	_	
51-9	9259-9262	two	_	
51-10	9263-9269	groups	_	
51-11	9269-9270	.	_	
51-12	9271-9274	2.6	_	
51-13	9275-9282	rs-fMRI	_	
51-14	9283-9295	connectivity	_	
51-15	9296-9304	analysis	_	
51-16	9305-9306	1	_	
51-17	9306-9307	.	_	

#Text=Feature extraction
#Text=Extracting brain functional networks and their corresponding time-course is the first step to extract both types of proposed features.
52-1	9308-9315	Feature	_	
52-2	9316-9326	extraction	_	
52-3	9327-9337	Extracting	_	
52-4	9338-9343	brain	_	
52-5	9344-9354	functional	_	
52-6	9355-9363	networks	_	
52-7	9364-9367	and	_	
52-8	9368-9373	their	_	
52-9	9374-9387	corresponding	_	
52-10	9388-9399	time-course	_	
52-11	9400-9402	is	_	
52-12	9403-9406	the	_	
52-13	9407-9412	first	_	
52-14	9413-9417	step	_	
52-15	9418-9420	to	_	
52-16	9421-9428	extract	_	
52-17	9429-9433	both	_	
52-18	9434-9439	types	_	
52-19	9440-9442	of	_	
52-20	9443-9451	proposed	_	
52-21	9452-9460	features	_	
52-22	9460-9461	.	_	

#Text=We applied Probabilistic Independent Component Analysis (PICA) by using the Multivariate Exploratory Linear Decomposition into Independent Components (MELODIC) toolbox of the FSL for this purpose.
53-1	9462-9464	We	_	
53-2	9465-9472	applied	_	
53-3	9473-9486	Probabilistic	_	
53-4	9487-9498	Independent	_	
53-5	9499-9508	Component	_	
53-6	9509-9517	Analysis	_	
53-7	9518-9519	(	_	
53-8	9519-9523	PICA	_	
53-9	9523-9524	)	_	
53-10	9525-9527	by	_	
53-11	9528-9533	using	_	
53-12	9534-9537	the	_	
53-13	9538-9550	Multivariate	_	
53-14	9551-9562	Exploratory	_	
53-15	9563-9569	Linear	_	
53-16	9570-9583	Decomposition	_	
53-17	9584-9588	into	_	
53-18	9589-9600	Independent	_	
53-19	9601-9611	Components	_	
53-20	9612-9613	(	_	
53-21	9613-9620	MELODIC	_	
53-22	9620-9621	)	_	
53-23	9622-9629	toolbox	_	
53-24	9630-9632	of	_	
53-25	9633-9636	the	_	
53-26	9637-9640	FSL	_	
53-27	9641-9644	for	_	
53-28	9645-9649	this	_	
53-29	9650-9657	purpose	_	
53-30	9657-9658	.	_	

#Text=ICA, a multivariate data-driven method which is a blind source separation method where individual regions in a given network show tight functional connectivity which enables isolation of a set of signals from their linear mixtures, and has yielded fruitful results with fMRI data.
54-1	9659-9662	ICA	_	
54-2	9662-9663	,	_	
54-3	9664-9665	a	_	
54-4	9666-9678	multivariate	_	
54-5	9679-9690	data-driven	_	
54-6	9691-9697	method	_	
54-7	9698-9703	which	_	
54-8	9704-9706	is	_	
54-9	9707-9708	a	_	
54-10	9709-9714	blind	_	
54-11	9715-9721	source	_	
54-12	9722-9732	separation	_	
54-13	9733-9739	method	_	
54-14	9740-9745	where	_	
54-15	9746-9756	individual	_	
54-16	9757-9764	regions	_	
54-17	9765-9767	in	_	
54-18	9768-9769	a	_	
54-19	9770-9775	given	_	
54-20	9776-9783	network	_	
54-21	9784-9788	show	_	
54-22	9789-9794	tight	_	
54-23	9795-9805	functional	_	
54-24	9806-9818	connectivity	_	
54-25	9819-9824	which	_	
54-26	9825-9832	enables	_	
54-27	9833-9842	isolation	_	
54-28	9843-9845	of	_	
54-29	9846-9847	a	_	
54-30	9848-9851	set	_	
54-31	9852-9854	of	_	
54-32	9855-9862	signals	_	
54-33	9863-9867	from	_	
54-34	9868-9873	their	_	
54-35	9874-9880	linear	_	
54-36	9881-9889	mixtures	_	
54-37	9889-9890	,	_	
54-38	9891-9894	and	_	
54-39	9895-9898	has	_	
54-40	9899-9906	yielded	_	
54-41	9907-9915	fruitful	_	
54-42	9916-9923	results	_	
54-43	9924-9928	with	_	
54-44	9929-9933	fMRI	_	
54-45	9934-9938	data	_	
54-46	9938-9939	.	_	

#Text=ICA estimates maximally independent components using independence measures based on higher order statistics.
55-1	9940-9943	ICA	_	
55-2	9944-9953	estimates	_	
55-3	9954-9963	maximally	_	
55-4	9964-9975	independent	_	
55-5	9976-9986	components	_	
55-6	9987-9992	using	_	
55-7	9993-10005	independence	_	
55-8	10006-10014	measures	_	
55-9	10015-10020	based	_	
55-10	10021-10023	on	_	
55-11	10024-10030	higher	_	
55-12	10031-10036	order	_	
55-13	10037-10047	statistics	_	
55-14	10047-10048	.	_	

#Text=Compared to general linear model approaches, ICA requires no specific temporal model (task-based design matrix), making it ideal for analyzing resting state data.
56-1	10049-10057	Compared	_	
56-2	10058-10060	to	_	
56-3	10061-10068	general	_	
56-4	10069-10075	linear	_	
56-5	10076-10081	model	_	
56-6	10082-10092	approaches	_	
56-7	10092-10093	,	_	
56-8	10094-10097	ICA	_	
56-9	10098-10106	requires	_	
56-10	10107-10109	no	_	
56-11	10110-10118	specific	_	
56-12	10119-10127	temporal	_	
56-13	10128-10133	model	_	
56-14	10134-10135	(	_	
56-15	10135-10145	task-based	_	
56-16	10146-10152	design	_	
56-17	10153-10159	matrix	_	
56-18	10159-10160	)	_	
56-19	10160-10161	,	_	
56-20	10162-10168	making	_	
56-21	10169-10171	it	_	
56-22	10172-10177	ideal	_	
56-23	10178-10181	for	_	
56-24	10182-10191	analyzing	_	
56-25	10192-10199	resting	_	
56-26	10200-10205	state	_	
56-27	10206-10210	data	_	
56-28	10210-10211	.	_	

#Text=Spatial components resulting from spatial ICA are maximally spatially independent but their corresponding time-courses can show a considerable amount of temporal dependency.
57-1	10212-10219	Spatial	_	
57-2	10220-10230	components	_	
57-3	10231-10240	resulting	_	
57-4	10241-10245	from	_	
57-5	10246-10253	spatial	_	
57-6	10254-10257	ICA	_	
57-7	10258-10261	are	_	
57-8	10262-10271	maximally	_	
57-9	10272-10281	spatially	_	
57-10	10282-10293	independent	_	
57-11	10294-10297	but	_	
57-12	10298-10303	their	_	
57-13	10304-10317	corresponding	_	
57-14	10318-10330	time-courses	_	
57-15	10331-10334	can	_	
57-16	10335-10339	show	_	
57-17	10340-10341	a	_	
57-18	10342-10354	considerable	_	
57-19	10355-10361	amount	_	
57-20	10362-10364	of	_	
57-21	10365-10373	temporal	_	
57-22	10374-10384	dependency	_	
57-23	10384-10385	.	_	

#Text=In order to create an unbiased template of resting-state networks, a group ICA was performed on all 92 AUD and controls.
58-1	10386-10388	In	_	
58-2	10389-10394	order	_	
58-3	10395-10397	to	_	
58-4	10398-10404	create	_	
58-5	10405-10407	an	_	
58-6	10408-10416	unbiased	_	
58-7	10417-10425	template	_	
58-8	10426-10428	of	_	
58-9	10429-10442	resting-state	_	
58-10	10443-10451	networks	_	
58-11	10451-10452	,	_	
58-12	10453-10454	a	_	
58-13	10455-10460	group	_	
58-14	10461-10464	ICA	_	
58-15	10465-10468	was	_	
58-16	10469-10478	performed	_	
58-17	10479-10481	on	_	
58-18	10482-10485	all	_	
58-19	10486-10488	92	_	
58-20	10489-10492	AUD	_	
58-21	10493-10496	and	_	
58-22	10497-10505	controls	_	
58-23	10505-10506	.	_	

#Text=A temporal concatenation tool in MELODIC was used to derive group level components across all subjects.
59-1	10507-10508	A	_	
59-2	10509-10517	temporal	_	
59-3	10518-10531	concatenation	_	
59-4	10532-10536	tool	_	
59-5	10537-10539	in	_	
59-6	10540-10547	MELODIC	_	
59-7	10548-10551	was	_	
59-8	10552-10556	used	_	
59-9	10557-10559	to	_	
59-10	10560-10566	derive	_	
59-11	10567-10572	group	_	
59-12	10573-10578	level	_	
59-13	10579-10589	components	_	
59-14	10590-10596	across	_	
59-15	10597-10600	all	_	
59-16	10601-10609	subjects	_	
59-17	10609-10610	.	_	

#Text=Pre-processed data were whitened and projected into a 37-dimensional subspace using PICA where the number of dimensions was estimated using an objective estimation of the amount of Gaussian noise through Bayesian analysis of the true dimensionality of the data (the number of activation and non-Gaussian noise sources).
60-1	10611-10624	Pre-processed	_	
60-2	10625-10629	data	_	
60-3	10630-10634	were	_	
60-4	10635-10643	whitened	_	
60-5	10644-10647	and	_	
60-6	10648-10657	projected	_	
60-7	10658-10662	into	_	
60-8	10663-10664	a	_	
60-9	10665-10667	37	_	
60-10	10667-10668	-	_	
60-11	10668-10679	dimensional	_	
60-12	10680-10688	subspace	_	
60-13	10689-10694	using	_	
60-14	10695-10699	PICA	_	
60-15	10700-10705	where	_	
60-16	10706-10709	the	_	
60-17	10710-10716	number	_	
60-18	10717-10719	of	_	
60-19	10720-10730	dimensions	_	
60-20	10731-10734	was	_	
60-21	10735-10744	estimated	_	
60-22	10745-10750	using	_	
60-23	10751-10753	an	_	
60-24	10754-10763	objective	_	
60-25	10764-10774	estimation	_	
60-26	10775-10777	of	_	
60-27	10778-10781	the	_	
60-28	10782-10788	amount	_	
60-29	10789-10791	of	_	
60-30	10792-10800	Gaussian	_	
60-31	10801-10806	noise	_	
60-32	10807-10814	through	_	
60-33	10815-10823	Bayesian	_	
60-34	10824-10832	analysis	_	
60-35	10833-10835	of	_	
60-36	10836-10839	the	_	
60-37	10840-10844	true	_	
60-38	10845-10859	dimensionality	_	
60-39	10860-10862	of	_	
60-40	10863-10866	the	_	
60-41	10867-10871	data	_	
60-42	10872-10873	(	_	
60-43	10873-10876	the	_	
60-44	10877-10883	number	_	
60-45	10884-10886	of	_	
60-46	10887-10897	activation	_	
60-47	10898-10901	and	_	
60-48	10902-10914	non-Gaussian	_	
60-49	10915-10920	noise	_	
60-50	10921-10928	sources	_	
60-51	10928-10929	)	_	
60-52	10929-10930	.	_	

#Text=The whitened observations were decomposed into sets of vectors which describe signal variation across the temporal domain (time-courses) and across the spatial domain (maps) by optimizing for non-Gaussian spatial source distributions using a fixed-point iteration technique.
61-1	10931-10934	The	_	
61-2	10935-10943	whitened	_	
61-3	10944-10956	observations	_	
61-4	10957-10961	were	_	
61-5	10962-10972	decomposed	_	
61-6	10973-10977	into	_	
61-7	10978-10982	sets	_	
61-8	10983-10985	of	_	
61-9	10986-10993	vectors	_	
61-10	10994-10999	which	_	
61-11	11000-11008	describe	_	
61-12	11009-11015	signal	_	
61-13	11016-11025	variation	_	
61-14	11026-11032	across	_	
61-15	11033-11036	the	_	
61-16	11037-11045	temporal	_	
61-17	11046-11052	domain	_	
61-18	11053-11054	(	_	
61-19	11054-11066	time-courses	_	
61-20	11066-11067	)	_	
61-21	11068-11071	and	_	
61-22	11072-11078	across	_	
61-23	11079-11082	the	_	
61-24	11083-11090	spatial	_	
61-25	11091-11097	domain	_	
61-26	11098-11099	(	_	
61-27	11099-11103	maps	_	
61-28	11103-11104	)	_	
61-29	11105-11107	by	_	
61-30	11108-11118	optimizing	_	
61-31	11119-11122	for	_	
61-32	11123-11135	non-Gaussian	_	
61-33	11136-11143	spatial	_	
61-34	11144-11150	source	_	
61-35	11151-11164	distributions	_	
61-36	11165-11170	using	_	
61-37	11171-11172	a	_	
61-38	11173-11184	fixed-point	_	
61-39	11185-11194	iteration	_	
61-40	11195-11204	technique	_	
61-41	11204-11205	.	_	

#Text=These FC components maps were standardized into z statistic images via a normalized mixture model fit, thresholded at z > 7, cluster size > 30 voxels.
62-1	11206-11211	These	_	
62-2	11212-11214	FC	_	
62-3	11215-11225	components	_	
62-4	11226-11230	maps	_	
62-5	11231-11235	were	_	
62-6	11236-11248	standardized	_	
62-7	11249-11253	into	_	
62-8	11254-11255	z	_	
62-9	11256-11265	statistic	_	
62-10	11266-11272	images	_	
62-11	11273-11276	via	_	
62-12	11277-11278	a	_	
62-13	11279-11289	normalized	_	
62-14	11290-11297	mixture	_	
62-15	11298-11303	model	_	
62-16	11304-11307	fit	_	
62-17	11307-11308	,	_	
62-18	11309-11320	thresholded	_	
62-19	11321-11323	at	_	
62-20	11324-11325	z	_	
62-21	11326-11327	>	_	
62-22	11328-11329	7	_	
62-23	11329-11330	,	_	
62-24	11331-11338	cluster	_	
62-25	11339-11343	size	_	
62-26	11344-11345	>	_	
62-27	11346-11348	30	_	
62-28	11349-11355	voxels	_	
62-29	11355-11356	.	_	

#Text=Two criteria were used to remove biologically irrelevant components: (1) those representing known artifacts such as motion, and high-frequency noise; and (2) those with connectivity patterns not located mainly in gray matter.
63-1	11357-11360	Two	_	
63-2	11361-11369	criteria	_	
63-3	11370-11374	were	_	
63-4	11375-11379	used	_	
63-5	11380-11382	to	_	
63-6	11383-11389	remove	_	
63-7	11390-11402	biologically	_	
63-8	11403-11413	irrelevant	_	
63-9	11414-11424	components	_	
63-10	11424-11425	:	_	
63-11	11426-11427	(	_	
63-12	11427-11428	1	_	
63-13	11428-11429	)	_	
63-14	11430-11435	those	_	
63-15	11436-11448	representing	_	
63-16	11449-11454	known	_	
63-17	11455-11464	artifacts	_	
63-18	11465-11469	such	_	
63-19	11470-11472	as	_	
63-20	11473-11479	motion	_	
63-21	11479-11480	,	_	
63-22	11481-11484	and	_	
63-23	11485-11499	high-frequency	_	
63-24	11500-11505	noise	_	
63-25	11505-11506	;	_	
63-26	11507-11510	and	_	
63-27	11511-11512	(	_	
63-28	11512-11513	2	_	
63-29	11513-11514	)	_	
63-30	11515-11520	those	_	
63-31	11521-11525	with	_	
63-32	11526-11538	connectivity	_	
63-33	11539-11547	patterns	_	
63-34	11548-11551	not	_	
63-35	11552-11559	located	_	
63-36	11560-11566	mainly	_	
63-37	11567-11569	in	_	
63-38	11570-11574	gray	_	
63-39	11575-11581	matter	_	
63-40	11581-11582	.	_	

#Text=Networks of interest were identified as anatomically and functionally classical RSNs upon visual inspection.
64-1	11583-11591	Networks	_	
64-2	11592-11594	of	_	
64-3	11595-11603	interest	_	
64-4	11604-11608	were	_	
64-5	11609-11619	identified	_	
64-6	11620-11622	as	_	
64-7	11623-11635	anatomically	_	
64-8	11636-11639	and	_	
64-9	11640-11652	functionally	_	
64-10	11653-11662	classical	_	
64-11	11663-11667	RSNs	_	
64-12	11668-11672	upon	_	
64-13	11673-11679	visual	_	
64-14	11680-11690	inspection	_	
64-15	11690-11691	.	_	

#Text=This procedure ended up with 32 component maps (Figure 1).
65-1	11692-11696	This	_	
65-2	11697-11706	procedure	_	
65-3	11707-11712	ended	_	
65-4	11713-11715	up	_	
65-5	11716-11720	with	_	
65-6	11721-11723	32	_	
65-7	11724-11733	component	_	
65-8	11734-11738	maps	_	
65-9	11739-11740	(	_	
65-10	11740-11746	Figure	_	
65-11	11747-11748	1	_	
65-12	11748-11749	)	_	
65-13	11749-11750	.	_	

#Text=The between-subject analysis was carried out using dual regression, a regression technique which back-reconstructs each group level component map at the individual subject level.
66-1	11751-11754	The	_	
66-2	11755-11770	between-subject	_	
66-3	11771-11779	analysis	_	
66-4	11780-11783	was	_	
66-5	11784-11791	carried	_	
66-6	11792-11795	out	_	
66-7	11796-11801	using	_	
66-8	11802-11806	dual	_	
66-9	11807-11817	regression	_	
66-10	11817-11818	,	_	
66-11	11819-11820	a	_	
66-12	11821-11831	regression	_	
66-13	11832-11841	technique	_	
66-14	11842-11847	which	_	
66-15	11848-11865	back-reconstructs	_	
66-16	11866-11870	each	_	
66-17	11871-11876	group	_	
66-18	11877-11882	level	_	
66-19	11883-11892	component	_	
66-20	11893-11896	map	_	
66-21	11897-11899	at	_	
66-22	11900-11903	the	_	
66-23	11904-11914	individual	_	
66-24	11915-11922	subject	_	
66-25	11923-11928	level	_	
66-26	11928-11929	.	_	

#Text=This technique allows for voxel-wise comparisons of rs-FC by carrying out the following steps: regresses the group level spatial maps into each individual’s 4D dataset to obtain a set of timeseries and then regresses those individual level timeseries into the same 4D dataset to obtain a subject-specific set of spatial maps.
67-1	11930-11934	This	_	
67-2	11935-11944	technique	_	
67-3	11945-11951	allows	_	
67-4	11952-11955	for	_	
67-5	11956-11966	voxel-wise	_	
67-6	11967-11978	comparisons	_	
67-7	11979-11981	of	_	
67-8	11982-11987	rs-FC	_	
67-9	11988-11990	by	_	
67-10	11991-11999	carrying	_	
67-11	12000-12003	out	_	
67-12	12004-12007	the	_	
67-13	12008-12017	following	_	
67-14	12018-12023	steps	_	
67-15	12023-12024	:	_	
67-16	12025-12034	regresses	_	
67-17	12035-12038	the	_	
67-18	12039-12044	group	_	
67-19	12045-12050	level	_	
67-20	12051-12058	spatial	_	
67-21	12059-12063	maps	_	
67-22	12064-12068	into	_	
67-23	12069-12073	each	_	
67-24	12074-12084	individual	_	
67-25	12084-12085	’	_	
67-26	12085-12086	s	_	
67-27	12087-12089	4D	_	
67-28	12090-12097	dataset	_	
67-29	12098-12100	to	_	
67-30	12101-12107	obtain	_	
67-31	12108-12109	a	_	
67-32	12110-12113	set	_	
67-33	12114-12116	of	_	
67-34	12117-12127	timeseries	_	
67-35	12128-12131	and	_	
67-36	12132-12136	then	_	
67-37	12137-12146	regresses	_	
67-38	12147-12152	those	_	
67-39	12153-12163	individual	_	
67-40	12164-12169	level	_	
67-41	12170-12180	timeseries	_	
67-42	12181-12185	into	_	
67-43	12186-12189	the	_	
67-44	12190-12194	same	_	
67-45	12195-12197	4D	_	
67-46	12198-12205	dataset	_	
67-47	12206-12208	to	_	
67-48	12209-12215	obtain	_	
67-49	12216-12217	a	_	
67-50	12218-12234	subject-specific	_	
67-51	12235-12238	set	_	
67-52	12239-12241	of	_	
67-53	12242-12249	spatial	_	
67-54	12250-12254	maps	_	
67-55	12254-12255	.	_	

#Text=The Harvard-Oxford cortical and subcortical atlases incorporated in FSL were used to identify the anatomical regions of the resulting PICA maps.
68-1	12256-12259	The	_	
68-2	12260-12274	Harvard-Oxford	_	
68-3	12275-12283	cortical	_	
68-4	12284-12287	and	_	
68-5	12288-12299	subcortical	_	
68-6	12300-12307	atlases	_	
68-7	12308-12320	incorporated	_	
68-8	12321-12323	in	_	
68-9	12324-12327	FSL	_	
68-10	12328-12332	were	_	
68-11	12333-12337	used	_	
68-12	12338-12340	to	_	
68-13	12341-12349	identify	_	
68-14	12350-12353	the	_	
68-15	12354-12364	anatomical	_	
68-16	12365-12372	regions	_	
68-17	12373-12375	of	_	
68-18	12376-12379	the	_	
68-19	12380-12389	resulting	_	
68-20	12390-12394	PICA	_	
68-21	12395-12399	maps	_	
68-22	12399-12400	.	_	

#Text=The FSL Cluster tools were used to report information about clusters in the selected maps.
69-1	12401-12404	The	_	
69-2	12405-12408	FSL	_	
69-3	12409-12416	Cluster	_	
69-4	12417-12422	tools	_	
69-5	12423-12427	were	_	
69-6	12428-12432	used	_	
69-7	12433-12435	to	_	
69-8	12436-12442	report	_	
69-9	12443-12454	information	_	
69-10	12455-12460	about	_	
69-11	12461-12469	clusters	_	
69-12	12470-12472	in	_	
69-13	12473-12476	the	_	
69-14	12477-12485	selected	_	
69-15	12486-12490	maps	_	
69-16	12490-12491	.	_	

#Text=The connectivity maps were overlaid onto the mean standardized structural T1 1-mm MNI template and visualized using Mricogl.
#Text=2.
70-1	12492-12495	The	_	
70-2	12496-12508	connectivity	_	
70-3	12509-12513	maps	_	
70-4	12514-12518	were	_	
70-5	12519-12527	overlaid	_	
70-6	12528-12532	onto	_	
70-7	12533-12536	the	_	
70-8	12537-12541	mean	_	
70-9	12542-12554	standardized	_	
70-10	12555-12565	structural	_	
70-11	12566-12568	T1	_	
70-12	12569-12570	1	_	
70-13	12570-12571	-	_	
70-14	12571-12573	mm	_	
70-15	12574-12577	MNI	_	
70-16	12578-12586	template	_	
70-17	12587-12590	and	_	
70-18	12591-12601	visualized	_	
70-19	12602-12607	using	_	
70-20	12608-12615	Mricogl	_	
70-21	12615-12616	.	_	
70-22	12617-12618	2	_	
70-23	12618-12619	.	_	

#Text=Feature selection
#Text=Within-network connectivity
#Text=The group level components maps thresholded at z > 7, cluster size > 30 voxels were used as masks on the subject-specific maps.
71-1	12620-12627	Feature	_	
71-2	12628-12637	selection	_	
71-3	12638-12652	Within-network	_	
71-4	12653-12665	connectivity	_	
71-5	12666-12669	The	_	
71-6	12670-12675	group	_	
71-7	12676-12681	level	_	
71-8	12682-12692	components	_	
71-9	12693-12697	maps	_	
71-10	12698-12709	thresholded	_	
71-11	12710-12712	at	_	
71-12	12713-12714	z	_	
71-13	12715-12716	>	_	
71-14	12717-12718	7	_	
71-15	12718-12719	,	_	
71-16	12720-12727	cluster	_	
71-17	12728-12732	size	_	
71-18	12733-12734	>	_	
71-19	12735-12737	30	_	
71-20	12738-12744	voxels	_	
71-21	12745-12749	were	_	
71-22	12750-12754	used	_	
71-23	12755-12757	as	_	
71-24	12758-12763	masks	_	
71-25	12764-12766	on	_	
71-26	12767-12770	the	_	
71-27	12771-12787	subject-specific	_	
71-28	12788-12792	maps	_	
71-29	12792-12793	.	_	

#Text=The averaged z value within each mask was calculated as within-network connectivity features, thus in total 32 within-network connectivity features were extracted for each subject.
72-1	12794-12797	The	_	
72-2	12798-12806	averaged	_	
72-3	12807-12808	z	_	
72-4	12809-12814	value	_	
72-5	12815-12821	within	_	
72-6	12822-12826	each	_	
72-7	12827-12831	mask	_	
72-8	12832-12835	was	_	
72-9	12836-12846	calculated	_	
72-10	12847-12849	as	_	
72-11	12850-12864	within-network	_	
72-12	12865-12877	connectivity	_	
72-13	12878-12886	features	_	
72-14	12886-12887	,	_	
72-15	12888-12892	thus	_	
72-16	12893-12895	in	_	
72-17	12896-12901	total	_	
72-18	12902-12904	32	_	
72-19	12905-12919	within-network	_	
72-20	12920-12932	connectivity	_	
72-21	12933-12941	features	_	
72-22	12942-12946	were	_	
72-23	12947-12956	extracted	_	
72-24	12957-12960	for	_	
72-25	12961-12965	each	_	
72-26	12966-12973	subject	_	
72-27	12973-12974	.	_	

#Text=Between-network connectivity
#Text=Even though all component maps are spatially independent, time series of the components may still have significant temporal correlations.
73-1	12975-12990	Between-network	_	
73-2	12991-13003	connectivity	_	
73-3	13004-13008	Even	_	
73-4	13009-13015	though	_	
73-5	13016-13019	all	_	
73-6	13020-13029	component	_	
73-7	13030-13034	maps	_	
73-8	13035-13038	are	_	
73-9	13039-13048	spatially	_	
73-10	13049-13060	independent	_	
73-11	13060-13061	,	_	
73-12	13062-13066	time	_	
73-13	13067-13073	series	_	
73-14	13074-13076	of	_	
73-15	13077-13080	the	_	
73-16	13081-13091	components	_	
73-17	13092-13095	may	_	
73-18	13096-13101	still	_	
73-19	13102-13106	have	_	
73-20	13107-13118	significant	_	
73-21	13119-13127	temporal	_	
73-22	13128-13140	correlations	_	
73-23	13140-13141	.	_	

#Text=Network interaction comparisons (Correlation coefficients, Pearson’s r) between each pair of networks were computed for each subject time series that were obtained by the first stage of the dual regression procedure.
74-1	13142-13149	Network	_	
74-2	13150-13161	interaction	_	
74-3	13162-13173	comparisons	_	
74-4	13174-13175	(	_	
74-5	13175-13186	Correlation	_	
74-6	13187-13199	coefficients	_	
74-7	13199-13200	,	_	
74-8	13201-13208	Pearson	_	
74-9	13208-13209	’	_	
74-10	13209-13210	s	_	
74-11	13211-13212	r	_	
74-12	13212-13213	)	_	
74-13	13214-13221	between	_	
74-14	13222-13226	each	_	
74-15	13227-13231	pair	_	
74-16	13232-13234	of	_	
74-17	13235-13243	networks	_	
74-18	13244-13248	were	_	
74-19	13249-13257	computed	_	
74-20	13258-13261	for	_	
74-21	13262-13266	each	_	
74-22	13267-13274	subject	_	
74-23	13275-13279	time	_	
74-24	13280-13286	series	_	
74-25	13287-13291	that	_	
74-26	13292-13296	were	_	
74-27	13297-13305	obtained	_	
74-28	13306-13308	by	_	
74-29	13309-13312	the	_	
74-30	13313-13318	first	_	
74-31	13319-13324	stage	_	
74-32	13325-13327	of	_	
74-33	13328-13331	the	_	
74-34	13332-13336	dual	_	
74-35	13337-13347	regression	_	
74-36	13348-13357	procedure	_	
74-37	13357-13358	.	_	

#Text=These correlation coefficients were Fisher z-transformed and used as between-network connectivity features (496 features, figure 2).
75-1	13359-13364	These	_	
75-2	13365-13376	correlation	_	
75-3	13377-13389	coefficients	_	
75-4	13390-13394	were	_	
75-5	13395-13401	Fisher	_	
75-6	13402-13415	z-transformed	_	
75-7	13416-13419	and	_	
75-8	13420-13424	used	_	
75-9	13425-13427	as	_	
75-10	13428-13443	between-network	_	
75-11	13444-13456	connectivity	_	
75-12	13457-13465	features	_	
75-13	13466-13467	(	_	
75-14	13467-13470	496	_	
75-15	13471-13479	features	_	
75-16	13479-13480	,	_	
75-17	13481-13487	figure	_	
75-18	13488-13489	2	_	
75-19	13489-13490	)	_	
75-20	13490-13491	.	_	

#Text=The differences in age and gender between AUD and controls do not make for ideal comparisons.
76-1	13492-13495	The	_	
76-2	13496-13507	differences	_	
76-3	13508-13510	in	_	
76-4	13511-13514	age	_	
76-5	13515-13518	and	_	
76-6	13519-13525	gender	_	
76-7	13526-13533	between	_	
76-8	13534-13537	AUD	_	
76-9	13538-13541	and	_	
76-10	13542-13550	controls	_	
76-11	13551-13553	do	_	
76-12	13554-13557	not	_	
76-13	13558-13562	make	_	
76-14	13563-13566	for	_	
76-15	13567-13572	ideal	_	
76-16	13573-13584	comparisons	_	
76-17	13584-13585	.	_	

#Text=To minimize the potential confounding influence of age and gender in these results, we performed a covariate analysis of age and gender for each network of interest.
#Text=2.7 Classification
#Text=Random forest was applied to both within-network and between-network functional connectivity from the 46 AUD and 46 controls.
#Text=1.
77-1	13586-13588	To	_	
77-2	13589-13597	minimize	_	
77-3	13598-13601	the	_	
77-4	13602-13611	potential	_	
77-5	13612-13623	confounding	_	
77-6	13624-13633	influence	_	
77-7	13634-13636	of	_	
77-8	13637-13640	age	_	
77-9	13641-13644	and	_	
77-10	13645-13651	gender	_	
77-11	13652-13654	in	_	
77-12	13655-13660	these	_	
77-13	13661-13668	results	_	
77-14	13668-13669	,	_	
77-15	13670-13672	we	_	
77-16	13673-13682	performed	_	
77-17	13683-13684	a	_	
77-18	13685-13694	covariate	_	
77-19	13695-13703	analysis	_	
77-20	13704-13706	of	_	
77-21	13707-13710	age	_	
77-22	13711-13714	and	_	
77-23	13715-13721	gender	_	
77-24	13722-13725	for	_	
77-25	13726-13730	each	_	
77-26	13731-13738	network	_	
77-27	13739-13741	of	_	
77-28	13742-13750	interest	_	
77-29	13750-13751	.	_	
77-30	13752-13755	2.7	_	
77-31	13756-13770	Classification	_	
77-32	13771-13777	Random	_	
77-33	13778-13784	forest	_	
77-34	13785-13788	was	_	
77-35	13789-13796	applied	_	
77-36	13797-13799	to	_	
77-37	13800-13804	both	_	
77-38	13805-13819	within-network	_	
77-39	13820-13823	and	_	
77-40	13824-13839	between-network	_	
77-41	13840-13850	functional	_	
77-42	13851-13863	connectivity	_	
77-43	13864-13868	from	_	
77-44	13869-13872	the	_	
77-45	13873-13875	46	_	
77-46	13876-13879	AUD	_	
77-47	13880-13883	and	_	
77-48	13884-13886	46	_	
77-49	13887-13895	controls	_	
77-50	13895-13896	.	_	
77-51	13897-13898	1	_	
77-52	13898-13899	.	_	

#Text=Random Forest
#Text=Random forest, an ensemble machine-learning algorithm, builds a group of weak learners of decision trees to form a “strong learner”, thereby improving the generalization ability of the classifier (Breiman 2001).
78-1	13900-13906	Random	_	
78-2	13907-13913	Forest	_	
78-3	13914-13920	Random	_	
78-4	13921-13927	forest	_	
78-5	13927-13928	,	_	
78-6	13929-13931	an	_	
78-7	13932-13940	ensemble	_	
78-8	13941-13957	machine-learning	_	
78-9	13958-13967	algorithm	_	
78-10	13967-13968	,	_	
78-11	13969-13975	builds	_	
78-12	13976-13977	a	_	
78-13	13978-13983	group	_	
78-14	13984-13986	of	_	
78-15	13987-13991	weak	_	
78-16	13992-14000	learners	_	
78-17	14001-14003	of	_	
78-18	14004-14012	decision	_	
78-19	14013-14018	trees	_	
78-20	14019-14021	to	_	
78-21	14022-14026	form	_	
78-22	14027-14028	a	_	
78-23	14029-14030	“	_	
78-24	14030-14036	strong	_	
78-25	14037-14044	learner	_	
78-26	14044-14045	”	_	
78-27	14045-14046	,	_	
78-28	14047-14054	thereby	_	
78-29	14055-14064	improving	_	
78-30	14065-14068	the	_	
78-31	14069-14083	generalization	_	
78-32	14084-14091	ability	_	
78-33	14092-14094	of	_	
78-34	14095-14098	the	_	
78-35	14099-14109	classifier	_	
78-36	14110-14111	(	_	
78-37	14111-14118	Breiman	_	
78-38	14119-14123	2001	_	
78-39	14123-14124	)	_	
78-40	14124-14125	.	_	

#Text=In constructing the ensemble of trees, random forest uses two levels of randomness: first each tree uses a bootstrapped version of the training data (bagging).
79-1	14126-14128	In	_	
79-2	14129-14141	constructing	_	
79-3	14142-14145	the	_	
79-4	14146-14154	ensemble	_	
79-5	14155-14157	of	_	
79-6	14158-14163	trees	_	
79-7	14163-14164	,	_	
79-8	14165-14171	random	_	
79-9	14172-14178	forest	_	
79-10	14179-14183	uses	_	
79-11	14184-14187	two	_	
79-12	14188-14194	levels	_	
79-13	14195-14197	of	_	
79-14	14198-14208	randomness	_	
79-15	14208-14209	:	_	
79-16	14210-14215	first	_	
79-17	14216-14220	each	_	
79-18	14221-14225	tree	_	
79-19	14226-14230	uses	_	
79-20	14231-14232	a	_	
79-21	14233-14245	bootstrapped	_	
79-22	14246-14253	version	_	
79-23	14254-14256	of	_	
79-24	14257-14260	the	_	
79-25	14261-14269	training	_	
79-26	14270-14274	data	_	
79-27	14275-14276	(	_	
79-28	14276-14283	bagging	_	
79-29	14283-14284	)	_	
79-30	14284-14285	.	_	

#Text=Specifically, about 66% of the training data was used for each tree with replacement; the remaining training data was used to estimate error and variable importance.
80-1	14286-14298	Specifically	_	
80-2	14298-14299	,	_	
80-3	14300-14305	about	_	
80-4	14306-14309	66%	_	
80-5	14310-14312	of	_	
80-6	14313-14316	the	_	
80-7	14317-14325	training	_	
80-8	14326-14330	data	_	
80-9	14331-14334	was	_	
80-10	14335-14339	used	_	
80-11	14340-14343	for	_	
80-12	14344-14348	each	_	
80-13	14349-14353	tree	_	
80-14	14354-14358	with	_	
80-15	14359-14370	replacement	_	
80-16	14370-14371	;	_	
80-17	14372-14375	the	_	
80-18	14376-14385	remaining	_	
80-19	14386-14394	training	_	
80-20	14395-14399	data	_	
80-21	14400-14403	was	_	
80-22	14404-14408	used	_	
80-23	14409-14411	to	_	
80-24	14412-14420	estimate	_	
80-25	14421-14426	error	_	
80-26	14427-14430	and	_	
80-27	14431-14439	variable	_	
80-28	14440-14450	importance	_	
80-29	14450-14451	.	_	

#Text=A second level of randomness is added at each node when growing a decision tree by randomly selecting a subset of variables to split.
81-1	14452-14453	A	_	
81-2	14454-14460	second	_	
81-3	14461-14466	level	_	
81-4	14467-14469	of	_	
81-5	14470-14480	randomness	_	
81-6	14481-14483	is	_	
81-7	14484-14489	added	_	
81-8	14490-14492	at	_	
81-9	14493-14497	each	_	
81-10	14498-14502	node	_	
81-11	14503-14507	when	_	
81-12	14508-14515	growing	_	
81-13	14516-14517	a	_	
81-14	14518-14526	decision	_	
81-15	14527-14531	tree	_	
81-16	14532-14534	by	_	
81-17	14535-14543	randomly	_	
81-18	14544-14553	selecting	_	
81-19	14554-14555	a	_	
81-20	14556-14562	subset	_	
81-21	14563-14565	of	_	
81-22	14566-14575	variables	_	
81-23	14576-14578	to	_	
81-24	14579-14584	split	_	
81-25	14584-14585	.	_	

#Text=At each internal node, a best feature among a random subset of features is selected so as to maximize the reduction of label impurity, typically measured with the class entropy.
82-1	14586-14588	At	_	
82-2	14589-14593	each	_	
82-3	14594-14602	internal	_	
82-4	14603-14607	node	_	
82-5	14607-14608	,	_	
82-6	14609-14610	a	_	
82-7	14611-14615	best	_	
82-8	14616-14623	feature	_	
82-9	14624-14629	among	_	
82-10	14630-14631	a	_	
82-11	14632-14638	random	_	
82-12	14639-14645	subset	_	
82-13	14646-14648	of	_	
82-14	14649-14657	features	_	
82-15	14658-14660	is	_	
82-16	14661-14669	selected	_	
82-17	14670-14672	so	_	
82-18	14673-14675	as	_	
82-19	14676-14678	to	_	
82-20	14679-14687	maximize	_	
82-21	14688-14691	the	_	
82-22	14692-14701	reduction	_	
82-23	14702-14704	of	_	
82-24	14705-14710	label	_	
82-25	14711-14719	impurity	_	
82-26	14719-14720	,	_	
82-27	14721-14730	typically	_	
82-28	14731-14739	measured	_	
82-29	14740-14744	with	_	
82-30	14745-14748	the	_	
82-31	14749-14754	class	_	
82-32	14755-14762	entropy	_	
82-33	14762-14763	.	_	

#Text=The process is recursively repeated until the tree has either reached a predefined depth or the number of samples in a node falls below a threshold, or all the samples belong to the same class.
83-1	14764-14767	The	_	
83-2	14768-14775	process	_	
83-3	14776-14778	is	_	
83-4	14779-14790	recursively	_	
83-5	14791-14799	repeated	_	
83-6	14800-14805	until	_	
83-7	14806-14809	the	_	
83-8	14810-14814	tree	_	
83-9	14815-14818	has	_	
83-10	14819-14825	either	_	
83-11	14826-14833	reached	_	
83-12	14834-14835	a	_	
83-13	14836-14846	predefined	_	
83-14	14847-14852	depth	_	
83-15	14853-14855	or	_	
83-16	14856-14859	the	_	
83-17	14860-14866	number	_	
83-18	14867-14869	of	_	
83-19	14870-14877	samples	_	
83-20	14878-14880	in	_	
83-21	14881-14882	a	_	
83-22	14883-14887	node	_	
83-23	14888-14893	falls	_	
83-24	14894-14899	below	_	
83-25	14900-14901	a	_	
83-26	14902-14911	threshold	_	
83-27	14911-14912	,	_	
83-28	14913-14915	or	_	
83-29	14916-14919	all	_	
83-30	14920-14923	the	_	
83-31	14924-14931	samples	_	
83-32	14932-14938	belong	_	
83-33	14939-14941	to	_	
83-34	14942-14945	the	_	
83-35	14946-14950	same	_	
83-36	14951-14956	class	_	
83-37	14956-14957	.	_	

#Text=The number of trees in the ensemble and the number of variables selected at each node are the two main parameters of the random forest algorithm.
84-1	14958-14961	The	_	
84-2	14962-14968	number	_	
84-3	14969-14971	of	_	
84-4	14972-14977	trees	_	
84-5	14978-14980	in	_	
84-6	14981-14984	the	_	
84-7	14985-14993	ensemble	_	
84-8	14994-14997	and	_	
84-9	14998-15001	the	_	
84-10	15002-15008	number	_	
84-11	15009-15011	of	_	
84-12	15012-15021	variables	_	
84-13	15022-15030	selected	_	
84-14	15031-15033	at	_	
84-15	15034-15038	each	_	
84-16	15039-15043	node	_	
84-17	15044-15047	are	_	
84-18	15048-15051	the	_	
84-19	15052-15055	two	_	
84-20	15056-15060	main	_	
84-21	15061-15071	parameters	_	
84-22	15072-15074	of	_	
84-23	15075-15078	the	_	
84-24	15079-15085	random	_	
84-25	15086-15092	forest	_	
84-26	15093-15102	algorithm	_	
84-27	15102-15103	.	_	

#Text=The random forest has been proven to achieve good performance with a different variety of datasets and has important advantages over other techniques in terms of its ability to handle highly non-linear biological data, robustness to noise, tuning simplicity (compared to other ensemble learning algorithms), and opportunity for efficient parallel processing.
85-1	15104-15107	The	_	
85-2	15108-15114	random	_	
85-3	15115-15121	forest	_	
85-4	15122-15125	has	_	
85-5	15126-15130	been	_	
85-6	15131-15137	proven	_	
85-7	15138-15140	to	_	
85-8	15141-15148	achieve	_	
85-9	15149-15153	good	_	
85-10	15154-15165	performance	_	
85-11	15166-15170	with	_	
85-12	15171-15172	a	_	
85-13	15173-15182	different	_	
85-14	15183-15190	variety	_	
85-15	15191-15193	of	_	
85-16	15194-15202	datasets	_	
85-17	15203-15206	and	_	
85-18	15207-15210	has	_	
85-19	15211-15220	important	_	
85-20	15221-15231	advantages	_	
85-21	15232-15236	over	_	
85-22	15237-15242	other	_	
85-23	15243-15253	techniques	_	
85-24	15254-15256	in	_	
85-25	15257-15262	terms	_	
85-26	15263-15265	of	_	
85-27	15266-15269	its	_	
85-28	15270-15277	ability	_	
85-29	15278-15280	to	_	
85-30	15281-15287	handle	_	
85-31	15288-15294	highly	_	
85-32	15295-15305	non-linear	_	
85-33	15306-15316	biological	_	
85-34	15317-15321	data	_	
85-35	15321-15322	,	_	
85-36	15323-15333	robustness	_	
85-37	15334-15336	to	_	
85-38	15337-15342	noise	_	
85-39	15342-15343	,	_	
85-40	15344-15350	tuning	_	
85-41	15351-15361	simplicity	_	
85-42	15362-15363	(	_	
85-43	15363-15371	compared	_	
85-44	15372-15374	to	_	
85-45	15375-15380	other	_	
85-46	15381-15389	ensemble	_	
85-47	15390-15398	learning	_	
85-48	15399-15409	algorithms	_	
85-49	15409-15410	)	_	
85-50	15410-15411	,	_	
85-51	15412-15415	and	_	
85-52	15416-15427	opportunity	_	
85-53	15428-15431	for	_	
85-54	15432-15441	efficient	_	
85-55	15442-15450	parallel	_	
85-56	15451-15461	processing	_	
85-57	15461-15462	.	_	

#Text=Classification of a new instance can be made by taking the majority vote from all the decision trees.
86-1	15463-15477	Classification	_	
86-2	15478-15480	of	_	
86-3	15481-15482	a	_	
86-4	15483-15486	new	_	
86-5	15487-15495	instance	_	
86-6	15496-15499	can	_	
86-7	15500-15502	be	_	
86-8	15503-15507	made	_	
86-9	15508-15510	by	_	
86-10	15511-15517	taking	_	
86-11	15518-15521	the	_	
86-12	15522-15530	majority	_	
86-13	15531-15535	vote	_	
86-14	15536-15540	from	_	
86-15	15541-15544	all	_	
86-16	15545-15548	the	_	
86-17	15549-15557	decision	_	
86-18	15558-15563	trees	_	
86-19	15563-15564	.	_	

#Text=It’s often helpful to calculate relative importance or contribution of each feature in predicting the label.
87-1	15565-15567	It	_	
87-2	15567-15568	’	_	
87-3	15568-15569	s	_	
87-4	15570-15575	often	_	
87-5	15576-15583	helpful	_	
87-6	15584-15586	to	_	
87-7	15587-15596	calculate	_	
87-8	15597-15605	relative	_	
87-9	15606-15616	importance	_	
87-10	15617-15619	or	_	
87-11	15620-15632	contribution	_	
87-12	15633-15635	of	_	
87-13	15636-15640	each	_	
87-14	15641-15648	feature	_	
87-15	15649-15651	in	_	
87-16	15652-15662	predicting	_	
87-17	15663-15666	the	_	
87-18	15667-15672	label	_	
87-19	15672-15673	.	_	

#Text=Random forest has several ways of constructing variable importance: 1) mean decrease impurity, i.e. average of the accumulated decrease in node impurity over all trees for each feature or 2) mean decrease accuracy, i.e. the decrease in accuracy on out-of-bag (OOB) samples by randomly permuting values for each feature.
88-1	15674-15680	Random	_	
88-2	15681-15687	forest	_	
88-3	15688-15691	has	_	
88-4	15692-15699	several	_	
88-5	15700-15704	ways	_	
88-6	15705-15707	of	_	
88-7	15708-15720	constructing	_	
88-8	15721-15729	variable	_	
88-9	15730-15740	importance	_	
88-10	15740-15741	:	_	
88-11	15742-15743	1	_	
88-12	15743-15744	)	_	
88-13	15745-15749	mean	_	
88-14	15750-15758	decrease	_	
88-15	15759-15767	impurity	_	
88-16	15767-15768	,	_	
88-17	15769-15772	i.e	_	
88-18	15772-15773	.	_	
88-19	15774-15781	average	_	
88-20	15782-15784	of	_	
88-21	15785-15788	the	_	
88-22	15789-15800	accumulated	_	
88-23	15801-15809	decrease	_	
88-24	15810-15812	in	_	
88-25	15813-15817	node	_	
88-26	15818-15826	impurity	_	
88-27	15827-15831	over	_	
88-28	15832-15835	all	_	
88-29	15836-15841	trees	_	
88-30	15842-15845	for	_	
88-31	15846-15850	each	_	
88-32	15851-15858	feature	_	
88-33	15859-15861	or	_	
88-34	15862-15863	2	_	
88-35	15863-15864	)	_	
88-36	15865-15869	mean	_	
88-37	15870-15878	decrease	_	
88-38	15879-15887	accuracy	_	
88-39	15887-15888	,	_	
88-40	15889-15892	i.e	_	
88-41	15892-15893	.	_	
88-42	15894-15897	the	_	
88-43	15898-15906	decrease	_	
88-44	15907-15909	in	_	
88-45	15910-15918	accuracy	_	
88-46	15919-15921	on	_	
88-47	15922-15932	out-of-bag	_	
88-48	15933-15934	(	_	
88-49	15934-15937	OOB	_	
88-50	15937-15938	)	_	
88-51	15939-15946	samples	_	
88-52	15947-15949	by	_	
88-53	15950-15958	randomly	_	
88-54	15959-15968	permuting	_	
88-55	15969-15975	values	_	
88-56	15976-15979	for	_	
88-57	15980-15984	each	_	
88-58	15985-15992	feature	_	
88-59	15992-15993	.	_	

#Text=In this work we will use the first method to measure feature importance.
89-1	15994-15996	In	_	
89-2	15997-16001	this	_	
89-3	16002-16006	work	_	
89-4	16007-16009	we	_	
89-5	16010-16014	will	_	
89-6	16015-16018	use	_	
89-7	16019-16022	the	_	
89-8	16023-16028	first	_	
89-9	16029-16035	method	_	
89-10	16036-16038	to	_	
89-11	16039-16046	measure	_	
89-12	16047-16054	feature	_	
89-13	16055-16065	importance	_	
89-14	16065-16066	.	_	

#Text=We used the python package scikit random forest with the parameters for the number of trees (ntree = 600) and the number of features analyzed at each node to find the best split (for a dataset with p features, square root of p are used in each split).
#Text=2.
90-1	16067-16069	We	_	
90-2	16070-16074	used	_	
90-3	16075-16078	the	_	
90-4	16079-16085	python	_	
90-5	16086-16093	package	_	
90-6	16094-16100	scikit	_	
90-7	16101-16107	random	_	
90-8	16108-16114	forest	_	
90-9	16115-16119	with	_	
90-10	16120-16123	the	_	
90-11	16124-16134	parameters	_	
90-12	16135-16138	for	_	
90-13	16139-16142	the	_	
90-14	16143-16149	number	_	
90-15	16150-16152	of	_	
90-16	16153-16158	trees	_	
90-17	16159-16160	(	_	
90-18	16160-16165	ntree	_	
90-19	16166-16167	=	_	
90-20	16168-16171	600	_	
90-21	16171-16172	)	_	
90-22	16173-16176	and	_	
90-23	16177-16180	the	_	
90-24	16181-16187	number	_	
90-25	16188-16190	of	_	
90-26	16191-16199	features	_	
90-27	16200-16208	analyzed	_	
90-28	16209-16211	at	_	
90-29	16212-16216	each	_	
90-30	16217-16221	node	_	
90-31	16222-16224	to	_	
90-32	16225-16229	find	_	
90-33	16230-16233	the	_	
90-34	16234-16238	best	_	
90-35	16239-16244	split	_	
90-36	16245-16246	(	_	
90-37	16246-16249	for	_	
90-38	16250-16251	a	_	
90-39	16252-16259	dataset	_	
90-40	16260-16264	with	_	
90-41	16265-16266	p	_	
90-42	16267-16275	features	_	
90-43	16275-16276	,	_	
90-44	16277-16283	square	_	
90-45	16284-16288	root	_	
90-46	16289-16291	of	_	
90-47	16292-16293	p	_	
90-48	16294-16297	are	_	
90-49	16298-16302	used	_	
90-50	16303-16305	in	_	
90-51	16306-16310	each	_	
90-52	16311-16316	split	_	
90-53	16316-16317	)	_	
90-54	16317-16318	.	_	
90-55	16319-16320	2	_	
90-56	16320-16321	.	_	

#Text=Feature elimination
#Text=When the total number of variables is large, but the fraction of relevant variables is small, then random forests are likely to perform poorly due to the small chances that the relevant variables being selected.
91-1	16322-16329	Feature	_	
91-2	16330-16341	elimination	_	
91-3	16342-16346	When	_	
91-4	16347-16350	the	_	
91-5	16351-16356	total	_	
91-6	16357-16363	number	_	
91-7	16364-16366	of	_	
91-8	16367-16376	variables	_	
91-9	16377-16379	is	_	
91-10	16380-16385	large	_	
91-11	16385-16386	,	_	
91-12	16387-16390	but	_	
91-13	16391-16394	the	_	
91-14	16395-16403	fraction	_	
91-15	16404-16406	of	_	
91-16	16407-16415	relevant	_	
91-17	16416-16425	variables	_	
91-18	16426-16428	is	_	
91-19	16429-16434	small	_	
91-20	16434-16435	,	_	
91-21	16436-16440	then	_	
91-22	16441-16447	random	_	
91-23	16448-16455	forests	_	
91-24	16456-16459	are	_	
91-25	16460-16466	likely	_	
91-26	16467-16469	to	_	
91-27	16470-16477	perform	_	
91-28	16478-16484	poorly	_	
91-29	16485-16488	due	_	
91-30	16489-16491	to	_	
91-31	16492-16495	the	_	
91-32	16496-16501	small	_	
91-33	16502-16509	chances	_	
91-34	16510-16514	that	_	
91-35	16515-16518	the	_	
91-36	16519-16527	relevant	_	
91-37	16528-16537	variables	_	
91-38	16538-16543	being	_	
91-39	16544-16552	selected	_	
91-40	16552-16553	.	_	

#Text=Moreover, when the dimensionality of feature space increases, the available observations become sparse which causes the problem of “curse of dimensionality” which refers to the phenomenon that as dimensionality of data increases, the available data becomes sparse, thus it is difficult to extract a meaningful conclusion from the data set.
92-1	16554-16562	Moreover	_	
92-2	16562-16563	,	_	
92-3	16564-16568	when	_	
92-4	16569-16572	the	_	
92-5	16573-16587	dimensionality	_	
92-6	16588-16590	of	_	
92-7	16591-16598	feature	_	
92-8	16599-16604	space	_	
92-9	16605-16614	increases	_	
92-10	16614-16615	,	_	
92-11	16616-16619	the	_	
92-12	16620-16629	available	_	
92-13	16630-16642	observations	_	
92-14	16643-16649	become	_	
92-15	16650-16656	sparse	_	
92-16	16657-16662	which	_	
92-17	16663-16669	causes	_	
92-18	16670-16673	the	_	
92-19	16674-16681	problem	_	
92-20	16682-16684	of	_	
92-21	16685-16686	“	_	
92-22	16686-16691	curse	_	
92-23	16692-16694	of	_	
92-24	16695-16709	dimensionality	_	
92-25	16709-16710	”	_	
92-26	16711-16716	which	_	
92-27	16717-16723	refers	_	
92-28	16724-16726	to	_	
92-29	16727-16730	the	_	
92-30	16731-16741	phenomenon	_	
92-31	16742-16746	that	_	
92-32	16747-16749	as	_	
92-33	16750-16764	dimensionality	_	
92-34	16765-16767	of	_	
92-35	16768-16772	data	_	
92-36	16773-16782	increases	_	
92-37	16782-16783	,	_	
92-38	16784-16787	the	_	
92-39	16788-16797	available	_	
92-40	16798-16802	data	_	
92-41	16803-16810	becomes	_	
92-42	16811-16817	sparse	_	
92-43	16817-16818	,	_	
92-44	16819-16823	thus	_	
92-45	16824-16826	it	_	
92-46	16827-16829	is	_	
92-47	16830-16839	difficult	_	
92-48	16840-16842	to	_	
92-49	16843-16850	extract	_	
92-50	16851-16852	a	_	
92-51	16853-16863	meaningful	_	
92-52	16864-16874	conclusion	_	
92-53	16875-16879	from	_	
92-54	16880-16883	the	_	
92-55	16884-16888	data	_	
92-56	16889-16892	set	_	
92-57	16892-16893	.	_	

#Text=Additional steps such as feature selection and reduction are needed to avoid curse of dimensionality.
93-1	16894-16904	Additional	_	
93-2	16905-16910	steps	_	
93-3	16911-16915	such	_	
93-4	16916-16918	as	_	
93-5	16919-16926	feature	_	
93-6	16927-16936	selection	_	
93-7	16937-16940	and	_	
93-8	16941-16950	reduction	_	
93-9	16951-16954	are	_	
93-10	16955-16961	needed	_	
93-11	16962-16964	to	_	
93-12	16965-16970	avoid	_	
93-13	16971-16976	curse	_	
93-14	16977-16979	of	_	
93-15	16980-16994	dimensionality	_	
93-16	16994-16995	.	_	

#Text=Random forest can be considered as an effective feature selection algorithm by using the feature importance scores.
94-1	16996-17002	Random	_	
94-2	17003-17009	forest	_	
94-3	17010-17013	can	_	
94-4	17014-17016	be	_	
94-5	17017-17027	considered	_	
94-6	17028-17030	as	_	
94-7	17031-17033	an	_	
94-8	17034-17043	effective	_	
94-9	17044-17051	feature	_	
94-10	17052-17061	selection	_	
94-11	17062-17071	algorithm	_	
94-12	17072-17074	by	_	
94-13	17075-17080	using	_	
94-14	17081-17084	the	_	
94-15	17085-17092	feature	_	
94-16	17093-17103	importance	_	
94-17	17104-17110	scores	_	
94-18	17110-17111	.	_	

#Text=In the current study, random forest was first performed on all features, and the ranking of average feature importance was used for feature elimination.
#Text=3.
95-1	17112-17114	In	_	
95-2	17115-17118	the	_	
95-3	17119-17126	current	_	
95-4	17127-17132	study	_	
95-5	17132-17133	,	_	
95-6	17134-17140	random	_	
95-7	17141-17147	forest	_	
95-8	17148-17151	was	_	
95-9	17152-17157	first	_	
95-10	17158-17167	performed	_	
95-11	17168-17170	on	_	
95-12	17171-17174	all	_	
95-13	17175-17183	features	_	
95-14	17183-17184	,	_	
95-15	17185-17188	and	_	
95-16	17189-17192	the	_	
95-17	17193-17200	ranking	_	
95-18	17201-17203	of	_	
95-19	17204-17211	average	_	
95-20	17212-17219	feature	_	
95-21	17220-17230	importance	_	
95-22	17231-17234	was	_	
95-23	17235-17239	used	_	
95-24	17240-17243	for	_	
95-25	17244-17251	feature	_	
95-26	17252-17263	elimination	_	
95-27	17263-17264	.	_	
95-28	17265-17266	3	_	
95-29	17266-17267	.	_	

#Text=Classification performance
#Text=The performance of the classifier was then evaluated based on accuracy, and precision.
96-1	17268-17282	Classification	_	
96-2	17283-17294	performance	_	
96-3	17295-17298	The	_	
96-4	17299-17310	performance	_	
96-5	17311-17313	of	_	
96-6	17314-17317	the	_	
96-7	17318-17328	classifier	_	
96-8	17329-17332	was	_	
96-9	17333-17337	then	_	
96-10	17338-17347	evaluated	_	
96-11	17348-17353	based	_	
96-12	17354-17356	on	_	
96-13	17357-17365	accuracy	_	
96-14	17365-17366	,	_	
96-15	17367-17370	and	_	
96-16	17371-17380	precision	_	
96-17	17380-17381	.	_	

#Text=The prediction data included true positive (TP), false negative (FN), true negative (TN), and false positive (FP) classifications.
97-1	17382-17385	The	_	
97-2	17386-17396	prediction	_	
97-3	17397-17401	data	_	
97-4	17402-17410	included	_	
97-5	17411-17415	true	_	
97-6	17416-17424	positive	_	
97-7	17425-17426	(	_	
97-8	17426-17428	TP	_	
97-9	17428-17429	)	_	
97-10	17429-17430	,	_	
97-11	17431-17436	false	_	
97-12	17437-17445	negative	_	
97-13	17446-17447	(	_	
97-14	17447-17449	FN	_	
97-15	17449-17450	)	_	
97-16	17450-17451	,	_	
97-17	17452-17456	true	_	
97-18	17457-17465	negative	_	
97-19	17466-17467	(	_	
97-20	17467-17469	TN	_	
97-21	17469-17470	)	_	
97-22	17470-17471	,	_	
97-23	17472-17475	and	_	
97-24	17476-17481	false	_	
97-25	17482-17490	positive	_	
97-26	17491-17492	(	_	
97-27	17492-17494	FP	_	
97-28	17494-17495	)	_	
97-29	17496-17511	classifications	_	
97-30	17511-17512	.	_	

#Text=The accuracy and precision were computed using the following formulas:  
#Text=To explore an optimal set of feature variables, datasets were entered individually, and the prediction accuracy was computed by using leave-one-out cross-validation (LOOCV).
98-1	17513-17516	The	_	
98-2	17517-17525	accuracy	_	
98-3	17526-17529	and	_	
98-4	17530-17539	precision	_	
98-5	17540-17544	were	_	
98-6	17545-17553	computed	_	
98-7	17554-17559	using	_	
98-8	17560-17563	the	_	
98-9	17564-17573	following	_	
98-10	17574-17582	formulas	_	
98-11	17582-17583	:	_	
98-12	17586-17588	To	_	
98-13	17589-17596	explore	_	
98-14	17597-17599	an	_	
98-15	17600-17607	optimal	_	
98-16	17608-17611	set	_	
98-17	17612-17614	of	_	
98-18	17615-17622	feature	_	
98-19	17623-17632	variables	_	
98-20	17632-17633	,	_	
98-21	17634-17642	datasets	_	
98-22	17643-17647	were	_	
98-23	17648-17655	entered	_	
98-24	17656-17668	individually	_	
98-25	17668-17669	,	_	
98-26	17670-17673	and	_	
98-27	17674-17677	the	_	
98-28	17678-17688	prediction	_	
98-29	17689-17697	accuracy	_	
98-30	17698-17701	was	_	
98-31	17702-17710	computed	_	
98-32	17711-17713	by	_	
98-33	17714-17719	using	_	
98-34	17720-17733	leave-one-out	_	
98-35	17734-17750	cross-validation	_	
98-36	17751-17752	(	_	
98-37	17752-17757	LOOCV	_	
98-38	17757-17758	)	_	
98-39	17758-17759	.	_	

#Text=In LOOCV, one subject’s data are left out of the dataset, and the random forest creates an optimal classifier using the remaining data.
99-1	17760-17762	In	_	
99-2	17763-17768	LOOCV	_	
99-3	17768-17769	,	_	
99-4	17770-17773	one	_	
99-5	17774-17781	subject	_	
99-6	17781-17782	’	_	
99-7	17782-17783	s	_	
99-8	17784-17788	data	_	
99-9	17789-17792	are	_	
99-10	17793-17797	left	_	
99-11	17798-17801	out	_	
99-12	17802-17804	of	_	
99-13	17805-17808	the	_	
99-14	17809-17816	dataset	_	
99-15	17816-17817	,	_	
99-16	17818-17821	and	_	
99-17	17822-17825	the	_	
99-18	17826-17832	random	_	
99-19	17833-17839	forest	_	
99-20	17840-17847	creates	_	
99-21	17848-17850	an	_	
99-22	17851-17858	optimal	_	
99-23	17859-17869	classifier	_	
99-24	17870-17875	using	_	
99-25	17876-17879	the	_	
99-26	17880-17889	remaining	_	
99-27	17890-17894	data	_	
99-28	17894-17895	.	_	

#Text=The classifier predicts the label (AUD or control) of the one subject who was left out, and the accuracy of this prediction is assessed.
100-1	17896-17899	The	_	
100-2	17900-17910	classifier	_	
100-3	17911-17919	predicts	_	
100-4	17920-17923	the	_	
100-5	17924-17929	label	_	
100-6	17930-17931	(	_	
100-7	17931-17934	AUD	_	
100-8	17935-17937	or	_	
100-9	17938-17945	control	_	
100-10	17945-17946	)	_	
100-11	17947-17949	of	_	
100-12	17950-17953	the	_	
100-13	17954-17957	one	_	
100-14	17958-17965	subject	_	
100-15	17966-17969	who	_	
100-16	17970-17973	was	_	
100-17	17974-17978	left	_	
100-18	17979-17982	out	_	
100-19	17982-17983	,	_	
100-20	17984-17987	and	_	
100-21	17988-17991	the	_	
100-22	17992-18000	accuracy	_	
100-23	18001-18003	of	_	
100-24	18004-18008	this	_	
100-25	18009-18019	prediction	_	
100-26	18020-18022	is	_	
100-27	18023-18031	assessed	_	
100-28	18031-18032	.	_	

#Text=This procedure was repeated as many times as the number of subjects, with a different subject being left out each time; finally, total accuracy was computed for each category (Figure 3).
101-1	18033-18037	This	_	
101-2	18038-18047	procedure	_	
101-3	18048-18051	was	_	
101-4	18052-18060	repeated	_	
101-5	18061-18063	as	_	
101-6	18064-18068	many	_	
101-7	18069-18074	times	_	
101-8	18075-18077	as	_	
101-9	18078-18081	the	_	
101-10	18082-18088	number	_	
101-11	18089-18091	of	_	
101-12	18092-18100	subjects	_	
101-13	18100-18101	,	_	
101-14	18102-18106	with	_	
101-15	18107-18108	a	_	
101-16	18109-18118	different	_	
101-17	18119-18126	subject	_	
101-18	18127-18132	being	_	
101-19	18133-18137	left	_	
101-20	18138-18141	out	_	
101-21	18142-18146	each	_	
101-22	18147-18151	time	_	
101-23	18151-18152	;	_	
101-24	18153-18160	finally	_	
101-25	18160-18161	,	_	
101-26	18162-18167	total	_	
101-27	18168-18176	accuracy	_	
101-28	18177-18180	was	_	
101-29	18181-18189	computed	_	
101-30	18190-18193	for	_	
101-31	18194-18198	each	_	
101-32	18199-18207	category	_	
101-33	18208-18209	(	_	
101-34	18209-18215	Figure	_	
101-35	18216-18217	3	_	
101-36	18217-18218	)	_	
101-37	18218-18219	.	_	

#Text=To test whether classification performance was significantly above chance, we randomly assign each subject as AUD or control and used this dataset to train and test each classifier.
102-1	18220-18222	To	_	
102-2	18223-18227	test	_	
102-3	18228-18235	whether	_	
102-4	18236-18250	classification	_	
102-5	18251-18262	performance	_	
102-6	18263-18266	was	_	
102-7	18267-18280	significantly	_	
102-8	18281-18286	above	_	
102-9	18287-18293	chance	_	
102-10	18293-18294	,	_	
102-11	18295-18297	we	_	
102-12	18298-18306	randomly	_	
102-13	18307-18313	assign	_	
102-14	18314-18318	each	_	
102-15	18319-18326	subject	_	
102-16	18327-18329	as	_	
102-17	18330-18333	AUD	_	
102-18	18334-18336	or	_	
102-19	18337-18344	control	_	
102-20	18345-18348	and	_	
102-21	18349-18353	used	_	
102-22	18354-18358	this	_	
102-23	18359-18366	dataset	_	
102-24	18367-18369	to	_	
102-25	18370-18375	train	_	
102-26	18376-18379	and	_	
102-27	18380-18384	test	_	
102-28	18385-18389	each	_	
102-29	18390-18400	classifier	_	
102-30	18400-18401	.	_	

#Text=This procedure was carried out 1000 time and obtained the distribution of accuracy (mean= 0.486; std= 0.071) and precision (mean=0.51; std=0.048).
103-1	18402-18406	This	_	
103-2	18407-18416	procedure	_	
103-3	18417-18420	was	_	
103-4	18421-18428	carried	_	
103-5	18429-18432	out	_	
103-6	18433-18437	1000	_	
103-7	18438-18442	time	_	
103-8	18443-18446	and	_	
103-9	18447-18455	obtained	_	
103-10	18456-18459	the	_	
103-11	18460-18472	distribution	_	
103-12	18473-18475	of	_	
103-13	18476-18484	accuracy	_	
103-14	18485-18486	(	_	
103-15	18486-18490	mean	_	
103-16	18490-18491	=	_	
103-17	18492-18497	0.486	_	
103-18	18497-18498	;	_	
103-19	18499-18502	std	_	
103-20	18502-18503	=	_	
103-21	18504-18509	0.071	_	
103-22	18509-18510	)	_	
103-23	18511-18514	and	_	
103-24	18515-18524	precision	_	
103-25	18525-18526	(	_	
103-26	18526-18530	mean	_	
103-27	18530-18531	=	_	
103-28	18531-18535	0.51	_	
103-29	18535-18536	;	_	
103-30	18537-18540	std	_	
103-31	18540-18541	=	_	
103-32	18541-18546	0.048	_	
103-33	18546-18547	)	_	
103-34	18547-18548	.	_	

#Text=Z-tests were used to test the statistical significance between the actual accuracy and precision values and the randomly generated values.
104-1	18549-18556	Z-tests	_	
104-2	18557-18561	were	_	
104-3	18562-18566	used	_	
104-4	18567-18569	to	_	
104-5	18570-18574	test	_	
104-6	18575-18578	the	_	
104-7	18579-18590	statistical	_	
104-8	18591-18603	significance	_	
104-9	18604-18611	between	_	
104-10	18612-18615	the	_	
104-11	18616-18622	actual	_	
104-12	18623-18631	accuracy	_	
104-13	18632-18635	and	_	
104-14	18636-18645	precision	_	
104-15	18646-18652	values	_	
104-16	18653-18656	and	_	
104-17	18657-18660	the	_	
104-18	18661-18669	randomly	_	
104-19	18670-18679	generated	_	
104-20	18680-18686	values	_	
104-21	18686-18687	.	_	

#Text=Whether the actual accuracy and precision values were 2 standard deviations above the generated values were also tested.
105-1	18688-18695	Whether	_	
105-2	18696-18699	the	_	
105-3	18700-18706	actual	_	
105-4	18707-18715	accuracy	_	
105-5	18716-18719	and	_	
105-6	18720-18729	precision	_	
105-7	18730-18736	values	_	
105-8	18737-18741	were	_	
105-9	18742-18743	2	_	
105-10	18744-18752	standard	_	
105-11	18753-18763	deviations	_	
105-12	18764-18769	above	_	
105-13	18770-18773	the	_	
105-14	18774-18783	generated	_	
105-15	18784-18790	values	_	
105-16	18791-18795	were	_	
105-17	18796-18800	also	_	
105-18	18801-18807	tested	_	
105-19	18807-18808	.	_	

#Text=Results
#Text=We trained and tested the classifier to distinguish the patterns of resting state functional connectivity between AUD and controls.
106-1	18809-18816	Results	_	
106-2	18817-18819	We	_	
106-3	18820-18827	trained	_	
106-4	18828-18831	and	_	
106-5	18832-18838	tested	_	
106-6	18839-18842	the	_	
106-7	18843-18853	classifier	_	
106-8	18854-18856	to	_	
106-9	18857-18868	distinguish	_	
106-10	18869-18872	the	_	
106-11	18873-18881	patterns	_	
106-12	18882-18884	of	_	
106-13	18885-18892	resting	_	
106-14	18893-18898	state	_	
106-15	18899-18909	functional	_	
106-16	18910-18922	connectivity	_	
106-17	18923-18930	between	_	
106-18	18931-18934	AUD	_	
106-19	18935-18938	and	_	
106-20	18939-18947	controls	_	
106-21	18947-18948	.	_	

#Text=Table 2 summarized the performance of the random forest with no feature elimination, 50% feature elimination and 90% feature elimination.
107-1	18949-18954	Table	_	
107-2	18955-18956	2	_	
107-3	18957-18967	summarized	_	
107-4	18968-18971	the	_	
107-5	18972-18983	performance	_	
107-6	18984-18986	of	_	
107-7	18987-18990	the	_	
107-8	18991-18997	random	_	
107-9	18998-19004	forest	_	
107-10	19005-19009	with	_	
107-11	19010-19012	no	_	
107-12	19013-19020	feature	_	
107-13	19021-19032	elimination	_	
107-14	19032-19033	,	_	
107-15	19034-19037	50%	_	
107-16	19038-19045	feature	_	
107-17	19046-19057	elimination	_	
107-18	19058-19061	and	_	
107-19	19062-19065	90%	_	
107-20	19066-19073	feature	_	
107-21	19074-19085	elimination	_	
107-22	19085-19086	.	_	

#Text=As can be seen from the Table 2, classification performance significantly improved with feature elimination.
108-1	19087-19089	As	_	
108-2	19090-19093	can	_	
108-3	19094-19096	be	_	
108-4	19097-19101	seen	_	
108-5	19102-19106	from	_	
108-6	19107-19110	the	_	
108-7	19111-19116	Table	_	
108-8	19117-19118	2	_	
108-9	19118-19119	,	_	
108-10	19120-19134	classification	_	
108-11	19135-19146	performance	_	
108-12	19147-19160	significantly	_	
108-13	19161-19169	improved	_	
108-14	19170-19174	with	_	
108-15	19175-19182	feature	_	
108-16	19183-19194	elimination	_	
108-17	19194-19195	.	_	

#Text=To identify the features maximally contributing to the classifier, we extracted the features that were utilized in the classifier following 90% feature elimination.
109-1	19196-19198	To	_	
109-2	19199-19207	identify	_	
109-3	19208-19211	the	_	
109-4	19212-19220	features	_	
109-5	19221-19230	maximally	_	
109-6	19231-19243	contributing	_	
109-7	19244-19246	to	_	
109-8	19247-19250	the	_	
109-9	19251-19261	classifier	_	
109-10	19261-19262	,	_	
109-11	19263-19265	we	_	
109-12	19266-19275	extracted	_	
109-13	19276-19279	the	_	
109-14	19280-19288	features	_	
109-15	19289-19293	that	_	
109-16	19294-19298	were	_	
109-17	19299-19307	utilized	_	
109-18	19308-19310	in	_	
109-19	19311-19314	the	_	
109-20	19315-19325	classifier	_	
109-21	19326-19335	following	_	
109-22	19336-19339	90%	_	
109-23	19340-19347	feature	_	
109-24	19348-19359	elimination	_	
109-25	19359-19360	.	_	

#Text=The within-network features that have the strongest predicting power were found in: executive control network (ECN1) including orbitofrontal cortex (OFC), middle frontal gyrus (MFG), frontal pole (FP) and inferior frontal gyrus (IFG); ECN2 including MFG, FP, IFG anterior cingulate gyrus (ACC); and reward network (RN) including thalamus, nucleus accumbens, putamen, and caudate (Figure 4).
110-1	19361-19364	The	_	
110-2	19365-19379	within-network	_	
110-3	19380-19388	features	_	
110-4	19389-19393	that	_	
110-5	19394-19398	have	_	
110-6	19399-19402	the	_	
110-7	19403-19412	strongest	_	
110-8	19413-19423	predicting	_	
110-9	19424-19429	power	_	
110-10	19430-19434	were	_	
110-11	19435-19440	found	_	
110-12	19441-19443	in	_	
110-13	19443-19444	:	_	
110-14	19445-19454	executive	_	
110-15	19455-19462	control	_	
110-16	19463-19470	network	_	
110-17	19471-19472	(	_	
110-18	19472-19476	ECN1	_	
110-19	19476-19477	)	_	
110-20	19478-19487	including	_	
110-21	19488-19501	orbitofrontal	_	
110-22	19502-19508	cortex	_	
110-23	19509-19510	(	_	
110-24	19510-19513	OFC	_	
110-25	19513-19514	)	_	
110-26	19514-19515	,	_	
110-27	19516-19522	middle	_	
110-28	19523-19530	frontal	_	
110-29	19531-19536	gyrus	_	
110-30	19537-19538	(	_	
110-31	19538-19541	MFG	_	
110-32	19541-19542	)	_	
110-33	19542-19543	,	_	
110-34	19544-19551	frontal	_	
110-35	19552-19556	pole	_	
110-36	19557-19558	(	_	
110-37	19558-19560	FP	_	
110-38	19560-19561	)	_	
110-39	19562-19565	and	_	
110-40	19566-19574	inferior	_	
110-41	19575-19582	frontal	_	
110-42	19583-19588	gyrus	_	
110-43	19589-19590	(	_	
110-44	19590-19593	IFG	_	
110-45	19593-19594	)	_	
110-46	19594-19595	;	_	
110-47	19596-19600	ECN2	_	
110-48	19601-19610	including	_	
110-49	19611-19614	MFG	_	
110-50	19614-19615	,	_	
110-51	19616-19618	FP	_	
110-52	19618-19619	,	_	
110-53	19620-19623	IFG	_	
110-54	19624-19632	anterior	_	
110-55	19633-19642	cingulate	_	
110-56	19643-19648	gyrus	_	
110-57	19649-19650	(	_	
110-58	19650-19653	ACC	_	
110-59	19653-19654	)	_	
110-60	19654-19655	;	_	
110-61	19656-19659	and	_	
110-62	19660-19666	reward	_	
110-63	19667-19674	network	_	
110-64	19675-19676	(	_	
110-65	19676-19678	RN	_	
110-66	19678-19679	)	_	
110-67	19680-19689	including	_	
110-68	19690-19698	thalamus	_	
110-69	19698-19699	,	_	
110-70	19700-19707	nucleus	_	
110-71	19708-19717	accumbens	_	
110-72	19717-19718	,	_	
110-73	19719-19726	putamen	_	
110-74	19726-19727	,	_	
110-75	19728-19731	and	_	
110-76	19732-19739	caudate	_	
110-77	19740-19741	(	_	
110-78	19741-19747	Figure	_	
110-79	19748-19749	4	_	
110-80	19749-19750	)	_	
110-81	19750-19751	.	_	

#Text=The stability of within-network features was tested using leave-one-out cross-validation and the results were presented in Figure 5.
111-1	19752-19755	The	_	
111-2	19756-19765	stability	_	
111-3	19766-19768	of	_	
111-4	19769-19783	within-network	_	
111-5	19784-19792	features	_	
111-6	19793-19796	was	_	
111-7	19797-19803	tested	_	
111-8	19804-19809	using	_	
111-9	19810-19823	leave-one-out	_	
111-10	19824-19840	cross-validation	_	
111-11	19841-19844	and	_	
111-12	19845-19848	the	_	
111-13	19849-19856	results	_	
111-14	19857-19861	were	_	
111-15	19862-19871	presented	_	
111-16	19872-19874	in	_	
111-17	19875-19881	Figure	_	
111-18	19882-19883	5	_	
111-19	19883-19884	.	_	

#Text=The three most important features were consistent across different feature elimination scenarios; thus, they can be used as stable features predictive of AUD and controls.
112-1	19885-19888	The	_	
112-2	19889-19894	three	_	
112-3	19895-19899	most	_	
112-4	19900-19909	important	_	
112-5	19910-19918	features	_	
112-6	19919-19923	were	_	
112-7	19924-19934	consistent	_	
112-8	19935-19941	across	_	
112-9	19942-19951	different	_	
112-10	19952-19959	feature	_	
112-11	19960-19971	elimination	_	
112-12	19972-19981	scenarios	_	
112-13	19981-19982	;	_	
112-14	19983-19987	thus	_	
112-15	19987-19988	,	_	
112-16	19989-19993	they	_	
112-17	19994-19997	can	_	
112-18	19998-20000	be	_	
112-19	20001-20005	used	_	
112-20	20006-20008	as	_	
112-21	20009-20015	stable	_	
112-22	20016-20024	features	_	
112-23	20025-20035	predictive	_	
112-24	20036-20038	of	_	
112-25	20039-20042	AUD	_	
112-26	20043-20046	and	_	
112-27	20047-20055	controls	_	
112-28	20055-20056	.	_	

#Text=The between-network features that have shown the strongest predicting power were found between Default Mode Network (DMN1) and RN, and between ECN and RN.
113-1	20057-20060	The	_	
113-2	20061-20076	between-network	_	
113-3	20077-20085	features	_	
113-4	20086-20090	that	_	
113-5	20091-20095	have	_	
113-6	20096-20101	shown	_	
113-7	20102-20105	the	_	
113-8	20106-20115	strongest	_	
113-9	20116-20126	predicting	_	
113-10	20127-20132	power	_	
113-11	20133-20137	were	_	
113-12	20138-20143	found	_	
113-13	20144-20151	between	_	
113-14	20152-20159	Default	_	
113-15	20160-20164	Mode	_	
113-16	20165-20172	Network	_	
113-17	20173-20174	(	_	
113-18	20174-20178	DMN1	_	
113-19	20178-20179	)	_	
113-20	20180-20183	and	_	
113-21	20184-20186	RN	_	
113-22	20186-20187	,	_	
113-23	20188-20191	and	_	
113-24	20192-20199	between	_	
113-25	20200-20203	ECN	_	
113-26	20204-20207	and	_	
113-27	20208-20210	RN	_	
113-28	20210-20211	.	_	

#Text=The stability of between-network features was presented in Figure 6.
114-1	20212-20215	The	_	
114-2	20216-20225	stability	_	
114-3	20226-20228	of	_	
114-4	20229-20244	between-network	_	
114-5	20245-20253	features	_	
114-6	20254-20257	was	_	
114-7	20258-20267	presented	_	
114-8	20268-20270	in	_	
114-9	20271-20277	Figure	_	
114-10	20278-20279	6	_	
114-11	20279-20280	.	_	

#Text=Discussion
#Text=Alcohol use disorder is a complex disease with multifaceted components, severity, and will likely lead to chronic adaptation of neurotransmission and neuronal circuits.
115-1	20281-20291	Discussion	_	
115-2	20292-20299	Alcohol	_	
115-3	20300-20303	use	_	
115-4	20304-20312	disorder	_	
115-5	20313-20315	is	_	
115-6	20316-20317	a	_	
115-7	20318-20325	complex	_	
115-8	20326-20333	disease	_	
115-9	20334-20338	with	_	
115-10	20339-20351	multifaceted	_	
115-11	20352-20362	components	_	
115-12	20362-20363	,	_	
115-13	20364-20372	severity	_	
115-14	20372-20373	,	_	
115-15	20374-20377	and	_	
115-16	20378-20382	will	_	
115-17	20383-20389	likely	_	
115-18	20390-20394	lead	_	
115-19	20395-20397	to	_	
115-20	20398-20405	chronic	_	
115-21	20406-20416	adaptation	_	
115-22	20417-20419	of	_	
115-23	20420-20437	neurotransmission	_	
115-24	20438-20441	and	_	
115-25	20442-20450	neuronal	_	
115-26	20451-20459	circuits	_	
115-27	20459-20460	.	_	

#Text=Recently, more focus has been devoted to the alterations of resting state and functional connectivity in AUD.
116-1	20461-20469	Recently	_	
116-2	20469-20470	,	_	
116-3	20471-20475	more	_	
116-4	20476-20481	focus	_	
116-5	20482-20485	has	_	
116-6	20486-20490	been	_	
116-7	20491-20498	devoted	_	
116-8	20499-20501	to	_	
116-9	20502-20505	the	_	
116-10	20506-20517	alterations	_	
116-11	20518-20520	of	_	
116-12	20521-20528	resting	_	
116-13	20529-20534	state	_	
116-14	20535-20538	and	_	
116-15	20539-20549	functional	_	
116-16	20550-20562	connectivity	_	
116-17	20563-20565	in	_	
116-18	20566-20569	AUD	_	
116-19	20569-20570	.	_	

#Text=To our knowledge, no study has applied machine-learning algorithms to determine the utility of the functional connectivity alterations in diagnosing the severity of the AUD progress or ultimately predicting those at risk.
117-1	20571-20573	To	_	
117-2	20574-20577	our	_	
117-3	20578-20587	knowledge	_	
117-4	20587-20588	,	_	
117-5	20589-20591	no	_	
117-6	20592-20597	study	_	
117-7	20598-20601	has	_	
117-8	20602-20609	applied	_	
117-9	20610-20626	machine-learning	_	
117-10	20627-20637	algorithms	_	
117-11	20638-20640	to	_	
117-12	20641-20650	determine	_	
117-13	20651-20654	the	_	
117-14	20655-20662	utility	_	
117-15	20663-20665	of	_	
117-16	20666-20669	the	_	
117-17	20670-20680	functional	_	
117-18	20681-20693	connectivity	_	
117-19	20694-20705	alterations	_	
117-20	20706-20708	in	_	
117-21	20709-20719	diagnosing	_	
117-22	20720-20723	the	_	
117-23	20724-20732	severity	_	
117-24	20733-20735	of	_	
117-25	20736-20739	the	_	
117-26	20740-20743	AUD	_	
117-27	20744-20752	progress	_	
117-28	20753-20755	or	_	
117-29	20756-20766	ultimately	_	
117-30	20767-20777	predicting	_	
117-31	20778-20783	those	_	
117-32	20784-20786	at	_	
117-33	20787-20791	risk	_	
117-34	20791-20792	.	_	

#Text=This is the first attempt to evaluate the application of a machine-learning approach to analyze the resting state functional connectivity of short-term abstinent AUD and controls.
118-1	20793-20797	This	_	
118-2	20798-20800	is	_	
118-3	20801-20804	the	_	
118-4	20805-20810	first	_	
118-5	20811-20818	attempt	_	
118-6	20819-20821	to	_	
118-7	20822-20830	evaluate	_	
118-8	20831-20834	the	_	
118-9	20835-20846	application	_	
118-10	20847-20849	of	_	
118-11	20850-20851	a	_	
118-12	20852-20868	machine-learning	_	
118-13	20869-20877	approach	_	
118-14	20878-20880	to	_	
118-15	20881-20888	analyze	_	
118-16	20889-20892	the	_	
118-17	20893-20900	resting	_	
118-18	20901-20906	state	_	
118-19	20907-20917	functional	_	
118-20	20918-20930	connectivity	_	
118-21	20931-20933	of	_	
118-22	20934-20944	short-term	_	
118-23	20945-20954	abstinent	_	
118-24	20955-20958	AUD	_	
118-25	20959-20962	and	_	
118-26	20963-20971	controls	_	
118-27	20971-20972	.	_	

#Text=First, we showed that the rs-FC features are able to automatically discriminate AUD from controls.
119-1	20973-20978	First	_	
119-2	20978-20979	,	_	
119-3	20980-20982	we	_	
119-4	20983-20989	showed	_	
119-5	20990-20994	that	_	
119-6	20995-20998	the	_	
119-7	20999-21004	rs-FC	_	
119-8	21005-21013	features	_	
119-9	21014-21017	are	_	
119-10	21018-21022	able	_	
119-11	21023-21025	to	_	
119-12	21026-21039	automatically	_	
119-13	21040-21052	discriminate	_	
119-14	21053-21056	AUD	_	
119-15	21057-21061	from	_	
119-16	21062-21070	controls	_	
119-17	21070-21071	.	_	

#Text=Second, we quantitatively compared the performance of within-network and between-network features that contribute most to the classifier and identified the features best detecting alcohol dependence.
120-1	21072-21078	Second	_	
120-2	21078-21079	,	_	
120-3	21080-21082	we	_	
120-4	21083-21097	quantitatively	_	
120-5	21098-21106	compared	_	
120-6	21107-21110	the	_	
120-7	21111-21122	performance	_	
120-8	21123-21125	of	_	
120-9	21126-21140	within-network	_	
120-10	21141-21144	and	_	
120-11	21145-21160	between-network	_	
120-12	21161-21169	features	_	
120-13	21170-21174	that	_	
120-14	21175-21185	contribute	_	
120-15	21186-21190	most	_	
120-16	21191-21193	to	_	
120-17	21194-21197	the	_	
120-18	21198-21208	classifier	_	
120-19	21209-21212	and	_	
120-20	21213-21223	identified	_	
120-21	21224-21227	the	_	
120-22	21228-21236	features	_	
120-23	21237-21241	best	_	
120-24	21242-21251	detecting	_	
120-25	21252-21259	alcohol	_	
120-26	21260-21270	dependence	_	
120-27	21270-21271	.	_	

#Text=With the help of the feature elimination method, our results showed that the within-network features distinguish AUD from controls with 87% accuracy and 90.5% precision, higher than the performance using between-network features (67.4% accuracy and 70.0% precision).
121-1	21272-21276	With	_	
121-2	21277-21280	the	_	
121-3	21281-21285	help	_	
121-4	21286-21288	of	_	
121-5	21289-21292	the	_	
121-6	21293-21300	feature	_	
121-7	21301-21312	elimination	_	
121-8	21313-21319	method	_	
121-9	21319-21320	,	_	
121-10	21321-21324	our	_	
121-11	21325-21332	results	_	
121-12	21333-21339	showed	_	
121-13	21340-21344	that	_	
121-14	21345-21348	the	_	
121-15	21349-21363	within-network	_	
121-16	21364-21372	features	_	
121-17	21373-21384	distinguish	_	
121-18	21385-21388	AUD	_	
121-19	21389-21393	from	_	
121-20	21394-21402	controls	_	
121-21	21403-21407	with	_	
121-22	21408-21411	87%	_	
121-23	21412-21420	accuracy	_	
121-24	21421-21424	and	_	
121-25	21425-21430	90.5%	_	
121-26	21431-21440	precision	_	
121-27	21440-21441	,	_	
121-28	21442-21448	higher	_	
121-29	21449-21453	than	_	
121-30	21454-21457	the	_	
121-31	21458-21469	performance	_	
121-32	21470-21475	using	_	
121-33	21476-21491	between-network	_	
121-34	21492-21500	features	_	
121-35	21501-21502	(	_	
121-36	21502-21507	67.4%	_	
121-37	21508-21516	accuracy	_	
121-38	21517-21520	and	_	
121-39	21521-21526	70.0%	_	
121-40	21527-21536	precision	_	
121-41	21536-21537	)	_	
121-42	21537-21538	.	_	

#Text=The within-networks contributed the most including two Executive Control Networks (ECN), and Reward Network (RN).
122-1	21539-21542	The	_	
122-2	21543-21558	within-networks	_	
122-3	21559-21570	contributed	_	
122-4	21571-21574	the	_	
122-5	21575-21579	most	_	
122-6	21580-21589	including	_	
122-7	21590-21593	two	_	
122-8	21594-21603	Executive	_	
122-9	21604-21611	Control	_	
122-10	21612-21620	Networks	_	
122-11	21621-21622	(	_	
122-12	21622-21625	ECN	_	
122-13	21625-21626	)	_	
122-14	21626-21627	,	_	
122-15	21628-21631	and	_	
122-16	21632-21638	Reward	_	
122-17	21639-21646	Network	_	
122-18	21647-21648	(	_	
122-19	21648-21650	RN	_	
122-20	21650-21651	)	_	
122-21	21651-21652	.	_	

#Text=The between-network connectivity between RN and Default Mode Network (DMN), RN and ECN contributes the most to the prediction.
123-1	21653-21656	The	_	
123-2	21657-21672	between-network	_	
123-3	21673-21685	connectivity	_	
123-4	21686-21693	between	_	
123-5	21694-21696	RN	_	
123-6	21697-21700	and	_	
123-7	21701-21708	Default	_	
123-8	21709-21713	Mode	_	
123-9	21714-21721	Network	_	
123-10	21722-21723	(	_	
123-11	21723-21726	DMN	_	
123-12	21726-21727	)	_	
123-13	21727-21728	,	_	
123-14	21729-21731	RN	_	
123-15	21732-21735	and	_	
123-16	21736-21739	ECN	_	
123-17	21740-21751	contributes	_	
123-18	21752-21755	the	_	
123-19	21756-21760	most	_	
123-20	21761-21763	to	_	
123-21	21764-21767	the	_	
123-22	21768-21778	prediction	_	
123-23	21778-21779	.	_	

#Text=Researchers have shown disrupted functional integration is associated with AUD.
124-1	21780-21791	Researchers	_	
124-2	21792-21796	have	_	
124-3	21797-21802	shown	_	
124-4	21803-21812	disrupted	_	
124-5	21813-21823	functional	_	
124-6	21824-21835	integration	_	
124-7	21836-21838	is	_	
124-8	21839-21849	associated	_	
124-9	21850-21854	with	_	
124-10	21855-21858	AUD	_	
124-11	21858-21859	.	_	

#Text=For example, several studies found decreased functional connectivity in AUD when compared with controls, such as DMN, ECN, SN and RN.
125-1	21860-21863	For	_	
125-2	21864-21871	example	_	
125-3	21871-21872	,	_	
125-4	21873-21880	several	_	
125-5	21881-21888	studies	_	
125-6	21889-21894	found	_	
125-7	21895-21904	decreased	_	
125-8	21905-21915	functional	_	
125-9	21916-21928	connectivity	_	
125-10	21929-21931	in	_	
125-11	21932-21935	AUD	_	
125-12	21936-21940	when	_	
125-13	21941-21949	compared	_	
125-14	21950-21954	with	_	
125-15	21955-21963	controls	_	
125-16	21963-21964	,	_	
125-17	21965-21969	such	_	
125-18	21970-21972	as	_	
125-19	21973-21976	DMN	_	
125-20	21976-21977	,	_	
125-21	21978-21981	ECN	_	
125-22	21981-21982	,	_	
125-23	21983-21985	SN	_	
125-24	21986-21989	and	_	
125-25	21990-21992	RN	_	
125-26	21992-21993	.	_	

#Text=On the other hand, several studies found increased functional connectivity in AUD, compared with controls.
126-1	21994-21996	On	_	
126-2	21997-22000	the	_	
126-3	22001-22006	other	_	
126-4	22007-22011	hand	_	
126-5	22011-22012	,	_	
126-6	22013-22020	several	_	
126-7	22021-22028	studies	_	
126-8	22029-22034	found	_	
126-9	22035-22044	increased	_	
126-10	22045-22055	functional	_	
126-11	22056-22068	connectivity	_	
126-12	22069-22071	in	_	
126-13	22072-22075	AUD	_	
126-14	22075-22076	,	_	
126-15	22077-22085	compared	_	
126-16	22086-22090	with	_	
126-17	22091-22099	controls	_	
126-18	22099-22100	.	_	

#Text=For example, patients with AUD also showed significant increased regional homogeneity in the posterior cingulate cortex, insula and reduction in the ACC, when compared with controls.
127-1	22101-22104	For	_	
127-2	22105-22112	example	_	
127-3	22112-22113	,	_	
127-4	22114-22122	patients	_	
127-5	22123-22127	with	_	
127-6	22128-22131	AUD	_	
127-7	22132-22136	also	_	
127-8	22137-22143	showed	_	
127-9	22144-22155	significant	_	
127-10	22156-22165	increased	_	
127-11	22166-22174	regional	_	
127-12	22175-22186	homogeneity	_	
127-13	22187-22189	in	_	
127-14	22190-22193	the	_	
127-15	22194-22203	posterior	_	
127-16	22204-22213	cingulate	_	
127-17	22214-22220	cortex	_	
127-18	22220-22221	,	_	
127-19	22222-22228	insula	_	
127-20	22229-22232	and	_	
127-21	22233-22242	reduction	_	
127-22	22243-22245	in	_	
127-23	22246-22249	the	_	
127-24	22250-22253	ACC	_	
127-25	22253-22254	,	_	
127-26	22255-22259	when	_	
127-27	22260-22268	compared	_	
127-28	22269-22273	with	_	
127-29	22274-22282	controls	_	
127-30	22282-22283	.	_	

#Text=Significant increased functional connectivity was found in DMN, ECN, SN, and attention network in AUD.
128-1	22284-22295	Significant	_	
128-2	22296-22305	increased	_	
128-3	22306-22316	functional	_	
128-4	22317-22329	connectivity	_	
128-5	22330-22333	was	_	
128-6	22334-22339	found	_	
128-7	22340-22342	in	_	
128-8	22343-22346	DMN	_	
128-9	22346-22347	,	_	
128-10	22348-22351	ECN	_	
128-11	22351-22352	,	_	
128-12	22353-22355	SN	_	
128-13	22355-22356	,	_	
128-14	22357-22360	and	_	
128-15	22361-22370	attention	_	
128-16	22371-22378	network	_	
128-17	22379-22381	in	_	
128-18	22382-22385	AUD	_	
128-19	22385-22386	.	_	

#Text=Long-term abstinent alcoholic subjects showed increased functional connectivity in ECN.
129-1	22387-22396	Long-term	_	
129-2	22397-22406	abstinent	_	
129-3	22407-22416	alcoholic	_	
129-4	22417-22425	subjects	_	
129-5	22426-22432	showed	_	
129-6	22433-22442	increased	_	
129-7	22443-22453	functional	_	
129-8	22454-22466	connectivity	_	
129-9	22467-22469	in	_	
129-10	22470-22473	ECN	_	
129-11	22473-22474	.	_	

#Text=In our previous study, we found significant increased within-network FC in SN, DMN, orbitofrontal cortex (OFCN), left- ECN and amygdala-striatum (ASN) networks in AUD when compared with controls.
130-1	22475-22477	In	_	
130-2	22478-22481	our	_	
130-3	22482-22490	previous	_	
130-4	22491-22496	study	_	
130-5	22496-22497	,	_	
130-6	22498-22500	we	_	
130-7	22501-22506	found	_	
130-8	22507-22518	significant	_	
130-9	22519-22528	increased	_	
130-10	22529-22543	within-network	_	
130-11	22544-22546	FC	_	
130-12	22547-22549	in	_	
130-13	22550-22552	SN	_	
130-14	22552-22553	,	_	
130-15	22554-22557	DMN	_	
130-16	22557-22558	,	_	
130-17	22559-22572	orbitofrontal	_	
130-18	22573-22579	cortex	_	
130-19	22580-22581	(	_	
130-20	22581-22585	OFCN	_	
130-21	22585-22586	)	_	
130-22	22586-22587	,	_	
130-23	22588-22592	left	_	
130-24	22592-22593	-	_	
130-25	22594-22597	ECN	_	
130-26	22598-22601	and	_	
130-27	22602-22619	amygdala-striatum	_	
130-28	22620-22621	(	_	
130-29	22621-22624	ASN	_	
130-30	22624-22625	)	_	
130-31	22626-22634	networks	_	
130-32	22635-22637	in	_	
130-33	22638-22641	AUD	_	
130-34	22642-22646	when	_	
130-35	22647-22655	compared	_	
130-36	22656-22660	with	_	
130-37	22661-22669	controls	_	
130-38	22669-22670	.	_	

#Text=These studies converge to support that the dysfunctional connectivity was associated with sustained alcohol use.
131-1	22671-22676	These	_	
131-2	22677-22684	studies	_	
131-3	22685-22693	converge	_	
131-4	22694-22696	to	_	
131-5	22697-22704	support	_	
131-6	22705-22709	that	_	
131-7	22710-22713	the	_	
131-8	22714-22727	dysfunctional	_	
131-9	22728-22740	connectivity	_	
131-10	22741-22744	was	_	
131-11	22745-22755	associated	_	
131-12	22756-22760	with	_	
131-13	22761-22770	sustained	_	
131-14	22771-22778	alcohol	_	
131-15	22779-22782	use	_	
131-16	22782-22783	.	_	

#Text=However, even though group-level functional connectivity differences were found between AUD and controls, they may not be used as biomarkers to classify severity of the disease progress or ultimately predicting relevant future events, such as relapse.
132-1	22784-22791	However	_	
132-2	22791-22792	,	_	
132-3	22793-22797	even	_	
132-4	22798-22804	though	_	
132-5	22805-22816	group-level	_	
132-6	22817-22827	functional	_	
132-7	22828-22840	connectivity	_	
132-8	22841-22852	differences	_	
132-9	22853-22857	were	_	
132-10	22858-22863	found	_	
132-11	22864-22871	between	_	
132-12	22872-22875	AUD	_	
132-13	22876-22879	and	_	
132-14	22880-22888	controls	_	
132-15	22888-22889	,	_	
132-16	22890-22894	they	_	
132-17	22895-22898	may	_	
132-18	22899-22902	not	_	
132-19	22903-22905	be	_	
132-20	22906-22910	used	_	
132-21	22911-22913	as	_	
132-22	22914-22924	biomarkers	_	
132-23	22925-22927	to	_	
132-24	22928-22936	classify	_	
132-25	22937-22945	severity	_	
132-26	22946-22948	of	_	
132-27	22949-22952	the	_	
132-28	22953-22960	disease	_	
132-29	22961-22969	progress	_	
132-30	22970-22972	or	_	
132-31	22973-22983	ultimately	_	
132-32	22984-22994	predicting	_	
132-33	22995-23003	relevant	_	
132-34	23004-23010	future	_	
132-35	23011-23017	events	_	
132-36	23017-23018	,	_	
132-37	23019-23023	such	_	
132-38	23024-23026	as	_	
132-39	23027-23034	relapse	_	
132-40	23034-23035	.	_	

#Text=In the current study, adding to our previous findings, we found that two ECNs, and the RN have the strongest classification power in distinguishing AUD from controls (one ECN overlapped with the previous OFCN, the other ECN overlapped with the previous LECN, and the RN overlapped with the previous ASN).
133-1	23036-23038	In	_	
133-2	23039-23042	the	_	
133-3	23043-23050	current	_	
133-4	23051-23056	study	_	
133-5	23056-23057	,	_	
133-6	23058-23064	adding	_	
133-7	23065-23067	to	_	
133-8	23068-23071	our	_	
133-9	23072-23080	previous	_	
133-10	23081-23089	findings	_	
133-11	23089-23090	,	_	
133-12	23091-23093	we	_	
133-13	23094-23099	found	_	
133-14	23100-23104	that	_	
133-15	23105-23108	two	_	
133-16	23109-23113	ECNs	_	
133-17	23113-23114	,	_	
133-18	23115-23118	and	_	
133-19	23119-23122	the	_	
133-20	23123-23125	RN	_	
133-21	23126-23130	have	_	
133-22	23131-23134	the	_	
133-23	23135-23144	strongest	_	
133-24	23145-23159	classification	_	
133-25	23160-23165	power	_	
133-26	23166-23168	in	_	
133-27	23169-23183	distinguishing	_	
133-28	23184-23187	AUD	_	
133-29	23188-23192	from	_	
133-30	23193-23201	controls	_	
133-31	23202-23203	(	_	
133-32	23203-23206	one	_	
133-33	23207-23210	ECN	_	
133-34	23211-23221	overlapped	_	
133-35	23222-23226	with	_	
133-36	23227-23230	the	_	
133-37	23231-23239	previous	_	
133-38	23240-23244	OFCN	_	
133-39	23244-23245	,	_	
133-40	23246-23249	the	_	
133-41	23250-23255	other	_	
133-42	23256-23259	ECN	_	
133-43	23260-23270	overlapped	_	
133-44	23271-23275	with	_	
133-45	23276-23279	the	_	
133-46	23280-23288	previous	_	
133-47	23289-23293	LECN	_	
133-48	23293-23294	,	_	
133-49	23295-23298	and	_	
133-50	23299-23302	the	_	
133-51	23303-23305	RN	_	
133-52	23306-23316	overlapped	_	
133-53	23317-23321	with	_	
133-54	23322-23325	the	_	
133-55	23326-23334	previous	_	
133-56	23335-23338	ASN	_	
133-57	23338-23339	)	_	
133-58	23339-23340	.	_	

#Text=We observed that within-network FC measures offered maximal information for identifying alcoholism, suggesting that connectivity measures within the ECN and RN are particularly informative in detecting alcoholism.
134-1	23341-23343	We	_	
134-2	23344-23352	observed	_	
134-3	23353-23357	that	_	
134-4	23358-23372	within-network	_	
134-5	23373-23375	FC	_	
134-6	23376-23384	measures	_	
134-7	23385-23392	offered	_	
134-8	23393-23400	maximal	_	
134-9	23401-23412	information	_	
134-10	23413-23416	for	_	
134-11	23417-23428	identifying	_	
134-12	23429-23439	alcoholism	_	
134-13	23439-23440	,	_	
134-14	23441-23451	suggesting	_	
134-15	23452-23456	that	_	
134-16	23457-23469	connectivity	_	
134-17	23470-23478	measures	_	
134-18	23479-23485	within	_	
134-19	23486-23489	the	_	
134-20	23490-23493	ECN	_	
134-21	23494-23497	and	_	
134-22	23498-23500	RN	_	
134-23	23501-23504	are	_	
134-24	23505-23517	particularly	_	
134-25	23518-23529	informative	_	
134-26	23530-23532	in	_	
134-27	23533-23542	detecting	_	
134-28	23543-23553	alcoholism	_	
134-29	23553-23554	.	_	

#Text=The classification performance improved with feature elimination suggesting that these few networks performed outstandingly among all other networks (87% accuracy and 90.5% precision).
135-1	23555-23558	The	_	
135-2	23559-23573	classification	_	
135-3	23574-23585	performance	_	
135-4	23586-23594	improved	_	
135-5	23595-23599	with	_	
135-6	23600-23607	feature	_	
135-7	23608-23619	elimination	_	
135-8	23620-23630	suggesting	_	
135-9	23631-23635	that	_	
135-10	23636-23641	these	_	
135-11	23642-23645	few	_	
135-12	23646-23654	networks	_	
135-13	23655-23664	performed	_	
135-14	23665-23678	outstandingly	_	
135-15	23679-23684	among	_	
135-16	23685-23688	all	_	
135-17	23689-23694	other	_	
135-18	23695-23703	networks	_	
135-19	23704-23705	(	_	
135-20	23705-23708	87%	_	
135-21	23709-23717	accuracy	_	
135-22	23718-23721	and	_	
135-23	23722-23727	90.5%	_	
135-24	23728-23737	precision	_	
135-25	23737-23738	)	_	
135-26	23738-23739	.	_	

#Text=Also, the rank of the networks did not change when doing the LOOCV tests under different feature elimination cases suggesting that the contribution of the features was very stable and robust.
136-1	23740-23744	Also	_	
136-2	23744-23745	,	_	
136-3	23746-23749	the	_	
136-4	23750-23754	rank	_	
136-5	23755-23757	of	_	
136-6	23758-23761	the	_	
136-7	23762-23770	networks	_	
136-8	23771-23774	did	_	
136-9	23775-23778	not	_	
136-10	23779-23785	change	_	
136-11	23786-23790	when	_	
136-12	23791-23796	doing	_	
136-13	23797-23800	the	_	
136-14	23801-23806	LOOCV	_	
136-15	23807-23812	tests	_	
136-16	23813-23818	under	_	
136-17	23819-23828	different	_	
136-18	23829-23836	feature	_	
136-19	23837-23848	elimination	_	
136-20	23849-23854	cases	_	
136-21	23855-23865	suggesting	_	
136-22	23866-23870	that	_	
136-23	23871-23874	the	_	
136-24	23875-23887	contribution	_	
136-25	23888-23890	of	_	
136-26	23891-23894	the	_	
136-27	23895-23903	features	_	
136-28	23904-23907	was	_	
136-29	23908-23912	very	_	
136-30	23913-23919	stable	_	
136-31	23920-23923	and	_	
136-32	23924-23930	robust	_	
136-33	23930-23931	.	_	

#Text=Therefore, dysfunction of the ECN1 including OFC, MFG, the RN including the thalamus, accumbens, putamen, caudate, and the ECN2 involving MFG, FP, IFG and ACC may be part of the underlying neurobiology of addiction.
137-1	23932-23941	Therefore	_	
137-2	23941-23942	,	_	
137-3	23943-23954	dysfunction	_	
137-4	23955-23957	of	_	
137-5	23958-23961	the	_	
137-6	23962-23966	ECN1	_	
137-7	23967-23976	including	_	
137-8	23977-23980	OFC	_	
137-9	23980-23981	,	_	
137-10	23982-23985	MFG	_	
137-11	23985-23986	,	_	
137-12	23987-23990	the	_	
137-13	23991-23993	RN	_	
137-14	23994-24003	including	_	
137-15	24004-24007	the	_	
137-16	24008-24016	thalamus	_	
137-17	24016-24017	,	_	
137-18	24018-24027	accumbens	_	
137-19	24027-24028	,	_	
137-20	24029-24036	putamen	_	
137-21	24036-24037	,	_	
137-22	24038-24045	caudate	_	
137-23	24045-24046	,	_	
137-24	24047-24050	and	_	
137-25	24051-24054	the	_	
137-26	24055-24059	ECN2	_	
137-27	24060-24069	involving	_	
137-28	24070-24073	MFG	_	
137-29	24073-24074	,	_	
137-30	24075-24077	FP	_	
137-31	24077-24078	,	_	
137-32	24079-24082	IFG	_	
137-33	24083-24086	and	_	
137-34	24087-24090	ACC	_	
137-35	24091-24094	may	_	
137-36	24095-24097	be	_	
137-37	24098-24102	part	_	
137-38	24103-24105	of	_	
137-39	24106-24109	the	_	
137-40	24110-24120	underlying	_	
137-41	24121-24133	neurobiology	_	
137-42	24134-24136	of	_	
137-43	24137-24146	addiction	_	
137-44	24146-24147	.	_	

#Text=On the other hand, the classification performance using between-network features only achieved 67.4% accuracy and 70.0% precision.
138-1	24148-24150	On	_	
138-2	24151-24154	the	_	
138-3	24155-24160	other	_	
138-4	24161-24165	hand	_	
138-5	24165-24166	,	_	
138-6	24167-24170	the	_	
138-7	24171-24185	classification	_	
138-8	24186-24197	performance	_	
138-9	24198-24203	using	_	
138-10	24204-24219	between-network	_	
138-11	24220-24228	features	_	
138-12	24229-24233	only	_	
138-13	24234-24242	achieved	_	
138-14	24243-24248	67.4%	_	
138-15	24249-24257	accuracy	_	
138-16	24258-24261	and	_	
138-17	24262-24267	70.0%	_	
138-18	24268-24277	precision	_	
138-19	24277-24278	.	_	

#Text=This lack of robustness was also reflected in the fact that the rank of the network coupling also changed when doing the LOOCV tests under different feature elimination cases.
139-1	24279-24283	This	_	
139-2	24284-24288	lack	_	
139-3	24289-24291	of	_	
139-4	24292-24302	robustness	_	
139-5	24303-24306	was	_	
139-6	24307-24311	also	_	
139-7	24312-24321	reflected	_	
139-8	24322-24324	in	_	
139-9	24325-24328	the	_	
139-10	24329-24333	fact	_	
139-11	24334-24338	that	_	
139-12	24339-24342	the	_	
139-13	24343-24347	rank	_	
139-14	24348-24350	of	_	
139-15	24351-24354	the	_	
139-16	24355-24362	network	_	
139-17	24363-24371	coupling	_	
139-18	24372-24376	also	_	
139-19	24377-24384	changed	_	
139-20	24385-24389	when	_	
139-21	24390-24395	doing	_	
139-22	24396-24399	the	_	
139-23	24400-24405	LOOCV	_	
139-24	24406-24411	tests	_	
139-25	24412-24417	under	_	
139-26	24418-24427	different	_	
139-27	24428-24435	feature	_	
139-28	24436-24447	elimination	_	
139-29	24448-24453	cases	_	
139-30	24453-24454	.	_	

#Text=These results suggested that the between-network coupling might only be a modest indicator to distinguish AUD from controls given the sample size we have.
140-1	24455-24460	These	_	
140-2	24461-24468	results	_	
140-3	24469-24478	suggested	_	
140-4	24479-24483	that	_	
140-5	24484-24487	the	_	
140-6	24488-24503	between-network	_	
140-7	24504-24512	coupling	_	
140-8	24513-24518	might	_	
140-9	24519-24523	only	_	
140-10	24524-24526	be	_	
140-11	24527-24528	a	_	
140-12	24529-24535	modest	_	
140-13	24536-24545	indicator	_	
140-14	24546-24548	to	_	
140-15	24549-24560	distinguish	_	
140-16	24561-24564	AUD	_	
140-17	24565-24569	from	_	
140-18	24570-24578	controls	_	
140-19	24579-24584	given	_	
140-20	24585-24588	the	_	
140-21	24589-24595	sample	_	
140-22	24596-24600	size	_	
140-23	24601-24603	we	_	
140-24	24604-24608	have	_	
140-25	24608-24609	.	_	

#Text=This may be due to the fact that we only used correlation to measure the weak dependency among network time courses.
141-1	24610-24614	This	_	
141-2	24615-24618	may	_	
141-3	24619-24621	be	_	
141-4	24622-24625	due	_	
141-5	24626-24628	to	_	
141-6	24629-24632	the	_	
141-7	24633-24637	fact	_	
141-8	24638-24642	that	_	
141-9	24643-24645	we	_	
141-10	24646-24650	only	_	
141-11	24651-24655	used	_	
141-12	24656-24667	correlation	_	
141-13	24668-24670	to	_	
141-14	24671-24678	measure	_	
141-15	24679-24682	the	_	
141-16	24683-24687	weak	_	
141-17	24688-24698	dependency	_	
141-18	24699-24704	among	_	
141-19	24705-24712	network	_	
141-20	24713-24717	time	_	
141-21	24718-24725	courses	_	
141-22	24725-24726	.	_	

#Text=Therefore, we might miss such weak dependency if two time courses have time-lagged correlation.
142-1	24727-24736	Therefore	_	
142-2	24736-24737	,	_	
142-3	24738-24740	we	_	
142-4	24741-24746	might	_	
142-5	24747-24751	miss	_	
142-6	24752-24756	such	_	
142-7	24757-24761	weak	_	
142-8	24762-24772	dependency	_	
142-9	24773-24775	if	_	
142-10	24776-24779	two	_	
142-11	24780-24784	time	_	
142-12	24785-24792	courses	_	
142-13	24793-24797	have	_	
142-14	24798-24809	time-lagged	_	
142-15	24810-24821	correlation	_	
142-16	24821-24822	.	_	

#Text=As such, alternative methods such as Granger causality, Autoregressive of model order one (AR1), or dynamic causal modeling may be applied to address this issue.
143-1	24823-24825	As	_	
143-2	24826-24830	such	_	
143-3	24830-24831	,	_	
143-4	24832-24843	alternative	_	
143-5	24844-24851	methods	_	
143-6	24852-24856	such	_	
143-7	24857-24859	as	_	
143-8	24860-24867	Granger	_	
143-9	24868-24877	causality	_	
143-10	24877-24878	,	_	
143-11	24879-24893	Autoregressive	_	
143-12	24894-24896	of	_	
143-13	24897-24902	model	_	
143-14	24903-24908	order	_	
143-15	24909-24912	one	_	
143-16	24913-24914	(	_	
143-17	24914-24917	AR1	_	
143-18	24917-24918	)	_	
143-19	24918-24919	,	_	
143-20	24920-24922	or	_	
143-21	24923-24930	dynamic	_	
143-22	24931-24937	causal	_	
143-23	24938-24946	modeling	_	
143-24	24947-24950	may	_	
143-25	24951-24953	be	_	
143-26	24954-24961	applied	_	
143-27	24962-24964	to	_	
143-28	24965-24972	address	_	
143-29	24973-24977	this	_	
143-30	24978-24983	issue	_	
143-31	24983-24984	.	_	

#Text=It is important to understand whether the disrupted functional connectivity was specific to AUD or addiction in general.
144-1	24985-24987	It	_	
144-2	24988-24990	is	_	
144-3	24991-25000	important	_	
144-4	25001-25003	to	_	
144-5	25004-25014	understand	_	
144-6	25015-25022	whether	_	
144-7	25023-25026	the	_	
144-8	25027-25036	disrupted	_	
144-9	25037-25047	functional	_	
144-10	25048-25060	connectivity	_	
144-11	25061-25064	was	_	
144-12	25065-25073	specific	_	
144-13	25074-25076	to	_	
144-14	25077-25080	AUD	_	
144-15	25081-25083	or	_	
144-16	25084-25093	addiction	_	
144-17	25094-25096	in	_	
144-18	25097-25104	general	_	
144-19	25104-25105	.	_	

#Text=We, therefore, first tested the influence of cigarette smoking on AUD since 65% of the AUD were smokers in our samples.
145-1	25106-25108	We	_	
145-2	25108-25109	,	_	
145-3	25110-25119	therefore	_	
145-4	25119-25120	,	_	
145-5	25121-25126	first	_	
145-6	25127-25133	tested	_	
145-7	25134-25137	the	_	
145-8	25138-25147	influence	_	
145-9	25148-25150	of	_	
145-10	25151-25160	cigarette	_	
145-11	25161-25168	smoking	_	
145-12	25169-25171	on	_	
145-13	25172-25175	AUD	_	
145-14	25176-25181	since	_	
145-15	25182-25185	65%	_	
145-16	25186-25188	of	_	
145-17	25189-25192	the	_	
145-18	25193-25196	AUD	_	
145-19	25197-25201	were	_	
145-20	25202-25209	smokers	_	
145-21	25210-25212	in	_	
145-22	25213-25216	our	_	
145-23	25217-25224	samples	_	
145-24	25224-25225	.	_	

#Text=Additional group analysis on AUD with smoking and AUD without smoking was conducted.
146-1	25226-25236	Additional	_	
146-2	25237-25242	group	_	
146-3	25243-25251	analysis	_	
146-4	25252-25254	on	_	
146-5	25255-25258	AUD	_	
146-6	25259-25263	with	_	
146-7	25264-25271	smoking	_	
146-8	25272-25275	and	_	
146-9	25276-25279	AUD	_	
146-10	25280-25287	without	_	
146-11	25288-25295	smoking	_	
146-12	25296-25299	was	_	
146-13	25300-25309	conducted	_	
146-14	25309-25310	.	_	

#Text=Functional connectivity strength did not differ between these two groups in any of the networks.
147-1	25311-25321	Functional	_	
147-2	25322-25334	connectivity	_	
147-3	25335-25343	strength	_	
147-4	25344-25347	did	_	
147-5	25348-25351	not	_	
147-6	25352-25358	differ	_	
147-7	25359-25366	between	_	
147-8	25367-25372	these	_	
147-9	25373-25376	two	_	
147-10	25377-25383	groups	_	
147-11	25384-25386	in	_	
147-12	25387-25390	any	_	
147-13	25391-25393	of	_	
147-14	25394-25397	the	_	
147-15	25398-25406	networks	_	
147-16	25406-25407	.	_	

#Text=Thus, no influence was found by this confounding factor in the case group.
148-1	25408-25412	Thus	_	
148-2	25412-25413	,	_	
148-3	25414-25416	no	_	
148-4	25417-25426	influence	_	
148-5	25427-25430	was	_	
148-6	25431-25436	found	_	
148-7	25437-25439	by	_	
148-8	25440-25444	this	_	
148-9	25445-25456	confounding	_	
148-10	25457-25463	factor	_	
148-11	25464-25466	in	_	
148-12	25467-25470	the	_	
148-13	25471-25475	case	_	
148-14	25476-25481	group	_	
148-15	25481-25482	.	_	

#Text=In addition, our results are consistent with another machine-learning study predicting smoking status, in which they also found within-network connectivity including ECN, FP and higher order networks is most informative in predicting nicotine dependence.
149-1	25483-25485	In	_	
149-2	25486-25494	addition	_	
149-3	25494-25495	,	_	
149-4	25496-25499	our	_	
149-5	25500-25507	results	_	
149-6	25508-25511	are	_	
149-7	25512-25522	consistent	_	
149-8	25523-25527	with	_	
149-9	25528-25535	another	_	
149-10	25536-25552	machine-learning	_	
149-11	25553-25558	study	_	
149-12	25559-25569	predicting	_	
149-13	25570-25577	smoking	_	
149-14	25578-25584	status	_	
149-15	25584-25585	,	_	
149-16	25586-25588	in	_	
149-17	25589-25594	which	_	
149-18	25595-25599	they	_	
149-19	25600-25604	also	_	
149-20	25605-25610	found	_	
149-21	25611-25625	within-network	_	
149-22	25626-25638	connectivity	_	
149-23	25639-25648	including	_	
149-24	25649-25652	ECN	_	
149-25	25652-25653	,	_	
149-26	25654-25656	FP	_	
149-27	25657-25660	and	_	
149-28	25661-25667	higher	_	
149-29	25668-25673	order	_	
149-30	25674-25682	networks	_	
149-31	25683-25685	is	_	
149-32	25686-25690	most	_	
149-33	25691-25702	informative	_	
149-34	25703-25705	in	_	
149-35	25706-25716	predicting	_	
149-36	25717-25725	nicotine	_	
149-37	25726-25736	dependence	_	
149-38	25736-25737	.	_	

#Text=These results may indicate a shared neuro-pathway for both AUD and nicotine dependence.
150-1	25738-25743	These	_	
150-2	25744-25751	results	_	
150-3	25752-25755	may	_	
150-4	25756-25764	indicate	_	
150-5	25765-25766	a	_	
150-6	25767-25773	shared	_	
150-7	25774-25787	neuro-pathway	_	
150-8	25788-25791	for	_	
150-9	25792-25796	both	_	
150-10	25797-25800	AUD	_	
150-11	25801-25804	and	_	
150-12	25805-25813	nicotine	_	
150-13	25814-25824	dependence	_	
150-14	25824-25825	.	_	

#Text=Further investigation is need in comorbidity of AUD and other addiction disorders.
151-1	25826-25833	Further	_	
151-2	25834-25847	investigation	_	
151-3	25848-25850	is	_	
151-4	25851-25855	need	_	
151-5	25856-25858	in	_	
151-6	25859-25870	comorbidity	_	
151-7	25871-25873	of	_	
151-8	25874-25877	AUD	_	
151-9	25878-25881	and	_	
151-10	25882-25887	other	_	
151-11	25888-25897	addiction	_	
151-12	25898-25907	disorders	_	
151-13	25907-25908	.	_	

#Text=Koob et al., 2010 have proposed that addiction is composed of three stages including binge/intoxication stage, withdrawal/negative affect stage and preoccupation/anticipation stage.
152-1	25909-25913	Koob	_	
152-2	25914-25916	et	_	
152-3	25917-25919	al	_	
152-4	25919-25920	.	_	
152-5	25920-25921	,	_	
152-6	25922-25926	2010	_	
152-7	25927-25931	have	_	
152-8	25932-25940	proposed	_	
152-9	25941-25945	that	_	
152-10	25946-25955	addiction	_	
152-11	25956-25958	is	_	
152-12	25959-25967	composed	_	
152-13	25968-25970	of	_	
152-14	25971-25976	three	_	
152-15	25977-25983	stages	_	
152-16	25984-25993	including	_	
152-17	25994-25999	binge	_	
152-18	25999-26000	/	_	
152-19	26000-26012	intoxication	_	
152-20	26013-26018	stage	_	
152-21	26018-26019	,	_	
152-22	26020-26030	withdrawal	_	
152-23	26030-26031	/	_	
152-24	26031-26039	negative	_	
152-25	26040-26046	affect	_	
152-26	26047-26052	stage	_	
152-27	26053-26056	and	_	
152-28	26057-26070	preoccupation	_	
152-29	26070-26071	/	_	
152-30	26071-26083	anticipation	_	
152-31	26084-26089	stage	_	
152-32	26089-26090	.	_	

#Text=Each stage involves discrete circuits: ventral stratum and ventral tegmental regions for binge/intoxication stage, amygdala in the withdrawal stage, and a wide range of distributed network including the OFC-striatum, PFC, amygdala, hippocampus, and insula involved in craving and the IFG, ACC, DLPFC for inhibitory control.
153-1	26091-26095	Each	_	
153-2	26096-26101	stage	_	
153-3	26102-26110	involves	_	
153-4	26111-26119	discrete	_	
153-5	26120-26128	circuits	_	
153-6	26128-26129	:	_	
153-7	26130-26137	ventral	_	
153-8	26138-26145	stratum	_	
153-9	26146-26149	and	_	
153-10	26150-26157	ventral	_	
153-11	26158-26167	tegmental	_	
153-12	26168-26175	regions	_	
153-13	26176-26179	for	_	
153-14	26180-26185	binge	_	
153-15	26185-26186	/	_	
153-16	26186-26198	intoxication	_	
153-17	26199-26204	stage	_	
153-18	26204-26205	,	_	
153-19	26206-26214	amygdala	_	
153-20	26215-26217	in	_	
153-21	26218-26221	the	_	
153-22	26222-26232	withdrawal	_	
153-23	26233-26238	stage	_	
153-24	26238-26239	,	_	
153-25	26240-26243	and	_	
153-26	26244-26245	a	_	
153-27	26246-26250	wide	_	
153-28	26251-26256	range	_	
153-29	26257-26259	of	_	
153-30	26260-26271	distributed	_	
153-31	26272-26279	network	_	
153-32	26280-26289	including	_	
153-33	26290-26293	the	_	
153-34	26294-26306	OFC-striatum	_	
153-35	26306-26307	,	_	
153-36	26308-26311	PFC	_	
153-37	26311-26312	,	_	
153-38	26313-26321	amygdala	_	
153-39	26321-26322	,	_	
153-40	26323-26334	hippocampus	_	
153-41	26334-26335	,	_	
153-42	26336-26339	and	_	
153-43	26340-26346	insula	_	
153-44	26347-26355	involved	_	
153-45	26356-26358	in	_	
153-46	26359-26366	craving	_	
153-47	26367-26370	and	_	
153-48	26371-26374	the	_	
153-49	26375-26378	IFG	_	
153-50	26378-26379	,	_	
153-51	26380-26383	ACC	_	
153-52	26383-26384	,	_	
153-53	26385-26390	DLPFC	_	
153-54	26391-26394	for	_	
153-55	26395-26405	inhibitory	_	
153-56	26406-26413	control	_	
153-57	26413-26414	.	_	

#Text=In the current study, we investigated the functional connectivity in short-term abstinent AUD participants who were in the third stage of addiction, and our results provided evidence that the machine-learning methods may offer a diagnostic tool for identifying the brain biomarkers to distinguish AUD from controls.
154-1	26415-26417	In	_	
154-2	26418-26421	the	_	
154-3	26422-26429	current	_	
154-4	26430-26435	study	_	
154-5	26435-26436	,	_	
154-6	26437-26439	we	_	
154-7	26440-26452	investigated	_	
154-8	26453-26456	the	_	
154-9	26457-26467	functional	_	
154-10	26468-26480	connectivity	_	
154-11	26481-26483	in	_	
154-12	26484-26494	short-term	_	
154-13	26495-26504	abstinent	_	
154-14	26505-26508	AUD	_	
154-15	26509-26521	participants	_	
154-16	26522-26525	who	_	
154-17	26526-26530	were	_	
154-18	26531-26533	in	_	
154-19	26534-26537	the	_	
154-20	26538-26543	third	_	
154-21	26544-26549	stage	_	
154-22	26550-26552	of	_	
154-23	26553-26562	addiction	_	
154-24	26562-26563	,	_	
154-25	26564-26567	and	_	
154-26	26568-26571	our	_	
154-27	26572-26579	results	_	
154-28	26580-26588	provided	_	
154-29	26589-26597	evidence	_	
154-30	26598-26602	that	_	
154-31	26603-26606	the	_	
154-32	26607-26623	machine-learning	_	
154-33	26624-26631	methods	_	
154-34	26632-26635	may	_	
154-35	26636-26641	offer	_	
154-36	26642-26643	a	_	
154-37	26644-26654	diagnostic	_	
154-38	26655-26659	tool	_	
154-39	26660-26663	for	_	
154-40	26664-26675	identifying	_	
154-41	26676-26679	the	_	
154-42	26680-26685	brain	_	
154-43	26686-26696	biomarkers	_	
154-44	26697-26699	to	_	
154-45	26700-26711	distinguish	_	
154-46	26712-26715	AUD	_	
154-47	26716-26720	from	_	
154-48	26721-26729	controls	_	
154-49	26729-26730	.	_	

#Text=In the future, this could be used for predicting and estimating the trajectory of AUD, such as identifying those at the first stage of addiction and are at risk of developing AUD, or ultimately predicting relapse and the treatment outcomes based on rs-FC phenotypes.
155-1	26731-26733	In	_	
155-2	26734-26737	the	_	
155-3	26738-26744	future	_	
155-4	26744-26745	,	_	
155-5	26746-26750	this	_	
155-6	26751-26756	could	_	
155-7	26757-26759	be	_	
155-8	26760-26764	used	_	
155-9	26765-26768	for	_	
155-10	26769-26779	predicting	_	
155-11	26780-26783	and	_	
155-12	26784-26794	estimating	_	
155-13	26795-26798	the	_	
155-14	26799-26809	trajectory	_	
155-15	26810-26812	of	_	
155-16	26813-26816	AUD	_	
155-17	26816-26817	,	_	
155-18	26818-26822	such	_	
155-19	26823-26825	as	_	
155-20	26826-26837	identifying	_	
155-21	26838-26843	those	_	
155-22	26844-26846	at	_	
155-23	26847-26850	the	_	
155-24	26851-26856	first	_	
155-25	26857-26862	stage	_	
155-26	26863-26865	of	_	
155-27	26866-26875	addiction	_	
155-28	26876-26879	and	_	
155-29	26880-26883	are	_	
155-30	26884-26886	at	_	
155-31	26887-26891	risk	_	
155-32	26892-26894	of	_	
155-33	26895-26905	developing	_	
155-34	26906-26909	AUD	_	
155-35	26909-26910	,	_	
155-36	26911-26913	or	_	
155-37	26914-26924	ultimately	_	
155-38	26925-26935	predicting	_	
155-39	26936-26943	relapse	_	
155-40	26944-26947	and	_	
155-41	26948-26951	the	_	
155-42	26952-26961	treatment	_	
155-43	26962-26970	outcomes	_	
155-44	26971-26976	based	_	
155-45	26977-26979	on	_	
155-46	26980-26985	rs-FC	_	
155-47	26986-26996	phenotypes	_	
155-48	26996-26997	.	_	

#Text=In the future, these individual-level brain features can be integrated with task-based brain features, behavior measures, clinical measures, genetic and environmental factors using the multivariate approach to get a better understanding of cause and effect of AUD.
156-1	26998-27000	In	_	
156-2	27001-27004	the	_	
156-3	27005-27011	future	_	
156-4	27011-27012	,	_	
156-5	27013-27018	these	_	
156-6	27019-27035	individual-level	_	
156-7	27036-27041	brain	_	
156-8	27042-27050	features	_	
156-9	27051-27054	can	_	
156-10	27055-27057	be	_	
156-11	27058-27068	integrated	_	
156-12	27069-27073	with	_	
156-13	27074-27084	task-based	_	
156-14	27085-27090	brain	_	
156-15	27091-27099	features	_	
156-16	27099-27100	,	_	
156-17	27101-27109	behavior	_	
156-18	27110-27118	measures	_	
156-19	27118-27119	,	_	
156-20	27120-27128	clinical	_	
156-21	27129-27137	measures	_	
156-22	27137-27138	,	_	
156-23	27139-27146	genetic	_	
156-24	27147-27150	and	_	
156-25	27151-27164	environmental	_	
156-26	27165-27172	factors	_	
156-27	27173-27178	using	_	
156-28	27179-27182	the	_	
156-29	27183-27195	multivariate	_	
156-30	27196-27204	approach	_	
156-31	27205-27207	to	_	
156-32	27208-27211	get	_	
156-33	27212-27213	a	_	
156-34	27214-27220	better	_	
156-35	27221-27234	understanding	_	
156-36	27235-27237	of	_	
156-37	27238-27243	cause	_	
156-38	27244-27247	and	_	
156-39	27248-27254	effect	_	
156-40	27255-27257	of	_	
156-41	27258-27261	AUD	_	
156-42	27261-27262	.	_	

#Text=For example, in a longitudinal study that identifies predictors of adolescent substance misuse, Whelan et al. 2014 not only showed the potential of neuroimaging as a tool to generate intermediate endophenotypes, but also highlighted the importance of combining neuroimaging with a wide range of potential causal factors including higher cognitive factors, personality, environmental factors, life experiences, genetics etc. to understand the mechanism underlying addiction.
157-1	27263-27266	For	_	
157-2	27267-27274	example	_	
157-3	27274-27275	,	_	
157-4	27276-27278	in	_	
157-5	27279-27280	a	_	
157-6	27281-27293	longitudinal	_	
157-7	27294-27299	study	_	
157-8	27300-27304	that	_	
157-9	27305-27315	identifies	_	
157-10	27316-27326	predictors	_	
157-11	27327-27329	of	_	
157-12	27330-27340	adolescent	_	
157-13	27341-27350	substance	_	
157-14	27351-27357	misuse	_	
157-15	27357-27358	,	_	
157-16	27359-27365	Whelan	_	
157-17	27366-27368	et	_	
157-18	27369-27371	al	_	
157-19	27371-27372	.	_	
157-20	27373-27377	2014	_	
157-21	27378-27381	not	_	
157-22	27382-27386	only	_	
157-23	27387-27393	showed	_	
157-24	27394-27397	the	_	
157-25	27398-27407	potential	_	
157-26	27408-27410	of	_	
157-27	27411-27423	neuroimaging	_	
157-28	27424-27426	as	_	
157-29	27427-27428	a	_	
157-30	27429-27433	tool	_	
157-31	27434-27436	to	_	
157-32	27437-27445	generate	_	
157-33	27446-27458	intermediate	_	
157-34	27459-27473	endophenotypes	_	
157-35	27473-27474	,	_	
157-36	27475-27478	but	_	
157-37	27479-27483	also	_	
157-38	27484-27495	highlighted	_	
157-39	27496-27499	the	_	
157-40	27500-27510	importance	_	
157-41	27511-27513	of	_	
157-42	27514-27523	combining	_	
157-43	27524-27536	neuroimaging	_	
157-44	27537-27541	with	_	
157-45	27542-27543	a	_	
157-46	27544-27548	wide	_	
157-47	27549-27554	range	_	
157-48	27555-27557	of	_	
157-49	27558-27567	potential	_	
157-50	27568-27574	causal	_	
157-51	27575-27582	factors	_	
157-52	27583-27592	including	_	
157-53	27593-27599	higher	_	
157-54	27600-27609	cognitive	_	
157-55	27610-27617	factors	_	
157-56	27617-27618	,	_	
157-57	27619-27630	personality	_	
157-58	27630-27631	,	_	
157-59	27632-27645	environmental	_	
157-60	27646-27653	factors	_	
157-61	27653-27654	,	_	
157-62	27655-27659	life	_	
157-63	27660-27671	experiences	_	
157-64	27671-27672	,	_	
157-65	27673-27681	genetics	_	
157-66	27682-27685	etc	_	
157-67	27685-27686	.	_	
157-68	27687-27689	to	_	
157-69	27690-27700	understand	_	
157-70	27701-27704	the	_	
157-71	27705-27714	mechanism	_	
157-72	27715-27725	underlying	_	
157-73	27726-27735	addiction	_	
157-74	27735-27736	.	_	

#Text=In this study, our results showed that with the help of machine-learning techniques we could deepen our understanding and better quantify the contribution of each brain networks to alcoholism.
158-1	27737-27739	In	_	
158-2	27740-27744	this	_	
158-3	27745-27750	study	_	
158-4	27750-27751	,	_	
158-5	27752-27755	our	_	
158-6	27756-27763	results	_	
158-7	27764-27770	showed	_	
158-8	27771-27775	that	_	
158-9	27776-27780	with	_	
158-10	27781-27784	the	_	
158-11	27785-27789	help	_	
158-12	27790-27792	of	_	
158-13	27793-27809	machine-learning	_	
158-14	27810-27820	techniques	_	
158-15	27821-27823	we	_	
158-16	27824-27829	could	_	
158-17	27830-27836	deepen	_	
158-18	27837-27840	our	_	
158-19	27841-27854	understanding	_	
158-20	27855-27858	and	_	
158-21	27859-27865	better	_	
158-22	27866-27874	quantify	_	
158-23	27875-27878	the	_	
158-24	27879-27891	contribution	_	
158-25	27892-27894	of	_	
158-26	27895-27899	each	_	
158-27	27900-27905	brain	_	
158-28	27906-27914	networks	_	
158-29	27915-27917	to	_	
158-30	27918-27928	alcoholism	_	
158-31	27928-27929	.	_	

#Text=Limitation
#Text=There are several potential limitations in our study that should be taken into account carefully.
159-1	27930-27940	Limitation	_	
159-2	27941-27946	There	_	
159-3	27947-27950	are	_	
159-4	27951-27958	several	_	
159-5	27959-27968	potential	_	
159-6	27969-27980	limitations	_	
159-7	27981-27983	in	_	
159-8	27984-27987	our	_	
159-9	27988-27993	study	_	
159-10	27994-27998	that	_	
159-11	27999-28005	should	_	
159-12	28006-28008	be	_	
159-13	28009-28014	taken	_	
159-14	28015-28019	into	_	
159-15	28020-28027	account	_	
159-16	28028-28037	carefully	_	
159-17	28037-28038	.	_	

#Text=First, clinical heterogeneity could have confounded results.
160-1	28039-28044	First	_	
160-2	28044-28045	,	_	
160-3	28046-28054	clinical	_	
160-4	28055-28068	heterogeneity	_	
160-5	28069-28074	could	_	
160-6	28075-28079	have	_	
160-7	28080-28090	confounded	_	
160-8	28091-28098	results	_	
160-9	28098-28099	.	_	

#Text=Alcoholism is a highly comorbid disease, as in most cases it is coupled with current or past use of other drugs (such as cocaine, cannabis, or opioid etc.) and psychiatric comorbidities.
161-1	28100-28110	Alcoholism	_	
161-2	28111-28113	is	_	
161-3	28114-28115	a	_	
161-4	28116-28122	highly	_	
161-5	28123-28131	comorbid	_	
161-6	28132-28139	disease	_	
161-7	28139-28140	,	_	
161-8	28141-28143	as	_	
161-9	28144-28146	in	_	
161-10	28147-28151	most	_	
161-11	28152-28157	cases	_	
161-12	28158-28160	it	_	
161-13	28161-28163	is	_	
161-14	28164-28171	coupled	_	
161-15	28172-28176	with	_	
161-16	28177-28184	current	_	
161-17	28185-28187	or	_	
161-18	28188-28192	past	_	
161-19	28193-28196	use	_	
161-20	28197-28199	of	_	
161-21	28200-28205	other	_	
161-22	28206-28211	drugs	_	
161-23	28212-28213	(	_	
161-24	28213-28217	such	_	
161-25	28218-28220	as	_	
161-26	28221-28228	cocaine	_	
161-27	28228-28229	,	_	
161-28	28230-28238	cannabis	_	
161-29	28238-28239	,	_	
161-30	28240-28242	or	_	
161-31	28243-28249	opioid	_	
161-32	28250-28253	etc	_	
161-33	28253-28254	.	_	
161-34	28254-28255	)	_	
161-35	28256-28259	and	_	
161-36	28260-28271	psychiatric	_	
161-37	28272-28285	comorbidities	_	
161-38	28285-28286	.	_	

#Text=However, since the subjects in the current study had different types of drug use or psychiatric disorders, it is unlikely that any particular one of the comorbidities might have contributed significantly to our results.
162-1	28287-28294	However	_	
162-2	28294-28295	,	_	
162-3	28296-28301	since	_	
162-4	28302-28305	the	_	
162-5	28306-28314	subjects	_	
162-6	28315-28317	in	_	
162-7	28318-28321	the	_	
162-8	28322-28329	current	_	
162-9	28330-28335	study	_	
162-10	28336-28339	had	_	
162-11	28340-28349	different	_	
162-12	28350-28355	types	_	
162-13	28356-28358	of	_	
162-14	28359-28363	drug	_	
162-15	28364-28367	use	_	
162-16	28368-28370	or	_	
162-17	28371-28382	psychiatric	_	
162-18	28383-28392	disorders	_	
162-19	28392-28393	,	_	
162-20	28394-28396	it	_	
162-21	28397-28399	is	_	
162-22	28400-28408	unlikely	_	
162-23	28409-28413	that	_	
162-24	28414-28417	any	_	
162-25	28418-28428	particular	_	
162-26	28429-28432	one	_	
162-27	28433-28435	of	_	
162-28	28436-28439	the	_	
162-29	28440-28453	comorbidities	_	
162-30	28454-28459	might	_	
162-31	28460-28464	have	_	
162-32	28465-28476	contributed	_	
162-33	28477-28490	significantly	_	
162-34	28491-28493	to	_	
162-35	28494-28497	our	_	
162-36	28498-28505	results	_	
162-37	28505-28506	.	_	

#Text=Therefore, alcohol use disorder is still the dominant factor contributing to the functional connectivity difference between case and control.
163-1	28507-28516	Therefore	_	
163-2	28516-28517	,	_	
163-3	28518-28525	alcohol	_	
163-4	28526-28529	use	_	
163-5	28530-28538	disorder	_	
163-6	28539-28541	is	_	
163-7	28542-28547	still	_	
163-8	28548-28551	the	_	
163-9	28552-28560	dominant	_	
163-10	28561-28567	factor	_	
163-11	28568-28580	contributing	_	
163-12	28581-28583	to	_	
163-13	28584-28587	the	_	
163-14	28588-28598	functional	_	
163-15	28599-28611	connectivity	_	
163-16	28612-28622	difference	_	
163-17	28623-28630	between	_	
163-18	28631-28635	case	_	
163-19	28636-28639	and	_	
163-20	28640-28647	control	_	
163-21	28647-28648	.	_	

#Text=Second, the AUD and control groups were not age and gender matched.
164-1	28649-28655	Second	_	
164-2	28655-28656	,	_	
164-3	28657-28660	the	_	
164-4	28661-28664	AUD	_	
164-5	28665-28668	and	_	
164-6	28669-28676	control	_	
164-7	28677-28683	groups	_	
164-8	28684-28688	were	_	
164-9	28689-28692	not	_	
164-10	28693-28696	age	_	
164-11	28697-28700	and	_	
164-12	28701-28707	gender	_	
164-13	28708-28715	matched	_	
164-14	28715-28716	.	_	

#Text=Consequently, we statistically controlled for age, in addition to gender, in our analysis.
165-1	28717-28729	Consequently	_	
165-2	28729-28730	,	_	
165-3	28731-28733	we	_	
165-4	28734-28747	statistically	_	
165-5	28748-28758	controlled	_	
165-6	28759-28762	for	_	
165-7	28763-28766	age	_	
165-8	28766-28767	,	_	
165-9	28768-28770	in	_	
165-10	28771-28779	addition	_	
165-11	28780-28782	to	_	
165-12	28783-28789	gender	_	
165-13	28789-28790	,	_	
165-14	28791-28793	in	_	
165-15	28794-28797	our	_	
165-16	28798-28806	analysis	_	
165-17	28806-28807	.	_	

#Text=To ensure that the classification performance was not affected by these factors, another analysis was carried out in which we used age, gender, and brain-based features in an analysis, and found age and gender features did not change the performance of classification.
166-1	28808-28810	To	_	
166-2	28811-28817	ensure	_	
166-3	28818-28822	that	_	
166-4	28823-28826	the	_	
166-5	28827-28841	classification	_	
166-6	28842-28853	performance	_	
166-7	28854-28857	was	_	
166-8	28858-28861	not	_	
166-9	28862-28870	affected	_	
166-10	28871-28873	by	_	
166-11	28874-28879	these	_	
166-12	28880-28887	factors	_	
166-13	28887-28888	,	_	
166-14	28889-28896	another	_	
166-15	28897-28905	analysis	_	
166-16	28906-28909	was	_	
166-17	28910-28917	carried	_	
166-18	28918-28921	out	_	
166-19	28922-28924	in	_	
166-20	28925-28930	which	_	
166-21	28931-28933	we	_	
166-22	28934-28938	used	_	
166-23	28939-28942	age	_	
166-24	28942-28943	,	_	
166-25	28944-28950	gender	_	
166-26	28950-28951	,	_	
166-27	28952-28955	and	_	
166-28	28956-28967	brain-based	_	
166-29	28968-28976	features	_	
166-30	28977-28979	in	_	
166-31	28980-28982	an	_	
166-32	28983-28991	analysis	_	
166-33	28991-28992	,	_	
166-34	28993-28996	and	_	
166-35	28997-29002	found	_	
166-36	29003-29006	age	_	
166-37	29007-29010	and	_	
166-38	29011-29017	gender	_	
166-39	29018-29026	features	_	
166-40	29027-29030	did	_	
166-41	29031-29034	not	_	
166-42	29035-29041	change	_	
166-43	29042-29045	the	_	
166-44	29046-29057	performance	_	
166-45	29058-29060	of	_	
166-46	29061-29075	classification	_	
166-47	29075-29076	.	_	

#Text=Future research with case and control groups matched for age and gender would increase the reliability of the current results.
167-1	29077-29083	Future	_	
167-2	29084-29092	research	_	
167-3	29093-29097	with	_	
167-4	29098-29102	case	_	
167-5	29103-29106	and	_	
167-6	29107-29114	control	_	
167-7	29115-29121	groups	_	
167-8	29122-29129	matched	_	
167-9	29130-29133	for	_	
167-10	29134-29137	age	_	
167-11	29138-29141	and	_	
167-12	29142-29148	gender	_	
167-13	29149-29154	would	_	
167-14	29155-29163	increase	_	
167-15	29164-29167	the	_	
167-16	29168-29179	reliability	_	
167-17	29180-29182	of	_	
167-18	29183-29186	the	_	
167-19	29187-29194	current	_	
167-20	29195-29202	results	_	
167-21	29202-29203	.	_	

#Text=Finally, for those participants with AUD having severe withdrawal symptoms during the first few days after stopping alcohol, benzodiazepines were given as needed as guided by the CIWA-Ar and vital signs monitoring.
168-1	29204-29211	Finally	_	
168-2	29211-29212	,	_	
168-3	29213-29216	for	_	
168-4	29217-29222	those	_	
168-5	29223-29235	participants	_	
168-6	29236-29240	with	_	
168-7	29241-29244	AUD	_	
168-8	29245-29251	having	_	
168-9	29252-29258	severe	_	
168-10	29259-29269	withdrawal	_	
168-11	29270-29278	symptoms	_	
168-12	29279-29285	during	_	
168-13	29286-29289	the	_	
168-14	29290-29295	first	_	
168-15	29296-29299	few	_	
168-16	29300-29304	days	_	
168-17	29305-29310	after	_	
168-18	29311-29319	stopping	_	
168-19	29320-29327	alcohol	_	
168-20	29327-29328	,	_	
168-21	29329-29344	benzodiazepines	_	
168-22	29345-29349	were	_	
168-23	29350-29355	given	_	
168-24	29356-29358	as	_	
168-25	29359-29365	needed	_	
168-26	29366-29368	as	_	
168-27	29369-29375	guided	_	
168-28	29376-29378	by	_	
168-29	29379-29382	the	_	
168-30	29383-29390	CIWA-Ar	_	
168-31	29391-29394	and	_	
168-32	29395-29400	vital	_	
168-33	29401-29406	signs	_	
168-34	29407-29417	monitoring	_	
168-35	29417-29418	.	_	

#Text=Although the fMRI session was conducted following hospitalization for at least 1 week (7 to 43 days), the benzodiazepines may still have had effects on the functional connectivity of the brain.
169-1	29419-29427	Although	_	
169-2	29428-29431	the	_	
169-3	29432-29436	fMRI	_	
169-4	29437-29444	session	_	
169-5	29445-29448	was	_	
169-6	29449-29458	conducted	_	
169-7	29459-29468	following	_	
169-8	29469-29484	hospitalization	_	
169-9	29485-29488	for	_	
169-10	29489-29491	at	_	
169-11	29492-29497	least	_	
169-12	29498-29499	1	_	
169-13	29500-29504	week	_	
169-14	29505-29506	(	_	
169-15	29506-29507	7	_	
169-16	29508-29510	to	_	
169-17	29511-29513	43	_	
169-18	29514-29518	days	_	
169-19	29518-29519	)	_	
169-20	29519-29520	,	_	
169-21	29521-29524	the	_	
169-22	29525-29540	benzodiazepines	_	
169-23	29541-29544	may	_	
169-24	29545-29550	still	_	
169-25	29551-29555	have	_	
169-26	29556-29559	had	_	
169-27	29560-29567	effects	_	
169-28	29568-29570	on	_	
169-29	29571-29574	the	_	
169-30	29575-29585	functional	_	
169-31	29586-29598	connectivity	_	
169-32	29599-29601	of	_	
169-33	29602-29605	the	_	
169-34	29606-29611	brain	_	
169-35	29611-29612	.	_	

#Text=Further tests are needed in this regard.
170-1	29613-29620	Further	_	
170-2	29621-29626	tests	_	
170-3	29627-29630	are	_	
170-4	29631-29637	needed	_	
170-5	29638-29640	in	_	
170-6	29641-29645	this	_	
170-7	29646-29652	regard	_	
170-8	29652-29653	.	_	

#Text=Other limitations include using relatively short resting-state scan time (5 mins).
171-1	29654-29659	Other	_	
171-2	29660-29671	limitations	_	
171-3	29672-29679	include	_	
171-4	29680-29685	using	_	
171-5	29686-29696	relatively	_	
171-6	29697-29702	short	_	
171-7	29703-29716	resting-state	_	
171-8	29717-29721	scan	_	
171-9	29722-29726	time	_	
171-10	29727-29728	(	_	
171-11	29728-29729	5	_	
171-12	29730-29734	mins	_	
171-13	29734-29735	)	_	
171-14	29735-29736	.	_	

#Text=Our data warrant replication in larger samples with longer scan time.
172-1	29737-29740	Our	_	
172-2	29741-29745	data	_	
172-3	29746-29753	warrant	_	
172-4	29754-29765	replication	_	
172-5	29766-29768	in	_	
172-6	29769-29775	larger	_	
172-7	29776-29783	samples	_	
172-8	29784-29788	with	_	
172-9	29789-29795	longer	_	
172-10	29796-29800	scan	_	
172-11	29801-29805	time	_	
172-12	29805-29806	.	_	

#Text=In conclusion, within-network functional connectivity offered maximal information for predicting AUD status.
173-1	29807-29809	In	_	
173-2	29810-29820	conclusion	_	
173-3	29820-29821	,	_	
173-4	29822-29836	within-network	_	
173-5	29837-29847	functional	_	
173-6	29848-29860	connectivity	_	
173-7	29861-29868	offered	_	
173-8	29869-29876	maximal	_	
173-9	29877-29888	information	_	
173-10	29889-29892	for	_	
173-11	29893-29903	predicting	_	
173-12	29904-29907	AUD	_	
173-13	29908-29914	status	_	
173-14	29914-29915	.	_	

#Text=Further, our results suggest that connectivity within the ECN and RN might be informative in predicting AUD.
174-1	29916-29923	Further	_	
174-2	29923-29924	,	_	
174-3	29925-29928	our	_	
174-4	29929-29936	results	_	
174-5	29937-29944	suggest	_	
174-6	29945-29949	that	_	
174-7	29950-29962	connectivity	_	
174-8	29963-29969	within	_	
174-9	29970-29973	the	_	
174-10	29974-29977	ECN	_	
174-11	29978-29981	and	_	
174-12	29982-29984	RN	_	
174-13	29985-29990	might	_	
174-14	29991-29993	be	_	
174-15	29994-30005	informative	_	
174-16	30006-30008	in	_	
174-17	30009-30019	predicting	_	
174-18	30020-30023	AUD	_	
174-19	30023-30024	.	_	

#Text=Further development of this approach might also provide useful information for therapeutic interventions or treatment effectiveness.
175-1	30025-30032	Further	_	
175-2	30033-30044	development	_	
175-3	30045-30047	of	_	
175-4	30048-30052	this	_	
175-5	30053-30061	approach	_	
175-6	30062-30067	might	_	
175-7	30068-30072	also	_	
175-8	30073-30080	provide	_	
175-9	30081-30087	useful	_	
175-10	30088-30099	information	_	
175-11	30100-30103	for	_	
175-12	30104-30115	therapeutic	_	
175-13	30116-30129	interventions	_	
175-14	30130-30132	or	_	
175-15	30133-30142	treatment	_	
175-16	30143-30156	effectiveness	_	
175-17	30156-30157	.	_	

#Text=More attention should be given to the patterns of information transmission and processing between these networks in AUD and perhaps other addictions.
176-1	30158-30162	More	_	
176-2	30163-30172	attention	_	
176-3	30173-30179	should	_	
176-4	30180-30182	be	_	
176-5	30183-30188	given	_	
176-6	30189-30191	to	_	
176-7	30192-30195	the	_	
176-8	30196-30204	patterns	_	
176-9	30205-30207	of	_	
176-10	30208-30219	information	_	
176-11	30220-30232	transmission	_	
176-12	30233-30236	and	_	
176-13	30237-30247	processing	_	
176-14	30248-30255	between	_	
176-15	30256-30261	these	_	
176-16	30262-30270	networks	_	
176-17	30271-30273	in	_	
176-18	30274-30277	AUD	_	
176-19	30278-30281	and	_	
176-20	30282-30289	perhaps	_	
176-21	30290-30295	other	_	
176-22	30296-30306	addictions	_	
176-23	30306-30307	.	_	

#Text=These findings may shed light on the mechanism underlying addiction.
177-1	30308-30313	These	_	
177-2	30314-30322	findings	_	
177-3	30323-30326	may	_	
177-4	30327-30331	shed	_	
177-5	30332-30337	light	_	
177-6	30338-30340	on	_	
177-7	30341-30344	the	_	
177-8	30345-30354	mechanism	_	
177-9	30355-30365	underlying	_	
177-10	30366-30375	addiction	_	
177-11	30375-30376	.	_	

#Text=Our findings suggest that machine-learning-based approaches to classifying rs-FC offer an additional and valuable technique for understanding large-scale differences in addiction-related neurobiology.
178-1	30377-30380	Our	_	
178-2	30381-30389	findings	_	
178-3	30390-30397	suggest	_	
178-4	30398-30402	that	_	
178-5	30403-30425	machine-learning-based	_	
178-6	30426-30436	approaches	_	
178-7	30437-30439	to	_	
178-8	30440-30451	classifying	_	
178-9	30452-30457	rs-FC	_	
178-10	30458-30463	offer	_	
178-11	30464-30466	an	_	
178-12	30467-30477	additional	_	
178-13	30478-30481	and	_	
178-14	30482-30490	valuable	_	
178-15	30491-30500	technique	_	
178-16	30501-30504	for	_	
178-17	30505-30518	understanding	_	
178-18	30519-30530	large-scale	_	
178-19	30531-30542	differences	_	
178-20	30543-30545	in	_	
178-21	30546-30563	addiction-related	_	
178-22	30564-30576	neurobiology	_	
178-23	30576-30577	.	_	

#Text=Conflict of Interest         
#Text=All authors acknowledge that there is no conflict of biomedical financial interests in performing this study or in preparing this manuscript.
179-1	30589-30597	Conflict	_	
179-2	30598-30600	of	_	
179-3	30601-30609	Interest	_	
179-4	30619-30622	All	_	
179-5	30623-30630	authors	_	
179-6	30631-30642	acknowledge	_	
179-7	30643-30647	that	_	
179-8	30648-30653	there	_	
179-9	30654-30656	is	_	
179-10	30657-30659	no	_	
179-11	30660-30668	conflict	_	
179-12	30669-30671	of	_	
179-13	30672-30682	biomedical	_	
179-14	30683-30692	financial	_	
179-15	30693-30702	interests	_	
179-16	30703-30705	in	_	
179-17	30706-30716	performing	_	
179-18	30717-30721	this	_	
179-19	30722-30727	study	_	
179-20	30728-30730	or	_	
179-21	30731-30733	in	_	
179-22	30734-30743	preparing	_	
179-23	30744-30748	this	_	
179-24	30749-30759	manuscript	_	
179-25	30759-30760	.	_	

#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
180-1	30761-30765	This	_	
180-2	30766-30768	is	_	
180-3	30769-30770	a	_	
180-4	30771-30774	PDF	_	
180-5	30775-30779	file	_	
180-6	30780-30782	of	_	
180-7	30783-30785	an	_	
180-8	30786-30794	unedited	_	
180-9	30795-30805	manuscript	_	
180-10	30806-30810	that	_	
180-11	30811-30814	has	_	
180-12	30815-30819	been	_	
180-13	30820-30828	accepted	_	
180-14	30829-30832	for	_	
180-15	30833-30844	publication	_	
180-16	30844-30845	.	_	

#Text=As a service to our customers we are providing this early version of the manuscript.
181-1	30846-30848	As	_	
181-2	30849-30850	a	_	
181-3	30851-30858	service	_	
181-4	30859-30861	to	_	
181-5	30862-30865	our	_	
181-6	30866-30875	customers	_	
181-7	30876-30878	we	_	
181-8	30879-30882	are	_	
181-9	30883-30892	providing	_	
181-10	30893-30897	this	_	
181-11	30898-30903	early	_	
181-12	30904-30911	version	_	
181-13	30912-30914	of	_	
181-14	30915-30918	the	_	
181-15	30919-30929	manuscript	_	
181-16	30929-30930	.	_	

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
182-1	30931-30934	The	_	
182-2	30935-30945	manuscript	_	
182-3	30946-30950	will	_	
182-4	30951-30958	undergo	_	
182-5	30959-30970	copyediting	_	
182-6	30970-30971	,	_	
182-7	30972-30983	typesetting	_	
182-8	30983-30984	,	_	
182-9	30985-30988	and	_	
182-10	30989-30995	review	_	
182-11	30996-30998	of	_	
182-12	30999-31002	the	_	
182-13	31003-31012	resulting	_	
182-14	31013-31018	proof	_	
182-15	31019-31025	before	_	
182-16	31026-31028	it	_	
182-17	31029-31031	is	_	
182-18	31032-31041	published	_	
182-19	31042-31044	in	_	
182-20	31045-31048	its	_	
182-21	31049-31054	final	_	
182-22	31055-31062	citable	_	
182-23	31063-31067	form	_	
182-24	31067-31068	.	_	

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
183-1	31069-31075	Please	_	
183-2	31076-31080	note	_	
183-3	31081-31085	that	_	
183-4	31086-31092	during	_	
183-5	31093-31096	the	_	
183-6	31097-31107	production	_	
183-7	31108-31115	process	_	
183-8	31116-31122	errors	_	
183-9	31123-31126	may	_	
183-10	31127-31129	be	_	
183-11	31130-31140	discovered	_	
183-12	31141-31146	which	_	
183-13	31147-31152	could	_	
183-14	31153-31159	affect	_	
183-15	31160-31163	the	_	
183-16	31164-31171	content	_	
183-17	31171-31172	,	_	
183-18	31173-31176	and	_	
183-19	31177-31180	all	_	
183-20	31181-31186	legal	_	
183-21	31187-31198	disclaimers	_	
183-22	31199-31203	that	_	
183-23	31204-31209	apply	_	
183-24	31210-31212	to	_	
183-25	31213-31216	the	_	
183-26	31217-31224	journal	_	
183-27	31225-31232	pertain	_	
183-28	31232-31233	.	_	

#Text=Resting-state synchrony in short-term versus long-term abstinent alcoholics
#Text=Disruption of functional connectivity of the default-mode network in alcoholism
#Text=Machine learning classification of resting state functional connectivity predicts smoking status
#Text=Classification of schizophrenia patients based on resting-state functional network connectivity
#Text=Functional connectivity classification of autism identifies highly predictive brain features but falls short of biomarker standards
#Text=Resting state functional magnetic resonance imaging and neural network classified autism and control
#Text=Salience network-based classification and prediction of symptom severity in children with autism
#Text=Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imaging
#Text=Abnormal functional resting-state networks in ADHD: graph theory and pattern recognition analysis of fMRI data
#Text=Automatic classification of early Parkinson’s disease with multi-modal MR imaging
#Text=Toward literature-based feature selection for diagnostic classification: a meta-analysis of resting-state fMRI in depression
#Text=Pattern classification of large-scale functional brain networks: identification of informative neuroimaging markers for epilepsy
#Text=Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - a multi-voxel pattern analysis
#Text=Distinct resting-state brain activities in heroin-dependent individuals
#Text=A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data
#Text=Investigations into resting-state connectivity using independent component analysis
#Text=Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients
#Text=A comparison of random forest and its Gini importance with standard chemometric methods for the feature selection and classification of spectral data
#Text=Machine learning for neuroimaging with scikit-learn
#Text=Model-free functional connectivity and impulsivity correlates of alcohol dependence: a resting-state study
#Text=The Resting Brain of Alcoholics
#Text=Reduced left executive control network functional connectivity is associated with alcohol use disorders
#Text=Resting-state synchrony in long-term abstinent alcoholics
#Text=Resting-state regional homogeneity as a biological marker for patients with Internet gaming disorder: A comparison with patients with alcohol use disorder and healthy controls
#Text=Multivariate Granger causality analysis of fMRI data
#Text=Multivariate autoregressive modeling of fMRI time series
#Text=Functional neural networks underlying response inhibition in adolescents and adults
#Text=Neurocircuitry of addiction
#Text=Neuropsychosocial profiles of current and future adolescent alcohol misusers
#Text=Spatial maps of 32 independent components grouped into 5 categories (Different colors represent different network sub-components in each category for A to D): A: default-model networks (3 components).
184-1	31234-31247	Resting-state	_	
184-2	31248-31257	synchrony	_	
184-3	31258-31260	in	_	
184-4	31261-31271	short-term	_	
184-5	31272-31278	versus	_	
184-6	31279-31288	long-term	_	
184-7	31289-31298	abstinent	_	
184-8	31299-31309	alcoholics	_	
184-9	31310-31320	Disruption	_	
184-10	31321-31323	of	_	
184-11	31324-31334	functional	_	
184-12	31335-31347	connectivity	_	
184-13	31348-31350	of	_	
184-14	31351-31354	the	_	
184-15	31355-31367	default-mode	_	
184-16	31368-31375	network	_	
184-17	31376-31378	in	_	
184-18	31379-31389	alcoholism	_	
184-19	31390-31397	Machine	_	
184-20	31398-31406	learning	_	
184-21	31407-31421	classification	_	
184-22	31422-31424	of	_	
184-23	31425-31432	resting	_	
184-24	31433-31438	state	_	
184-25	31439-31449	functional	_	
184-26	31450-31462	connectivity	_	
184-27	31463-31471	predicts	_	
184-28	31472-31479	smoking	_	
184-29	31480-31486	status	_	
184-30	31487-31501	Classification	_	
184-31	31502-31504	of	_	
184-32	31505-31518	schizophrenia	_	
184-33	31519-31527	patients	_	
184-34	31528-31533	based	_	
184-35	31534-31536	on	_	
184-36	31537-31550	resting-state	_	
184-37	31551-31561	functional	_	
184-38	31562-31569	network	_	
184-39	31570-31582	connectivity	_	
184-40	31583-31593	Functional	_	
184-41	31594-31606	connectivity	_	
184-42	31607-31621	classification	_	
184-43	31622-31624	of	_	
184-44	31625-31631	autism	_	
184-45	31632-31642	identifies	_	
184-46	31643-31649	highly	_	
184-47	31650-31660	predictive	_	
184-48	31661-31666	brain	_	
184-49	31667-31675	features	_	
184-50	31676-31679	but	_	
184-51	31680-31685	falls	_	
184-52	31686-31691	short	_	
184-53	31692-31694	of	_	
184-54	31695-31704	biomarker	_	
184-55	31705-31714	standards	_	
184-56	31715-31722	Resting	_	
184-57	31723-31728	state	_	
184-58	31729-31739	functional	_	
184-59	31740-31748	magnetic	_	
184-60	31749-31758	resonance	_	
184-61	31759-31766	imaging	_	
184-62	31767-31770	and	_	
184-63	31771-31777	neural	_	
184-64	31778-31785	network	_	
184-65	31786-31796	classified	_	
184-66	31797-31803	autism	_	
184-67	31804-31807	and	_	
184-68	31808-31815	control	_	
184-69	31816-31824	Salience	_	
184-70	31825-31838	network-based	_	
184-71	31839-31853	classification	_	
184-72	31854-31857	and	_	
184-73	31858-31868	prediction	_	
184-74	31869-31871	of	_	
184-75	31872-31879	symptom	_	
184-76	31880-31888	severity	_	
184-77	31889-31891	in	_	
184-78	31892-31900	children	_	
184-79	31901-31905	with	_	
184-80	31906-31912	autism	_	
184-81	31913-31927	Classification	_	
184-82	31928-31930	of	_	
184-83	31931-31940	Alzheimer	_	
184-84	31941-31948	disease	_	
184-85	31948-31949	,	_	
184-86	31950-31954	mild	_	
184-87	31955-31964	cognitive	_	
184-88	31965-31975	impairment	_	
184-89	31975-31976	,	_	
184-90	31977-31980	and	_	
184-91	31981-31987	normal	_	
184-92	31988-31997	cognitive	_	
184-93	31998-32004	status	_	
184-94	32005-32009	with	_	
184-95	32010-32021	large-scale	_	
184-96	32022-32029	network	_	
184-97	32030-32038	analysis	_	
184-98	32039-32044	based	_	
184-99	32045-32047	on	_	
184-100	32048-32061	resting-state	_	
184-101	32062-32072	functional	_	
184-102	32073-32075	MR	_	
184-103	32076-32083	imaging	_	
184-104	32084-32092	Abnormal	_	
184-105	32093-32103	functional	_	
184-106	32104-32117	resting-state	_	
184-107	32118-32126	networks	_	
184-108	32127-32129	in	_	
184-109	32130-32134	ADHD	_	
184-110	32134-32135	:	_	
184-111	32136-32141	graph	_	
184-112	32142-32148	theory	_	
184-113	32149-32152	and	_	
184-114	32153-32160	pattern	_	
184-115	32161-32172	recognition	_	
184-116	32173-32181	analysis	_	
184-117	32182-32184	of	_	
184-118	32185-32189	fMRI	_	
184-119	32190-32194	data	_	
184-120	32195-32204	Automatic	_	
184-121	32205-32219	classification	_	
184-122	32220-32222	of	_	
184-123	32223-32228	early	_	
184-124	32229-32238	Parkinson	_	
184-125	32238-32239	’	_	
184-126	32239-32240	s	_	
184-127	32241-32248	disease	_	
184-128	32249-32253	with	_	
184-129	32254-32265	multi-modal	_	
184-130	32266-32268	MR	_	
184-131	32269-32276	imaging	_	
184-132	32277-32283	Toward	_	
184-133	32284-32300	literature-based	_	
184-134	32301-32308	feature	_	
184-135	32309-32318	selection	_	
184-136	32319-32322	for	_	
184-137	32323-32333	diagnostic	_	
184-138	32334-32348	classification	_	
184-139	32348-32349	:	_	
184-140	32350-32351	a	_	
184-141	32352-32365	meta-analysis	_	
184-142	32366-32368	of	_	
184-143	32369-32382	resting-state	_	
184-144	32383-32387	fMRI	_	
184-145	32388-32390	in	_	
184-146	32391-32401	depression	_	
184-147	32402-32409	Pattern	_	
184-148	32410-32424	classification	_	
184-149	32425-32427	of	_	
184-150	32428-32439	large-scale	_	
184-151	32440-32450	functional	_	
184-152	32451-32456	brain	_	
184-153	32457-32465	networks	_	
184-154	32465-32466	:	_	
184-155	32467-32481	identification	_	
184-156	32482-32484	of	_	
184-157	32485-32496	informative	_	
184-158	32497-32509	neuroimaging	_	
184-159	32510-32517	markers	_	
184-160	32518-32521	for	_	
184-161	32522-32530	epilepsy	_	
184-162	32531-32538	Resting	_	
184-163	32539-32544	state	_	
184-164	32545-32555	functional	_	
184-165	32556-32564	magnetic	_	
184-166	32565-32574	resonance	_	
184-167	32575-32582	imaging	_	
184-168	32583-32590	reveals	_	
184-169	32591-32599	distinct	_	
184-170	32600-32605	brain	_	
184-171	32606-32614	activity	_	
184-172	32615-32617	in	_	
184-173	32618-32623	heavy	_	
184-174	32624-32632	cannabis	_	
184-175	32633-32638	users	_	
184-176	32639-32640	-	_	
184-177	32641-32642	a	_	
184-178	32643-32654	multi-voxel	_	
184-179	32655-32662	pattern	_	
184-180	32663-32671	analysis	_	
184-181	32672-32680	Distinct	_	
184-182	32681-32694	resting-state	_	
184-183	32695-32700	brain	_	
184-184	32701-32711	activities	_	
184-185	32712-32714	in	_	
184-186	32715-32731	heroin-dependent	_	
184-187	32732-32743	individuals	_	
184-188	32744-32745	A	_	
184-189	32746-32752	review	_	
184-190	32753-32755	of	_	
184-191	32756-32761	group	_	
184-192	32762-32765	ICA	_	
184-193	32766-32769	for	_	
184-194	32770-32774	fMRI	_	
184-195	32775-32779	data	_	
184-196	32780-32783	and	_	
184-197	32784-32787	ICA	_	
184-198	32788-32791	for	_	
184-199	32792-32797	joint	_	
184-200	32798-32807	inference	_	
184-201	32808-32810	of	_	
184-202	32811-32818	imaging	_	
184-203	32818-32819	,	_	
184-204	32820-32827	genetic	_	
184-205	32827-32828	,	_	
184-206	32829-32832	and	_	
184-207	32833-32836	ERP	_	
184-208	32837-32841	data	_	
184-209	32842-32856	Investigations	_	
184-210	32857-32861	into	_	
184-211	32862-32875	resting-state	_	
184-212	32876-32888	connectivity	_	
184-213	32889-32894	using	_	
184-214	32895-32906	independent	_	
184-215	32907-32916	component	_	
184-216	32917-32925	analysis	_	
184-217	32926-32932	Effect	_	
184-218	32933-32935	of	_	
184-219	32936-32941	brain	_	
184-220	32942-32951	structure	_	
184-221	32951-32952	,	_	
184-222	32953-32958	brain	_	
184-223	32959-32967	function	_	
184-224	32967-32968	,	_	
184-225	32969-32972	and	_	
184-226	32973-32978	brain	_	
184-227	32979-32991	connectivity	_	
184-228	32992-32994	on	_	
184-229	32995-33002	relapse	_	
184-230	33003-33005	in	_	
184-231	33006-33023	alcohol-dependent	_	
184-232	33024-33032	patients	_	
184-233	33033-33034	A	_	
184-234	33035-33045	comparison	_	
184-235	33046-33048	of	_	
184-236	33049-33055	random	_	
184-237	33056-33062	forest	_	
184-238	33063-33066	and	_	
184-239	33067-33070	its	_	
184-240	33071-33075	Gini	_	
184-241	33076-33086	importance	_	
184-242	33087-33091	with	_	
184-243	33092-33100	standard	_	
184-244	33101-33112	chemometric	_	
184-245	33113-33120	methods	_	
184-246	33121-33124	for	_	
184-247	33125-33128	the	_	
184-248	33129-33136	feature	_	
184-249	33137-33146	selection	_	
184-250	33147-33150	and	_	
184-251	33151-33165	classification	_	
184-252	33166-33168	of	_	
184-253	33169-33177	spectral	_	
184-254	33178-33182	data	_	
184-255	33183-33190	Machine	_	
184-256	33191-33199	learning	_	
184-257	33200-33203	for	_	
184-258	33204-33216	neuroimaging	_	
184-259	33217-33221	with	_	
184-260	33222-33234	scikit-learn	_	
184-261	33235-33245	Model-free	_	
184-262	33246-33256	functional	_	
184-263	33257-33269	connectivity	_	
184-264	33270-33273	and	_	
184-265	33274-33285	impulsivity	_	
184-266	33286-33296	correlates	_	
184-267	33297-33299	of	_	
184-268	33300-33307	alcohol	_	
184-269	33308-33318	dependence	_	
184-270	33318-33319	:	_	
184-271	33320-33321	a	_	
184-272	33322-33335	resting-state	_	
184-273	33336-33341	study	_	
184-274	33342-33345	The	_	
184-275	33346-33353	Resting	_	
184-276	33354-33359	Brain	_	
184-277	33360-33362	of	_	
184-278	33363-33373	Alcoholics	_	
184-279	33374-33381	Reduced	_	
184-280	33382-33386	left	_	
184-281	33387-33396	executive	_	
184-282	33397-33404	control	_	
184-283	33405-33412	network	_	
184-284	33413-33423	functional	_	
184-285	33424-33436	connectivity	_	
184-286	33437-33439	is	_	
184-287	33440-33450	associated	_	
184-288	33451-33455	with	_	
184-289	33456-33463	alcohol	_	
184-290	33464-33467	use	_	
184-291	33468-33477	disorders	_	
184-292	33478-33491	Resting-state	_	
184-293	33492-33501	synchrony	_	
184-294	33502-33504	in	_	
184-295	33505-33514	long-term	_	
184-296	33515-33524	abstinent	_	
184-297	33525-33535	alcoholics	_	
184-298	33536-33549	Resting-state	_	
184-299	33550-33558	regional	_	
184-300	33559-33570	homogeneity	_	
184-301	33571-33573	as	_	
184-302	33574-33575	a	_	
184-303	33576-33586	biological	_	
184-304	33587-33593	marker	_	
184-305	33594-33597	for	_	
184-306	33598-33606	patients	_	
184-307	33607-33611	with	_	
184-308	33612-33620	Internet	_	
184-309	33621-33627	gaming	_	
184-310	33628-33636	disorder	_	
184-311	33636-33637	:	_	
184-312	33638-33639	A	_	
184-313	33640-33650	comparison	_	
184-314	33651-33655	with	_	
184-315	33656-33664	patients	_	
184-316	33665-33669	with	_	
184-317	33670-33677	alcohol	_	
184-318	33678-33681	use	_	
184-319	33682-33690	disorder	_	
184-320	33691-33694	and	_	
184-321	33695-33702	healthy	_	
184-322	33703-33711	controls	_	
184-323	33712-33724	Multivariate	_	
184-324	33725-33732	Granger	_	
184-325	33733-33742	causality	_	
184-326	33743-33751	analysis	_	
184-327	33752-33754	of	_	
184-328	33755-33759	fMRI	_	
184-329	33760-33764	data	_	
184-330	33765-33777	Multivariate	_	
184-331	33778-33792	autoregressive	_	
184-332	33793-33801	modeling	_	
184-333	33802-33804	of	_	
184-334	33805-33809	fMRI	_	
184-335	33810-33814	time	_	
184-336	33815-33821	series	_	
184-337	33822-33832	Functional	_	
184-338	33833-33839	neural	_	
184-339	33840-33848	networks	_	
184-340	33849-33859	underlying	_	
184-341	33860-33868	response	_	
184-342	33869-33879	inhibition	_	
184-343	33880-33882	in	_	
184-344	33883-33894	adolescents	_	
184-345	33895-33898	and	_	
184-346	33899-33905	adults	_	
184-347	33906-33920	Neurocircuitry	_	
184-348	33921-33923	of	_	
184-349	33924-33933	addiction	_	
184-350	33934-33951	Neuropsychosocial	_	
184-351	33952-33960	profiles	_	
184-352	33961-33963	of	_	
184-353	33964-33971	current	_	
184-354	33972-33975	and	_	
184-355	33976-33982	future	_	
184-356	33983-33993	adolescent	_	
184-357	33994-34001	alcohol	_	
184-358	34002-34010	misusers	_	
184-359	34011-34018	Spatial	_	
184-360	34019-34023	maps	_	
184-361	34024-34026	of	_	
184-362	34027-34029	32	_	
184-363	34030-34041	independent	_	
184-364	34042-34052	components	_	
184-365	34053-34060	grouped	_	
184-366	34061-34065	into	_	
184-367	34066-34067	5	_	
184-368	34068-34078	categories	_	
184-369	34079-34080	(	_	
184-370	34080-34089	Different	_	
184-371	34090-34096	colors	_	
184-372	34097-34106	represent	_	
184-373	34107-34116	different	_	
184-374	34117-34124	network	_	
184-375	34125-34139	sub-components	_	
184-376	34140-34142	in	_	
184-377	34143-34147	each	_	
184-378	34148-34156	category	_	
184-379	34157-34160	for	_	
184-380	34161-34162	A	_	
184-381	34163-34165	to	_	
184-382	34166-34167	D	_	
184-383	34167-34168	)	_	
184-384	34168-34169	:	_	
184-385	34170-34171	A	_	
184-386	34171-34172	:	_	
184-387	34173-34186	default-model	_	
184-388	34187-34195	networks	_	
184-389	34196-34197	(	_	
184-390	34197-34198	3	_	
184-391	34199-34209	components	_	
184-392	34209-34210	)	_	
184-393	34210-34211	.	_	

#Text=B: Visual networks (7 components) C: Sensorimotor networks (6 components) D: executive control networks (12 components) E: all other networks (4 components) including salience network (Green), subcortical network (Blue), auditory network (Violet), cerebellar (Yellow)
#Text=Between-network functional connectivity features: correlation coefficients matrices between each pair of networks in AUD (left) and controls (right)
#Text=The procedure of feature extraction and pattern classification
#Text=Within-network features maximally contributing to classification performance including ECN1 (Violet), ECN2 (Blue), RN (Cyan)
#Text=The stability of within-network features that have the strongest predicting power (ECN1, RN and ECN2).
185-1	34212-34213	B	_	
185-2	34213-34214	:	_	
185-3	34215-34221	Visual	_	
185-4	34222-34230	networks	_	
185-5	34231-34232	(	_	
185-6	34232-34233	7	_	
185-7	34234-34244	components	_	
185-8	34244-34245	)	_	
185-9	34246-34247	C	_	
185-10	34247-34248	:	_	
185-11	34249-34261	Sensorimotor	_	
185-12	34262-34270	networks	_	
185-13	34271-34272	(	_	
185-14	34272-34273	6	_	
185-15	34274-34284	components	_	
185-16	34284-34285	)	_	
185-17	34286-34287	D	_	
185-18	34287-34288	:	_	
185-19	34289-34298	executive	_	
185-20	34299-34306	control	_	
185-21	34307-34315	networks	_	
185-22	34316-34317	(	_	
185-23	34317-34319	12	_	
185-24	34320-34330	components	_	
185-25	34330-34331	)	_	
185-26	34332-34333	E	_	
185-27	34333-34334	:	_	
185-28	34335-34338	all	_	
185-29	34339-34344	other	_	
185-30	34345-34353	networks	_	
185-31	34354-34355	(	_	
185-32	34355-34356	4	_	
185-33	34357-34367	components	_	
185-34	34367-34368	)	_	
185-35	34369-34378	including	_	
185-36	34379-34387	salience	_	
185-37	34388-34395	network	_	
185-38	34396-34397	(	_	
185-39	34397-34402	Green	_	
185-40	34402-34403	)	_	
185-41	34403-34404	,	_	
185-42	34405-34416	subcortical	_	
185-43	34417-34424	network	_	
185-44	34425-34426	(	_	
185-45	34426-34430	Blue	_	
185-46	34430-34431	)	_	
185-47	34431-34432	,	_	
185-48	34433-34441	auditory	_	
185-49	34442-34449	network	_	
185-50	34450-34451	(	_	
185-51	34451-34457	Violet	_	
185-52	34457-34458	)	_	
185-53	34458-34459	,	_	
185-54	34460-34470	cerebellar	_	
185-55	34471-34472	(	_	
185-56	34472-34478	Yellow	_	
185-57	34478-34479	)	_	
185-58	34480-34495	Between-network	_	
185-59	34496-34506	functional	_	
185-60	34507-34519	connectivity	_	
185-61	34520-34528	features	_	
185-62	34528-34529	:	_	
185-63	34530-34541	correlation	_	
185-64	34542-34554	coefficients	_	
185-65	34555-34563	matrices	_	
185-66	34564-34571	between	_	
185-67	34572-34576	each	_	
185-68	34577-34581	pair	_	
185-69	34582-34584	of	_	
185-70	34585-34593	networks	_	
185-71	34594-34596	in	_	
185-72	34597-34600	AUD	_	
185-73	34601-34602	(	_	
185-74	34602-34606	left	_	
185-75	34606-34607	)	_	
185-76	34608-34611	and	_	
185-77	34612-34620	controls	_	
185-78	34621-34622	(	_	
185-79	34622-34627	right	_	
185-80	34627-34628	)	_	
185-81	34629-34632	The	_	
185-82	34633-34642	procedure	_	
185-83	34643-34645	of	_	
185-84	34646-34653	feature	_	
185-85	34654-34664	extraction	_	
185-86	34665-34668	and	_	
185-87	34669-34676	pattern	_	
185-88	34677-34691	classification	_	
185-89	34692-34706	Within-network	_	
185-90	34707-34715	features	_	
185-91	34716-34725	maximally	_	
185-92	34726-34738	contributing	_	
185-93	34739-34741	to	_	
185-94	34742-34756	classification	_	
185-95	34757-34768	performance	_	
185-96	34769-34778	including	_	
185-97	34779-34783	ECN1	_	
185-98	34784-34785	(	_	
185-99	34785-34791	Violet	_	
185-100	34791-34792	)	_	
185-101	34792-34793	,	_	
185-102	34794-34798	ECN2	_	
185-103	34799-34800	(	_	
185-104	34800-34804	Blue	_	
185-105	34804-34805	)	_	
185-106	34805-34806	,	_	
185-107	34807-34809	RN	_	
185-108	34810-34811	(	_	
185-109	34811-34815	Cyan	_	
185-110	34815-34816	)	_	
185-111	34817-34820	The	_	
185-112	34821-34830	stability	_	
185-113	34831-34833	of	_	
185-114	34834-34848	within-network	_	
185-115	34849-34857	features	_	
185-116	34858-34862	that	_	
185-117	34863-34867	have	_	
185-118	34868-34871	the	_	
185-119	34872-34881	strongest	_	
185-120	34882-34892	predicting	_	
185-121	34893-34898	power	_	
185-122	34899-34900	(	_	
185-123	34900-34904	ECN1	_	
185-124	34904-34905	,	_	
185-125	34906-34908	RN	_	
185-126	34909-34912	and	_	
185-127	34913-34917	ECN2	_	
185-128	34917-34918	)	_	
185-129	34918-34919	.	_	

#Text=The mean and standard error of feature importance of 92 random forests by using leave-one-out cross-validation (LOOCV) were calculated and presented in the figure.
186-1	34920-34923	The	_	
186-2	34924-34928	mean	_	
186-3	34929-34932	and	_	
186-4	34933-34941	standard	_	
186-5	34942-34947	error	_	
186-6	34948-34950	of	_	
186-7	34951-34958	feature	_	
186-8	34959-34969	importance	_	
186-9	34970-34972	of	_	
186-10	34973-34975	92	_	
186-11	34976-34982	random	_	
186-12	34983-34990	forests	_	
186-13	34991-34993	by	_	
186-14	34994-34999	using	_	
186-15	35000-35013	leave-one-out	_	
186-16	35014-35030	cross-validation	_	
186-17	35031-35032	(	_	
186-18	35032-35037	LOOCV	_	
186-19	35037-35038	)	_	
186-20	35039-35043	were	_	
186-21	35044-35054	calculated	_	
186-22	35055-35058	and	_	
186-23	35059-35068	presented	_	
186-24	35069-35071	in	_	
186-25	35072-35075	the	_	
186-26	35076-35082	figure	_	
186-27	35082-35083	.	_	

#Text=The stability of between-network features that have the strongest predicting power.
187-1	35084-35087	The	_	
187-2	35088-35097	stability	_	
187-3	35098-35100	of	_	
187-4	35101-35116	between-network	_	
187-5	35117-35125	features	_	
187-6	35126-35130	that	_	
187-7	35131-35135	have	_	
187-8	35136-35139	the	_	
187-9	35140-35149	strongest	_	
187-10	35150-35160	predicting	_	
187-11	35161-35166	power	_	
187-12	35166-35167	.	_	

#Text=The prediction accuracy was computed 92 times by using leave-one-out cross-validation (LOOCV).
188-1	35168-35171	The	_	
188-2	35172-35182	prediction	_	
188-3	35183-35191	accuracy	_	
188-4	35192-35195	was	_	
188-5	35196-35204	computed	_	
188-6	35205-35207	92	_	
188-7	35208-35213	times	_	
188-8	35214-35216	by	_	
188-9	35217-35222	using	_	
188-10	35223-35236	leave-one-out	_	
188-11	35237-35253	cross-validation	_	
188-12	35254-35255	(	_	
188-13	35255-35260	LOOCV	_	
188-14	35260-35261	)	_	
188-15	35261-35262	.	_	

#Text=The mean and standard error of feature importance of 92 random forests by using leave-one-out cross-validation (LOOCV) were presented in the figure.
189-1	35263-35266	The	_	
189-2	35267-35271	mean	_	
189-3	35272-35275	and	_	
189-4	35276-35284	standard	_	
189-5	35285-35290	error	_	
189-6	35291-35293	of	_	
189-7	35294-35301	feature	_	
189-8	35302-35312	importance	_	
189-9	35313-35315	of	_	
189-10	35316-35318	92	_	
189-11	35319-35325	random	_	
189-12	35326-35333	forests	_	
189-13	35334-35336	by	_	
189-14	35337-35342	using	_	
189-15	35343-35356	leave-one-out	_	
189-16	35357-35373	cross-validation	_	
189-17	35374-35375	(	_	
189-18	35375-35380	LOOCV	_	
189-19	35380-35381	)	_	
189-20	35382-35386	were	_	
189-21	35387-35396	presented	_	
189-22	35397-35399	in	_	
189-23	35400-35403	the	_	
189-24	35404-35410	figure	_	
189-25	35410-35411	.	_	

#Text=Demographic and clinical profile of the participants in this study
#Text=\tAUD\tControl\tp\t \tNumber of Participants\t46\t46\t\t \tAge, years\t40.4 (±9.7)\t32.0 (±8.9)\tp<0.01\t \tSmokers (N/%)\t30 (65.2%)\t1 (2.2%)\t\t \tGender (N/%)\t\t\tp=0.13\t \t Male\t33 (71.7%)\t26 (56.5%)\t\t \t Female\t13 (28.3%)\t20 (43.5%)\t\t \tRace (N/%)\t\t\t\t \t Caucasian\t25 (54.3%)\t29 (63.0%)\t\t \t Africa-American\t19 (41.2%)\t13 (28.3%)\t\t \t Asian\t2 (4.3%)\t4 (8.7%)\t\t \tDays of withdrawal before MRI\t26.9 (±8.7)\tN/A\t\t \t
#Text=Performance of the random forest with no feature elimination, 50% feature elimination and 90% feature elimination (*two standard deviation above chance)
#Text=\t\tWithin-RSN\tBetween-RSN\t \tNo feature elimination\tAccuracy\t72.80%*\t54.30%\t \tPrecision\t76.90%*\t54.50%\t \t50% feature elimination\tAccuracy\t76.10%*\t64.10%*\t \tPrecision\t80.00%*\t64.40%*\t \t90% feature elimination\tAccuracy\t87.00%*\t67.40%*\t \tPrecision\t90.50%*\t70.00%*\t \t
#Text=Highlights
#Text=Diagnosis of alcohol use disorder using resting state functional connectivity
#Text=Quantify resting-state within-network and between-network connectivity features in a multivariate fashion
#Text=Offer new insights into the identification of potential biomarkers for the clinical diagnosis of AUD
190-1	35412-35423	Demographic	_	
190-2	35424-35427	and	_	
190-3	35428-35436	clinical	_	
190-4	35437-35444	profile	_	
190-5	35445-35447	of	_	
190-6	35448-35451	the	_	
190-7	35452-35464	participants	_	
190-8	35465-35467	in	_	
190-9	35468-35472	this	_	
190-10	35473-35478	study	_	
190-11	35480-35483	AUD	_	
190-12	35484-35491	Control	_	
190-13	35492-35493	p	_	
190-14	35496-35502	Number	_	
190-15	35503-35505	of	_	
190-16	35506-35518	Participants	_	
190-17	35519-35521	46	_	
190-18	35522-35524	46	_	
190-19	35528-35531	Age	_	
190-20	35531-35532	,	_	
190-21	35533-35538	years	_	
190-22	35539-35543	40.4	_	
190-23	35544-35545	(	_	
190-24	35545-35546	±	_	
190-25	35546-35549	9.7	_	
190-26	35549-35550	)	_	
190-27	35551-35555	32.0	_	
190-28	35556-35557	(	_	
190-29	35557-35558	±	_	
190-30	35558-35561	8.9	_	
190-31	35561-35562	)	_	
190-32	35563-35564	p	_	
190-33	35564-35565	<	_	
190-34	35565-35569	0.01	_	
190-35	35572-35579	Smokers	_	
190-36	35580-35581	(	_	
190-37	35581-35582	N	_	
190-38	35582-35583	/	_	
190-39	35583-35584	%	_	
190-40	35584-35585	)	_	
190-41	35586-35588	30	_	
190-42	35589-35590	(	_	
190-43	35590-35595	65.2%	_	
190-44	35595-35596	)	_	
190-45	35597-35598	1	_	
190-46	35599-35600	(	_	
190-47	35600-35604	2.2%	_	
190-48	35604-35605	)	_	
190-49	35609-35615	Gender	_	
190-50	35616-35617	(	_	
190-51	35617-35618	N	_	
190-52	35618-35619	/	_	
190-53	35619-35620	%	_	
190-54	35620-35621	)	_	
190-55	35624-35625	p	_	
190-56	35625-35626	=	_	
190-57	35626-35630	0.13	_	
190-58	35634-35638	Male	_	
190-59	35639-35641	33	_	
190-60	35642-35643	(	_	
190-61	35643-35648	71.7%	_	
190-62	35648-35649	)	_	
190-63	35650-35652	26	_	
190-64	35653-35654	(	_	
190-65	35654-35659	56.5%	_	
190-66	35659-35660	)	_	
190-67	35665-35671	Female	_	
190-68	35672-35674	13	_	
190-69	35675-35676	(	_	
190-70	35676-35681	28.3%	_	
190-71	35681-35682	)	_	
190-72	35683-35685	20	_	
190-73	35686-35687	(	_	
190-74	35687-35692	43.5%	_	
190-75	35692-35693	)	_	
190-76	35697-35701	Race	_	
190-77	35702-35703	(	_	
190-78	35703-35704	N	_	
190-79	35704-35705	/	_	
190-80	35705-35706	%	_	
190-81	35706-35707	)	_	
190-82	35714-35723	Caucasian	_	
190-83	35724-35726	25	_	
190-84	35727-35728	(	_	
190-85	35728-35733	54.3%	_	
190-86	35733-35734	)	_	
190-87	35735-35737	29	_	
190-88	35738-35739	(	_	
190-89	35739-35744	63.0%	_	
190-90	35744-35745	)	_	
190-91	35750-35765	Africa-American	_	
190-92	35766-35768	19	_	
190-93	35769-35770	(	_	
190-94	35770-35775	41.2%	_	
190-95	35775-35776	)	_	
190-96	35777-35779	13	_	
190-97	35780-35781	(	_	
190-98	35781-35786	28.3%	_	
190-99	35786-35787	)	_	
190-100	35792-35797	Asian	_	
190-101	35798-35799	2	_	
190-102	35800-35801	(	_	
190-103	35801-35805	4.3%	_	
190-104	35805-35806	)	_	
190-105	35807-35808	4	_	
190-106	35809-35810	(	_	
190-107	35810-35814	8.7%	_	
190-108	35814-35815	)	_	
190-109	35819-35823	Days	_	
190-110	35824-35826	of	_	
190-111	35827-35837	withdrawal	_	
190-112	35838-35844	before	_	
190-113	35845-35848	MRI	_	
190-114	35849-35853	26.9	_	
190-115	35854-35855	(	_	
190-116	35855-35856	±	_	
190-117	35856-35859	8.7	_	
190-118	35859-35860	)	_	
190-119	35861-35862	N	_	
190-120	35862-35863	/	_	
190-121	35863-35864	A	_	
190-122	35869-35880	Performance	_	
190-123	35881-35883	of	_	
190-124	35884-35887	the	_	
190-125	35888-35894	random	_	
190-126	35895-35901	forest	_	
190-127	35902-35906	with	_	
190-128	35907-35909	no	_	
190-129	35910-35917	feature	_	
190-130	35918-35929	elimination	_	
190-131	35929-35930	,	_	
190-132	35931-35934	50%	_	
190-133	35935-35942	feature	_	
190-134	35943-35954	elimination	_	
190-135	35955-35958	and	_	
190-136	35959-35962	90%	_	
190-137	35963-35970	feature	_	
190-138	35971-35982	elimination	_	
190-139	35983-35984	(	_	
190-140	35984-35985	*	_	
190-141	35985-35988	two	_	
190-142	35989-35997	standard	_	
190-143	35998-36007	deviation	_	
190-144	36008-36013	above	_	
190-145	36014-36020	chance	_	
190-146	36020-36021	)	_	
190-147	36024-36034	Within-RSN	_	
190-148	36035-36046	Between-RSN	_	
190-149	36049-36051	No	_	
190-150	36052-36059	feature	_	
190-151	36060-36071	elimination	_	
190-152	36072-36080	Accuracy	_	
190-153	36081-36087	72.80%	_	
190-154	36087-36088	*	_	
190-155	36089-36095	54.30%	_	
190-156	36098-36107	Precision	_	
190-157	36108-36114	76.90%	_	
190-158	36114-36115	*	_	
190-159	36116-36122	54.50%	_	
190-160	36125-36128	50%	_	
190-161	36129-36136	feature	_	
190-162	36137-36148	elimination	_	
190-163	36149-36157	Accuracy	_	
190-164	36158-36164	76.10%	_	
190-165	36164-36165	*	_	
190-166	36166-36172	64.10%	_	
190-167	36172-36173	*	_	
190-168	36176-36185	Precision	_	
190-169	36186-36192	80.00%	_	
190-170	36192-36193	*	_	
190-171	36194-36200	64.40%	_	
190-172	36200-36201	*	_	
190-173	36204-36207	90%	_	
190-174	36208-36215	feature	_	
190-175	36216-36227	elimination	_	
190-176	36228-36236	Accuracy	_	
190-177	36237-36243	87.00%	_	
190-178	36243-36244	*	_	
190-179	36245-36251	67.40%	_	
190-180	36251-36252	*	_	
190-181	36255-36264	Precision	_	
190-182	36265-36271	90.50%	_	
190-183	36271-36272	*	_	
190-184	36273-36279	70.00%	_	
190-185	36279-36280	*	_	
190-186	36284-36294	Highlights	_	
190-187	36295-36304	Diagnosis	_	
190-188	36305-36307	of	_	
190-189	36308-36315	alcohol	_	
190-190	36316-36319	use	_	
190-191	36320-36328	disorder	_	
190-192	36329-36334	using	_	
190-193	36335-36342	resting	_	
190-194	36343-36348	state	_	
190-195	36349-36359	functional	_	
190-196	36360-36372	connectivity	_	
190-197	36373-36381	Quantify	_	
190-198	36382-36395	resting-state	_	
190-199	36396-36410	within-network	_	
190-200	36411-36414	and	_	
190-201	36415-36430	between-network	_	
190-202	36431-36443	connectivity	_	
190-203	36444-36452	features	_	
190-204	36453-36455	in	_	
190-205	36456-36457	a	_	
190-206	36458-36470	multivariate	_	
190-207	36471-36478	fashion	_	
190-208	36479-36484	Offer	_	
190-209	36485-36488	new	_	
190-210	36489-36497	insights	_	
190-211	36498-36502	into	_	
190-212	36503-36506	the	_	
190-213	36507-36521	identification	_	
190-214	36522-36524	of	_	
190-215	36525-36534	potential	_	
190-216	36535-36545	biomarkers	_	
190-217	36546-36549	for	_	
190-218	36550-36553	the	_	
190-219	36554-36562	clinical	_	
190-220	36563-36572	diagnosis	_	
190-221	36573-36575	of	_	
190-222	36576-36579	AUD	_	
